data_1w4e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1w4e _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.424 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.94 0.4 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.402 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -168.32 155.42 7.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.401 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 5.5 mtm -61.53 150.69 80.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.8 -26.02 22.72 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -91.04 -27.89 18.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.088 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.413 ' CG1' HG13 ' A' ' 158' ' ' VAL . 95.5 t -68.67 -49.44 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.32 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -54.56 -29.4 51.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -77.74 -42.71 33.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.172 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.475 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -64.24 -48.13 76.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.41 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.16 -45.71 83.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 2.4 ttt180 -54.68 -31.82 58.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.386 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -84.58 -38.2 20.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.092 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -83.54 26.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.044 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.01 18.23 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.163 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.461 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 60.4 t -107.48 137.76 37.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.001 0.52 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.478 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t70 -116.17 127.56 54.9 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.3 mm -47.0 -26.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.592 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -62.7 -36.51 83.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.16 0.505 . . . . 0.0 110.585 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -87.67 -6.57 58.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.865 179.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.443 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.53 112.28 39.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.1 102.12 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.403 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -69.89 136.21 27.12 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.494 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.624 0.249 . . . . 0.0 111.092 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.23 128.81 9.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.165 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.18 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -111.85 30.15 7.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 93.05 18.59 39.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.741 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.424 ' HG3' HG21 ' A' ' 130' ' ' ILE . 34.7 ttm180 -72.35 141.15 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.311 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.413 HG13 ' CG1' ' A' ' 135' ' ' VAL . 25.6 t -76.11 130.56 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.26 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.7 mt -106.26 163.98 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.968 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -56.22 -32.63 64.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.695 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.68 -36.31 83.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.82 -48.98 72.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.774 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.475 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 40.3 mm -52.59 -53.24 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.755 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.1 -48.07 81.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.948 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.31 72.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.461 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 70.1 t90 -60.36 -57.02 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.384 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.417 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.5 mt -54.7 -32.21 59.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.045 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.981 0.42 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.401 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -169.26 150.34 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.194 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.6 mtp -57.5 157.71 12.87 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.713 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.78 -26.31 65.62 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.515 2.143 . . . . 0.0 112.178 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.03 -28.06 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.944 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.82 -51.38 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.442 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 51.5 mtt180 -54.63 -30.2 54.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -77.74 -41.37 37.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.232 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.487 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 49.1 t80 -65.33 -48.03 74.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.887 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.96 -46.08 79.4 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.55 -32.01 57.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.167 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.38 -38.14 20.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.622 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -83.79 26.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.807 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 22.78 21.01 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.921 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.455 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 62.1 t -108.62 137.85 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 122.971 0.508 . . . . 0.0 111.172 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.49 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 62.8 t0 -116.14 127.49 54.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 32.2 mm -47.09 -26.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.532 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -62.79 -36.22 82.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 110.581 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -87.96 -5.85 58.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.91 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.427 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.26 117.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.887 0.375 . . . . 0.0 111.507 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.69 103.03 9.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.501 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -82.72 144.84 23.33 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.909 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.29 26.1 9.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.702 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -81.01 94.85 1.6 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.947 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 60.31 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.605 0.24 . . . . 0.0 111.392 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 23.8 m-80 -97.88 27.23 4.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.2 26.08 34.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 131' ' ' ALA . 33.2 ttp85 -77.89 141.49 39.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.401 ' HA ' ' CA ' ' A' ' 151' ' ' GLY . 42.9 t -75.62 133.53 31.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.237 0.542 . . . . 0.0 111.617 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 17.7 mt -106.25 161.07 14.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.685 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -56.11 -32.26 64.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.684 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.15 -36.67 84.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.9 m-20 -64.01 -48.68 75.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.796 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.487 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 40.5 mm -52.67 -52.31 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.766 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -58.1 -47.41 83.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.94 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.47 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.455 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 68.0 t90 -60.93 -57.0 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.414 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.5 mt -54.96 -32.19 61.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.4 mt . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -162.48 155.86 20.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.367 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.6 mtm -69.61 154.94 94.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.732 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 -28.11 45.15 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.127 . . . . 0.0 112.351 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.3 p -91.04 -32.3 15.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 158' ' ' VAL . 72.2 t -68.07 -48.36 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.443 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 10.0 mtt180 -54.56 -29.27 50.64 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -77.65 -41.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.157 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.49 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 50.6 t80 -65.48 -48.12 73.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.425 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.23 -45.97 82.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -54.59 -31.85 57.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.306 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.49 -37.67 21.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -84.17 27.67 0.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.951 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.7 20.23 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.957 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.475 HG23 ' HG ' ' A' ' 167' ' ' LEU . 60.8 t -109.01 138.41 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.953 0.501 . . . . 0.0 111.184 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.473 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.1 t0 -116.13 127.1 54.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 39.1 mm -47.36 -25.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.599 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.455 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 17.5 ptt180 -63.16 -36.98 85.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.076 0.465 . . . . 0.0 110.444 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 1.1 mt -83.26 -10.45 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.48 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 162' ' ' ASP . 2.7 t -114.13 114.03 45.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.925 0.393 . . . . 0.0 111.429 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -77.92 99.17 5.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 141.9 26.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.588 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.21 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.641 0.258 . . . . 0.0 111.027 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.36 120.69 6.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.132 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.55 -86.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.467 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -113.97 36.93 3.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.773 0.321 . . . . 0.0 111.181 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.48 25.93 24.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.645 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -81.58 143.96 31.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.677 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 135' ' ' VAL . 43.8 t -80.58 133.36 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.9 mt -106.89 162.87 13.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.721 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -56.29 -32.63 64.78 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.698 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -64.13 -36.47 84.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.7 m-20 -65.36 -49.65 68.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.741 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.49 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 39.5 mm -52.59 -48.63 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.623 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -59.91 -48.01 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.49 -37.18 77.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.951 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.462 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 76.8 t90 -59.86 -56.99 14.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.475 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.5 mt -56.54 -31.85 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.958 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.249 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.04 0.448 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.409 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -169.51 152.4 4.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.106 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 159.98 7.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.96 -25.26 77.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.46 2.107 . . . . 0.0 112.199 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.03 -29.16 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.401 ' CG1' HG13 ' A' ' 158' ' ' VAL . 66.4 t -68.27 -47.91 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.334 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -54.65 -29.46 52.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -77.73 -43.07 32.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.48 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.4 t80 -64.03 -48.24 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.907 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.53 -45.4 83.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -31.87 59.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.177 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.57 -38.17 20.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -83.75 26.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.933 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.93 22.3 19.31 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.027 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.461 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 60.0 t -107.99 137.47 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.988 0.515 . . . . 0.0 111.151 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.471 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 19.4 t0 -116.14 127.42 54.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.3 mm -47.31 -25.74 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.681 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -62.8 -36.23 82.46 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.201 0.525 . . . . 0.0 110.429 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -87.97 -6.86 57.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.783 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.44 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.9 t -114.67 111.92 37.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.78 103.46 5.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.524 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.81 141.1 23.17 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.829 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.22 26.11 9.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 110.772 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -83.87 98.32 2.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.033 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.93 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.4 m-80 -100.41 33.2 2.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.25 26.04 60.43 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.611 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.409 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 8.7 ttp-105 -80.61 140.88 35.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.401 HG13 ' CG1' ' A' ' 135' ' ' VAL . 28.5 t -73.41 138.0 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 111.521 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.7 mt -111.93 161.5 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.697 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -32.69 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.791 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.29 -35.47 80.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 10.0 m-20 -65.4 -48.65 72.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.015 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.48 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 42.4 mm -52.68 -53.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.769 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -58.06 -46.22 85.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.28 77.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.461 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 70.1 t90 -60.01 -56.93 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.516 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.5 mt -54.78 -32.18 59.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.036 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 121.017 0.437 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.431 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -168.98 153.03 5.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.072 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.4 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -58.68 146.86 73.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.644 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.51 -25.03 13.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.575 2.183 . . . . 0.0 112.457 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.8 t -90.71 -34.13 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 158' ' ' VAL . 49.5 t -65.45 -43.5 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.293 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 78.1 mtm-85 -54.74 -30.41 56.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -77.65 -42.25 35.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.3 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.485 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.5 t80 -63.92 -48.09 77.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.922 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.411 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.7 -45.51 82.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.73 59.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.359 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -84.64 -38.58 19.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.212 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.405 ' HE3' ' CE1' ' A' ' 138' ' ' TYR . 19.8 mmtp -83.42 27.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.977 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.85 17.88 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.055 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.46 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 62.0 t -107.71 137.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 122.983 0.513 . . . . 0.0 111.046 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.498 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 18.8 t0 -116.08 126.7 54.11 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.2 mm -47.25 -25.63 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 111.594 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -36.85 84.51 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.187 0.517 . . . . 0.0 110.45 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -86.83 -6.96 58.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.875 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 162' ' ' ASP . 2.8 t -114.8 123.72 70.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 111.479 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.53 101.69 13.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.531 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.405 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -75.97 143.12 29.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.11 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 111.033 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.6 126.26 8.8 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.113 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.623 0.249 . . . . 0.0 111.468 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.03 36.99 3.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 90.95 15.67 55.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.431 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 46.0 ttm-85 -69.56 142.24 53.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 135' ' ' VAL . 46.6 t -78.97 132.26 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.262 0.553 . . . . 0.0 111.468 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.7 mt -107.21 163.48 12.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -55.86 -32.63 63.83 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.779 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.89 -36.57 84.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.12 -49.13 73.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.816 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.485 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 38.7 mm -52.62 -52.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.7 -42.96 84.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.05 78.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.98 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.467 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 65.8 t90 -61.01 -57.06 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.508 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.447 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.6 mt -56.02 -33.62 65.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.952 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.258 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.954 0.407 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.405 ' CA ' ' HG3' ' A' ' 157' ' ' ARG . . . -165.5 148.45 7.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.437 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 4.8 mmm -61.25 153.49 67.59 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.636 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.63 -25.81 76.59 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.548 2.166 . . . . 0.0 112.4 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.2 m -90.82 -32.56 16.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.094 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 86.0 t -65.98 -46.21 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.5 mtp85 -54.58 -27.95 42.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 0.0 109.995 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -77.73 -46.31 22.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.003 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.452 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 54.4 t80 -61.78 -48.0 82.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.734 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.4 -44.54 90.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -32.06 59.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.21 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.6 -39.8 18.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -81.98 25.52 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.2 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.01 21.68 18.01 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.464 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 59.9 t -105.79 136.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 122.906 0.483 . . . . 0.0 110.996 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.466 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t70 -116.11 127.03 54.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.8 mm -46.87 -25.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.643 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -62.6 -36.15 81.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.265 0.555 . . . . 0.0 110.526 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.466 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -88.75 -6.23 57.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.424 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.3 t -114.29 121.95 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.305 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -86.83 106.51 17.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.36 137.76 19.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.819 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.23 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.729 0.3 . . . . 0.0 111.03 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 131.88 10.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.081 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.21 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -113.89 30.27 7.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.89 17.34 38.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.669 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' CA ' ' A' ' 131' ' ' ALA . 24.7 ttm105 -73.79 138.96 44.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.708 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.402 HG13 ' CG1' ' A' ' 135' ' ' VAL . 23.2 t -74.61 135.82 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.171 0.51 . . . . 0.0 111.369 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.6 mt -108.51 163.98 12.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.03 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -33.61 67.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -36.69 84.61 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.3 m-20 -65.14 -47.42 77.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.679 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.452 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 42.7 mm -52.77 -52.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.686 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.05 -41.38 87.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.65 84.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.929 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.466 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 67.5 t90 -59.8 -57.07 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.425 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.9 mt -56.48 -32.27 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.86 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.263 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.032 0.444 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -165.2 149.91 9.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.061 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.95 149.08 97.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.816 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.98 -24.44 32.13 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.63 2.22 . . . . 0.0 112.204 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 77.5 p -91.0 -35.07 14.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.97 -46.13 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 67.0 mtm180 -54.64 -28.78 49.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.962 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -77.78 -44.24 28.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.469 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.3 t80 -63.25 -48.06 79.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.416 ' HB1' ' HB ' ' A' ' 144' ' ' VAL . . . -64.85 -45.38 86.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.98 58.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.297 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -84.71 -37.85 20.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.045 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -84.06 26.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.979 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.88 22.17 18.58 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.131 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.463 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 59.9 t -106.94 137.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.947 0.499 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.499 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t0 -116.07 127.71 55.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.6 mm -47.33 -26.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.687 0.28 . . . . 0.0 111.522 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -63.06 -36.42 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.14 0.495 . . . . 0.0 110.575 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -87.86 -5.28 58.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.959 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.429 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.81 123.54 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-O 120.948 0.404 . . . . 0.0 111.583 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.98 109.02 17.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.374 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.406 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -87.44 139.42 16.0 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.116 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.16 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.682 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -84.14 101.0 2.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.842 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.52 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.597 0.237 . . . . 0.0 111.54 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 153' ' ' GLY . 55.9 m-80 -96.33 29.17 2.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.707 0.289 . . . . 0.0 111.205 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.06 25.98 50.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.768 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -80.87 140.47 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.783 0.325 . . . . 0.0 110.679 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.406 ' HA ' ' CA ' ' A' ' 151' ' ' GLY . 22.0 t -74.64 134.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.177 0.513 . . . . 0.0 111.344 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.8 mt -106.74 163.01 13.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.15 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -56.24 -33.39 65.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -36.67 84.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.2 m-20 -64.79 -47.51 77.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.901 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.469 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 44.5 mm -52.81 -52.78 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.888 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.98 -45.57 86.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.16 78.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.463 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 69.7 t90 -59.7 -57.03 14.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.13 0.491 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.416 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.5 mt -54.41 -32.28 56.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.996 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.433 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.108 0.48 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 152.67 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.294 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.461 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 35.2 mmm -60.89 159.12 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.686 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.72 -27.07 60.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.227 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.6 m -90.97 -32.52 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 67.7 t -64.92 -46.52 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -54.7 -27.84 43.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -77.78 -43.72 29.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.0 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.461 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.6 t80 -63.54 -48.11 78.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.772 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . . . -65.18 -45.22 85.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -31.84 58.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.197 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.65 -38.6 19.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.086 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -83.07 27.66 0.55 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.043 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.86 22.34 18.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.093 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.469 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 58.3 t -108.96 137.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 122.961 0.504 . . . . 0.0 111.252 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t0 -116.1 127.74 55.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.7 mm -47.1 -26.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.452 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 19.2 ptt85 -64.07 -34.94 79.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 110.639 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 1.0 OUTLIER -85.87 -8.36 58.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.7 t -114.63 121.59 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.942 0.401 . . . . 0.0 111.545 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.58 104.96 15.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.406 ' HA2' ' N ' ' A' ' 158' ' ' VAL . . . -82.07 141.52 21.63 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.01 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 26.1 9.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.761 0.315 . . . . 0.0 110.829 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.05 119.0 5.53 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.58 -82.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -114.08 37.09 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.813 0.34 . . . . 0.0 111.201 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.96 26.0 27.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.569 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.433 ' HG3' HG21 ' A' ' 130' ' ' ILE . 3.2 ttt180 -81.16 138.94 35.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.786 0.327 . . . . 0.0 110.767 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.406 ' N ' ' HA2' ' A' ' 151' ' ' GLY . 13.1 t -77.48 134.54 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 111.341 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -107.17 165.23 11.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.258 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -57.85 -33.97 69.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -36.09 82.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.2 m-20 -65.71 -47.69 74.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.767 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.461 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 45.3 mm -52.9 -52.76 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.839 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.24 -44.81 88.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.42 86.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.054 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.469 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 77.6 t90 -57.92 -57.01 14.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.514 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.5 mt -54.95 -33.14 62.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.975 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.975 0.416 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -170.02 152.54 4.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.098 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.41 160.02 7.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.5 -25.81 80.1 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.235 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.7 t -91.06 -29.2 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG1' HG13 ' A' ' 158' ' ' VAL . 66.0 t -68.02 -48.44 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 5.3 mtp180 -54.62 -29.13 51.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.912 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.64 -41.81 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.237 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.496 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 45.6 t80 -65.16 -48.13 74.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.98 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.77 -46.08 80.08 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.6 -31.81 57.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.362 178.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -84.42 -38.43 20.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.256 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.607 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -83.31 21.91 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.876 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.16 17.77 46.44 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.985 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.465 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 58.7 t -103.94 137.25 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.094 0.558 . . . . 0.0 110.851 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.446 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t0 -116.08 127.43 54.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.0 mm -46.13 -26.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.812 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.479 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.1 OUTLIER -64.07 -37.33 87.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -82.98 -8.89 59.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.414 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -114.49 115.15 48.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.863 0.363 . . . . 0.0 111.499 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.5 109.97 6.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.668 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.43 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -71.89 130.99 17.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.676 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 26.19 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.708 0.289 . . . . 0.0 110.935 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -103.38 121.61 7.16 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.325 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.36 -84.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.3 m-80 -109.19 35.72 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.045 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 84.63 26.04 40.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.424 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 31.2 ttm180 -80.97 147.0 30.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.727 0.299 . . . . 0.0 110.831 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.415 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 37.1 t -81.16 132.05 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.267 0.556 . . . . 0.0 111.331 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.0 mt -108.99 165.07 11.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.956 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.419 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 3.3 tptt -55.92 -32.08 63.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -64.65 -37.97 89.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -62.64 -49.74 73.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.61 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.496 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 35.4 mm -52.69 -52.26 28.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.582 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.47 -45.34 94.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.13 81.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 70.9 t90 -58.3 -57.09 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.306 0.574 . . . . 0.0 110.21 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' A' ' 144' ' ' VAL . 9.1 mt -61.07 -31.9 71.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.865 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.029 0.443 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -167.53 148.07 5.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.043 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.1 mtm -63.02 148.72 92.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.751 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -51.49 -26.46 21.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.541 2.161 . . . . 0.0 112.402 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.2 t -90.3 -29.09 18.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.73 -48.25 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.381 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 7.0 mtt85 -54.65 -29.21 51.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.965 0.412 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.63 -44.32 28.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.191 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.3 t80 -63.63 -48.01 79.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.921 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.403 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . . . -65.24 -45.79 83.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.7 -31.82 58.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.299 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -84.4 -38.75 19.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.32 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -84.3 28.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.917 -179.142 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 21.64 17.55 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.234 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.46 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 56.8 t -106.95 136.69 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 122.852 0.461 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.489 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 32.2 t0 -116.16 126.83 54.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.2 mm -46.55 -25.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.754 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.77 84.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.209 0.528 . . . . 0.0 110.585 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -87.26 -5.91 58.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.924 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.409 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.7 t -114.77 126.1 72.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.961 0.41 . . . . 0.0 111.397 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.87 105.7 17.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.71 23.21 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.707 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.1 26.04 9.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.9 140.44 14.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 51.49 -90.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.215 . . . . 0.0 111.4 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -114.16 25.7 10.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.34 10.72 30.96 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.824 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -65.66 139.99 58.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 0.0 110.72 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.11 132.83 31.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.445 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.0 mt -104.4 165.09 11.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.208 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -34.16 67.91 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.63 84.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.3 m-20 -64.75 -47.47 78.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.777 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.467 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 42.9 mm -52.89 -52.51 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.725 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -58.44 -41.66 85.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.04 85.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.461 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 67.1 t90 -59.85 -57.04 14.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.417 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.425 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.5 mt -54.65 -32.44 59.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.983 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.237 -179.949 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.064 0.459 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.41 146.28 3.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.82 160.03 8.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.11 -25.23 65.78 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.563 2.175 . . . . 0.0 112.319 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.02 -31.5 16.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.3 -46.58 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.25 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 4.6 mtp180 -54.71 -29.12 52.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.73 -43.98 29.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.194 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.487 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 47.7 t80 -63.95 -47.99 78.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.929 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.405 ' HB3' ' CD1' ' A' ' 163' ' ' ILE . . . -65.5 -46.94 77.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.79 58.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.235 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.28 -38.14 20.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.312 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.596 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -83.35 19.07 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.766 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.36 14.89 55.84 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.039 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.466 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 61.8 t -100.11 138.29 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 122.98 0.512 . . . . 0.0 110.769 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.499 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 11.2 t70 -116.08 127.99 55.31 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.8 mm -47.52 -26.13 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.531 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 -62.96 -36.2 82.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 110.575 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -88.12 -6.05 58.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.91 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.437 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.11 122.33 68.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.393 . . . . 0.0 111.365 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -85.66 115.32 23.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.69 136.7 16.94 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.2 26.01 9.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 111.025 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.6 145.5 17.75 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.859 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 48.97 -93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.194 0.198 . . . . 0.0 111.389 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -114.08 29.38 8.05 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.91 18.37 25.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -74.15 137.63 43.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.753 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.0 t -74.23 135.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.133 0.492 . . . . 0.0 111.217 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.9 mt -108.31 166.76 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -58.23 -33.7 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.93 -35.25 80.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.7 m-20 -66.28 -47.45 73.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.784 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.487 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 43.3 mm -52.8 -52.46 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.577 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.71 -44.82 90.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.47 80.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.976 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.466 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 67.4 t90 -58.4 -56.99 14.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.579 . . . . 0.0 110.357 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.439 ' HG ' HG23 ' A' ' 144' ' ' VAL . 11.2 mt -59.99 -27.42 66.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.094 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.257 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.415 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -166.06 148.35 7.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.229 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.62 150.12 37.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.61 -26.94 13.68 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.607 2.204 . . . . 0.0 112.382 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.98 -29.4 17.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 158' ' ' VAL . 87.0 t -68.93 -51.47 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.421 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.1 OUTLIER -54.53 -29.62 51.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.884 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -77.66 -41.62 37.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.157 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.499 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.0 t80 -65.29 -48.17 74.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.995 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.45 -46.6 79.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -54.65 -31.67 57.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.489 178.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -84.41 -38.36 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.067 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -83.95 22.62 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.05 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.48 16.46 36.29 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.293 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.466 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 61.3 t -101.23 137.89 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.962 0.505 . . . . 0.0 110.707 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.5 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 34.6 t0 -116.03 127.51 54.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 36.8 mm -47.2 -26.17 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -62.82 -37.0 85.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.171 0.51 . . . . 0.0 110.521 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -86.85 -6.63 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.846 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 166' ' ' TRP . 2.5 t -115.78 119.84 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.925 0.393 . . . . 0.0 111.527 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.63 101.82 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.547 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -79.39 145.45 27.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.864 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.32 25.96 9.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.744 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -86.93 110.1 3.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.076 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.27 -82.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.614 0.245 . . . . 0.0 111.491 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.0 m-80 -104.2 29.16 6.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 111.007 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.94 26.04 23.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.415 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 13.1 ttp-105 -75.78 139.52 41.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.43 ' CG1' HD12 ' A' ' 163' ' ' ILE . 47.4 t -74.21 131.99 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.29 0.567 . . . . 0.0 111.468 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -106.29 163.47 12.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.751 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -55.7 -31.82 62.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.603 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.2 -38.0 89.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.262 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -61.72 -49.9 74.6 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.729 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.499 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 33.6 mm -52.68 -54.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.789 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -56.68 -48.01 78.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.065 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.38 74.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.023 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.466 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 63.8 t90 -59.32 -57.01 14.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.198 0.523 . . . . 0.0 110.324 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.448 ' HG ' HG23 ' A' ' 144' ' ' VAL . 11.4 mt -60.46 -21.71 62.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.232 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.142 179.963 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.039 0.447 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.4 ' CA ' ' HG3' ' A' ' 157' ' ' ARG . . . -165.54 154.58 12.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.089 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.7 mtp -71.37 149.85 93.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.757 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -51.41 -31.64 39.21 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.53 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 p -85.18 -29.81 24.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.8 -46.86 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.531 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.9 mtp180 -54.77 -29.91 55.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.979 0.419 . . . . 0.0 109.946 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -77.77 -44.85 26.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.139 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.473 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.7 t80 -62.59 -48.21 80.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.415 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -64.92 -45.35 86.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.62 -31.98 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.372 178.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.67 -38.08 20.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.173 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HE3' ' CE1' ' A' ' 138' ' ' TYR . 20.3 mmtp -84.18 26.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.909 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 21.48 16.66 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.181 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.459 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 60.8 t -106.17 137.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 122.926 0.491 . . . . 0.0 110.986 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 59.3 t0 -116.09 127.38 54.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.4 mm -47.01 -26.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.668 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -35.87 81.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.202 0.525 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -88.28 -5.75 58.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.925 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.432 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.78 117.7 56.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 111.379 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.34 112.83 12.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.676 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -81.22 131.8 10.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.744 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 26.09 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.613 0.244 . . . . 0.0 110.93 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -102.61 124.69 8.26 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.461 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.46 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.0 p30 -113.13 30.62 7.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 91.64 26.03 21.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.56 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' CA ' ' A' ' 131' ' ' ALA . 43.5 ttm-85 -81.51 143.83 31.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.802 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.427 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 24.6 t -79.44 132.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.129 0.49 . . . . 0.0 111.322 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.3 mt -105.22 163.98 12.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.083 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.37 -33.22 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.25 -36.2 83.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -65.16 -47.26 77.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.473 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 44.4 mm -52.81 -51.67 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.782 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -58.86 -45.4 90.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.865 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.78 75.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.464 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 64.7 t90 -60.79 -57.05 14.31 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.142 0.496 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.409 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.7 mt -55.69 -33.4 64.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.957 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.198 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.413 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 121.085 0.469 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -166.26 147.42 6.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.082 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.89 148.49 91.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.32 -26.47 27.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 p -89.34 -34.94 16.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 158' ' ' VAL . 99.3 t -66.02 -46.76 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 8.9 mtp-105 -54.71 -29.16 52.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.88 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -77.65 -42.99 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.301 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.497 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.8 t80 -64.52 -48.18 76.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.886 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 144' ' ' VAL . . . -64.95 -46.39 81.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.68 -31.76 58.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.413 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -84.46 -37.68 21.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.075 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.419 ' O ' HD23 ' A' ' 167' ' ' LEU . 47.9 mmtt -84.64 22.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.832 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.72 16.62 31.3 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.317 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.464 HG23 ' HG ' ' A' ' 167' ' ' LEU . 61.4 t -101.1 137.73 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 122.761 0.424 . . . . 0.0 110.652 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.6 t0 -116.08 127.25 54.71 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 32.7 mm -46.85 -26.38 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.507 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.87 -37.44 86.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 110.527 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -86.51 -6.73 58.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.851 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.7 126.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.954 0.406 . . . . 0.0 111.546 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -91.92 103.96 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.509 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.49 143.79 29.72 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.814 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.307 . . . . 0.0 110.864 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.37 140.82 15.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.731 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.98 -91.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.541 0.21 . . . . 0.0 111.385 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.13 26.21 10.48 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.743 0.306 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.2 6.83 33.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.818 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HG3' HG21 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -60.93 139.75 57.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 135' ' ' VAL . 25.2 t -79.76 131.93 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -104.43 167.16 9.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.306 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HG3' ' CD2' ' A' ' 138' ' ' TYR . 1.3 ttmt -57.54 -35.7 70.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.44 -35.5 79.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.212 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -66.61 -47.94 71.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.497 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 43.2 mm -52.92 -53.58 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.41 -39.86 80.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.32 86.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.462 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 69.1 t90 -57.64 -57.03 14.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.294 0.569 . . . . 0.0 110.274 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 144' ' ' VAL . 11.1 mt -59.23 -30.91 68.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.976 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.404 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.7 mp . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.058 0.456 . . . . 0.0 110.711 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.25 155.47 5.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.244 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.403 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 1.6 mtp -61.65 157.0 51.06 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.397 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.99 -25.43 77.62 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.483 2.122 . . . . 0.0 112.248 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -29.43 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.285 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.447 HG13 HG13 ' A' ' 158' ' ' VAL . 45.6 t -69.3 -46.91 76.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.773 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 8.1 mtp180 -54.56 -30.72 54.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -77.62 -40.97 40.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.281 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.489 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 50.5 t80 -64.66 -48.15 75.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.883 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.7 -45.5 82.53 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.8 58.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.465 178.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.73 -38.33 19.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -83.32 27.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.77 17.7 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.075 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.461 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 58.8 t -107.94 137.14 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 122.935 0.494 . . . . 0.0 111.134 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.492 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.4 t0 -116.07 126.52 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.5 mm -46.95 -25.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.606 -179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.56 -37.56 86.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.0 110.439 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.6 OUTLIER -85.68 -7.87 58.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.795 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -115.04 115.71 50.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.414 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 108.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.636 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.66 134.78 24.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.803 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.21 26.0 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 110.801 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -89.7 101.17 2.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.863 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt 57.36 -84.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.605 0.24 . . . . 0.0 111.33 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.13 9.58 25.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.49 26.01 7.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.691 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.404 ' HG3' HG21 ' A' ' 130' ' ' ILE . 28.8 ttm180 -79.04 145.46 33.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.868 0.366 . . . . 0.0 110.796 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.447 HG13 HG13 ' A' ' 135' ' ' VAL . 17.3 t -80.14 126.48 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.222 0.534 . . . . 0.0 111.227 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.3 mt -105.11 164.66 11.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.185 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -56.05 -33.03 64.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.8 -37.2 86.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.9 m-20 -63.2 -48.91 76.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.759 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.489 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 39.8 mm -52.71 -53.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.715 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.61 -41.91 82.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.78 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.25 83.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.461 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 70.4 t90 -60.12 -56.96 15.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.334 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.446 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.3 mt -54.83 -32.77 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.046 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -179.936 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.415 HG21 ' HG3' ' A' ' 157' ' ' ARG . 3.3 mp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.092 0.472 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.403 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.08 147.73 3.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.994 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.3 mtp -59.13 159.96 13.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.681 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.64 -25.52 69.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.499 2.132 . . . . 0.0 112.348 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.3 t -90.97 -33.3 15.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.14 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 158' ' ' VAL . 46.4 t -66.32 -44.68 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.361 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 61.3 mtp85 -54.76 -29.95 55.3 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -77.66 -42.43 34.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.156 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.481 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 50.6 t80 -64.21 -47.96 77.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.976 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.0 -45.68 80.71 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.88 58.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.26 178.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.62 -38.73 19.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -82.99 27.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.85 -178.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.44 19.94 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.913 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.464 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 57.6 t -108.39 138.01 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 0.0 110.997 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.504 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t70 -116.16 127.02 54.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.406 HG22 ' HB ' ' A' ' 158' ' ' VAL . 38.0 mm -46.65 -26.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.667 0.27 . . . . 0.0 111.626 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 mtt85 -63.03 -37.09 85.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.26 0.553 . . . . 0.0 110.64 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -86.9 -5.32 59.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.958 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.42 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.49 118.97 60.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.872 0.367 . . . . 0.0 111.496 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.51 116.31 17.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -82.05 131.65 10.55 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.048 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 25.96 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.663 0.268 . . . . 0.0 110.732 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.12 118.63 6.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.074 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.68 -87.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.631 0.253 . . . . 0.0 111.52 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -99.07 28.14 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.726 0.298 . . . . 0.0 111.04 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.17 26.13 34.86 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.737 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.415 ' HG3' HG21 ' A' ' 130' ' ' ILE . 22.4 ttm180 -78.88 143.55 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.741 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.442 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 18.0 t -77.79 129.93 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.234 0.54 . . . . 0.0 111.334 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.5 mt -105.44 166.47 10.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.361 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -57.65 -33.69 68.57 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.18 -35.86 82.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -65.67 -47.58 75.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.823 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.481 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 42.0 mm -52.88 -52.27 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.799 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -57.77 -46.3 84.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.83 72.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.018 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.464 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 62.9 t90 -61.55 -57.13 13.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.377 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.419 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.6 mt -56.44 -34.67 67.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.945 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.407 HG21 ' HG3' ' A' ' 157' ' ' ARG . 3.3 mt . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.878 0.371 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.407 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -165.94 149.9 7.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.261 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.6 mtt -59.9 148.78 75.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.69 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -50.96 -25.22 15.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.474 2.116 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.2 p -90.97 -34.73 15.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.053 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.438 HG13 HG13 ' A' ' 158' ' ' VAL . 54.8 t -65.19 -44.91 95.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.322 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.3 mtp85 -54.67 -30.1 54.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.82 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.71 -41.32 38.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.266 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.495 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 50.2 t80 -65.09 -48.06 75.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.927 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.424 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.73 -46.12 80.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -31.7 58.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.346 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -84.61 -38.76 19.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.279 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -84.16 28.17 0.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.988 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 21.22 16.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.223 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' A' ' 167' ' ' LEU . 52.9 t -106.83 137.1 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 122.975 0.51 . . . . 0.0 110.969 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 24.6 t0 -116.03 126.18 53.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 28.1 mm -46.59 -25.51 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -62.98 -37.07 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.226 0.536 . . . . 0.0 110.465 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -86.73 -5.8 59.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.874 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 166' ' ' TRP . 2.6 t -114.8 124.5 71.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.934 0.397 . . . . 0.0 111.296 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.33 103.64 15.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.51 140.42 21.13 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.847 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.282 . . . . 0.0 110.925 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.61 120.03 6.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.087 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt 57.73 -86.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.549 0.214 . . . . 0.0 111.469 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.65 37.04 2.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 26.09 32.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.635 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.407 ' HG3' HG21 ' A' ' 130' ' ' ILE . 29.0 ttm180 -80.45 142.37 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.438 HG13 HG13 ' A' ' 135' ' ' VAL . 43.5 t -76.97 132.65 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.567 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.5 mt -106.96 163.53 12.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.739 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.405 ' HE2' ' CE1' ' A' ' 138' ' ' TYR . 9.1 tttm -56.18 -32.13 64.06 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.744 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.83 85.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.5 m-20 -64.43 -49.21 72.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.882 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.495 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 40.1 mm -52.53 -51.78 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.88 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -58.46 -47.15 84.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.997 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.6 -34.91 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.465 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 63.4 t90 -61.71 -57.12 13.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 0.0 110.491 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HG ' HG23 ' A' ' 144' ' ' VAL . 2.5 mt -55.61 -23.91 30.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.263 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.608 -179.806 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.522 -0.135 0 CA-C-O 120.958 0.409 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -162.83 154.65 18.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.413 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.4 mtp -65.82 160.02 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.88 -26.42 82.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.51 2.14 . . . . 0.0 112.186 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -91.04 -31.92 16.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 158' ' ' VAL . 45.2 t -70.17 -46.63 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.414 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.8 mtt180 -54.56 -31.94 57.49 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -77.7 -39.94 43.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.462 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 44.8 t80 -65.89 -48.17 72.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.052 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.413 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -66.32 -46.29 77.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 7.1 tpp85 -54.6 -31.79 57.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.318 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.49 -38.44 20.1 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.414 ' O ' HD23 ' A' ' 167' ' ' LEU . 17.4 mmtp -84.25 27.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.92 19.38 14.52 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.307 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.464 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 60.9 t -104.99 136.71 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 122.954 0.502 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 14.7 t0 -116.04 126.54 53.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.402 HG21 ' CG2' ' A' ' 158' ' ' VAL . 34.6 mm -45.44 -26.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.41 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -64.94 -35.31 80.75 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.565 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.446 HD11 ' CZ2' ' A' ' 166' ' ' TRP . 0.9 OUTLIER -84.53 -8.17 59.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 178.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.435 HG23 ' CG ' ' A' ' 166' ' ' TRP . 2.2 t -114.83 120.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.503 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -81.94 105.55 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.88 141.42 20.91 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.99 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.02 9.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.777 0.323 . . . . 0.0 110.779 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -89.22 111.41 3.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.847 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt 54.84 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.523 0.201 . . . . 0.0 111.483 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 67.6 m-80 -100.39 36.97 1.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 111.066 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.79 25.98 59.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.568 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -78.17 141.71 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.852 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.427 ' CG1' HD12 ' A' ' 163' ' ' ILE . 42.0 t -75.25 133.06 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 0.0 111.332 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.0 mt -107.24 164.51 12.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.856 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.416 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -55.8 -32.1 63.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.01 -37.65 88.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.6 m-20 -62.62 -49.91 73.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.517 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 32.5 mm -52.79 -53.2 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.598 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.43 -47.94 82.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.808 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.17 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.464 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 65.2 t90 -59.81 -56.68 18.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.242 0.544 . . . . 0.0 110.239 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.44 ' HG ' HG23 ' A' ' 144' ' ' VAL . 9.3 mt -62.32 -31.04 71.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.953 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.017 0.437 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.51 144.01 2.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.088 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.2 mtp -58.95 147.65 72.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.24 -25.91 25.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.49 2.126 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.1 p -87.78 -36.75 17.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 158' ' ' VAL . 48.0 t -67.07 -45.68 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.34 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 59.6 mtm180 -54.74 -29.96 55.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -41.16 38.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.201 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.493 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.8 t80 -65.19 -48.16 74.42 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.836 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 144' ' ' VAL . . . -65.46 -46.29 80.43 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 4.2 tpt85 -54.63 -31.63 57.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.29 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.47 -38.09 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.425 ' O ' HD22 ' A' ' 167' ' ' LEU . 19.2 mmtp -84.09 22.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.937 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.53 35.32 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.224 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.467 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 61.7 t -101.31 137.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 123.041 0.536 . . . . 0.0 110.606 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.489 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.7 t0 -116.04 126.02 53.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 146' ' ' ILE . 33.7 mm -45.69 -26.37 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.803 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -62.94 -37.31 86.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.277 0.56 . . . . 0.0 110.58 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -86.16 -6.01 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.884 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -114.4 123.47 70.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.332 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -86.13 106.34 17.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.534 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.39 136.86 19.43 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.826 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 26.05 9.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.065 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.34 137.96 13.86 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.967 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.1 -90.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.594 0.235 . . . . 0.0 111.472 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -114.05 28.56 8.66 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.93 35.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.683 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -69.87 140.32 53.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.662 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 135' ' ' VAL . 15.0 t -77.35 131.38 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.2 mt -104.54 167.77 9.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.468 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.93 70.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.58 -34.62 78.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.267 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -67.04 -47.29 71.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.756 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.493 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 43.6 mm -52.87 -52.52 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.622 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.48 -44.46 89.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.88 74.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.467 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 56.5 t90 -61.22 -56.26 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.425 HD22 ' O ' ' A' ' 142' ' ' LYS . 4.6 mt -60.75 -34.38 74.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.849 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.274 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.976 0.417 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.33 154.7 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.24 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.9 mtp -60.41 155.12 50.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.26 -27.39 56.8 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.656 2.237 . . . . 0.0 112.525 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -91.03 -27.29 18.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.403 ' CG1' HG13 ' A' ' 158' ' ' VAL . 57.6 t -69.89 -47.47 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -54.65 -30.25 54.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.59 33.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.481 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 50.2 t80 -64.42 -48.2 76.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.006 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.415 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.64 -45.98 80.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -54.7 -31.77 58.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.335 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.63 -38.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -83.29 27.78 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.048 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.02 18.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.057 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.453 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 53.3 t -108.12 136.61 43.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 122.921 0.489 . . . . 0.0 110.964 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.451 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 30.5 t0 -116.18 126.49 53.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.7 mm -45.93 -26.18 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.803 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -62.39 -36.49 82.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.267 0.556 . . . . 0.0 110.524 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.46 HD13 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.84 -6.8 57.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.834 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 166' ' ' TRP . 2.4 t -113.67 114.73 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.04 100.45 7.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.526 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.23 141.99 27.69 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.68 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.28 26.08 9.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 110.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.99 118.68 5.56 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.325 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.73 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -114.15 28.75 8.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.85 22.13 21.61 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.62 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.416 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 39.3 ttm180 -76.5 140.99 41.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 110.573 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.403 HG13 ' CG1' ' A' ' 135' ' ' VAL . 40.6 t -74.02 137.99 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.375 0.607 . . . . 0.0 111.539 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.6 mt -113.66 163.08 15.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.638 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.75 -32.52 63.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.809 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -64.28 -36.37 83.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.4 m-20 -64.39 -49.33 72.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.859 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.481 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 35.5 mm -52.68 -54.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.003 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.16 -47.14 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.983 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.72 -35.74 75.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.149 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.46 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 63.8 t90 -60.99 -57.0 14.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.584 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.419 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.5 mt -55.18 -32.27 62.05 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.194 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.807 0.337 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.12 -28.83 8.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 173.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 73.2 t -94.06 136.41 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.179 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.424 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.6 mp -129.98 111.97 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.596 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.402 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -168.32 155.42 7.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.401 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 5.5 mtm -61.53 150.69 80.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.8 -26.02 22.72 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -91.04 -27.89 18.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.088 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.413 ' CG1' HG13 ' A' ' 158' ' ' VAL . 95.5 t -68.67 -49.44 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.32 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -54.56 -29.4 51.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -77.74 -42.71 33.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.172 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.475 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.4 t80 -64.24 -48.13 76.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.41 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.16 -45.71 83.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 2.4 ttt180 -54.68 -31.82 58.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.386 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -84.58 -38.2 20.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.092 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -83.54 26.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.044 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.01 18.23 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.163 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.461 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 60.4 t -107.48 137.76 37.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.001 0.52 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.478 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t70 -116.17 127.56 54.9 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.444 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 33.3 mm -47.0 -26.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.592 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -62.7 -36.51 83.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.16 0.505 . . . . 0.0 110.585 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -87.67 -6.57 58.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.865 179.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.443 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.53 112.28 39.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.1 102.12 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.403 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -69.89 136.21 27.12 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.494 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.624 0.249 . . . . 0.0 111.092 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.23 128.81 9.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.165 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.18 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -111.85 30.15 7.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 93.05 18.59 39.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.741 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.424 ' HG3' HG21 ' A' ' 130' ' ' ILE . 34.7 ttm180 -72.35 141.15 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.311 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.413 HG13 ' CG1' ' A' ' 135' ' ' VAL . 25.6 t -76.11 130.56 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.26 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.7 mt -106.26 163.98 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.968 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -56.22 -32.63 64.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.695 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.68 -36.31 83.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.82 -48.98 72.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.774 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.475 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 40.3 mm -52.59 -53.24 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.755 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.1 -48.07 81.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.948 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.31 72.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.461 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 70.1 t90 -60.36 -57.02 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.384 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.417 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.5 mt -54.7 -32.21 59.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.045 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.97 -25.06 64.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.28 -32.45 7.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.504 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.414 -1.215 . . . . 0.0 112.479 179.948 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.848 0.356 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -91.73 151.06 20.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.6 mtp-105 -97.98 -33.19 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.993 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.463 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 74.2 t -94.41 141.38 15.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.05 112.72 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.401 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -169.26 150.34 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.194 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.6 mtp -57.5 157.71 12.87 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.713 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.78 -26.31 65.62 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.515 2.143 . . . . 0.0 112.178 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.03 -28.06 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.944 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.82 -51.38 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.442 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 51.5 mtt180 -54.63 -30.2 54.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -77.74 -41.37 37.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.232 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.487 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 49.1 t80 -65.33 -48.03 74.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.887 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.96 -46.08 79.4 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.55 -32.01 57.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.167 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.38 -38.14 20.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.622 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -83.79 26.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.807 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 22.78 21.01 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.921 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.455 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 62.1 t -108.62 137.85 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 122.971 0.508 . . . . 0.0 111.172 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.49 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 62.8 t0 -116.14 127.49 54.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 32.2 mm -47.09 -26.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.532 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -62.79 -36.22 82.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 110.581 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -87.96 -5.85 58.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.91 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.427 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.26 117.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.887 0.375 . . . . 0.0 111.507 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.69 103.03 9.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.501 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -82.72 144.84 23.33 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.909 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.29 26.1 9.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.702 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -81.01 94.85 1.6 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.947 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 60.31 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.605 0.24 . . . . 0.0 111.392 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 23.8 m-80 -97.88 27.23 4.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.2 26.08 34.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 131' ' ' ALA . 33.2 ttp85 -77.89 141.49 39.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.401 ' HA ' ' CA ' ' A' ' 151' ' ' GLY . 42.9 t -75.62 133.53 31.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.237 0.542 . . . . 0.0 111.617 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 17.7 mt -106.25 161.07 14.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.685 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -56.11 -32.26 64.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.684 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.15 -36.67 84.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.9 m-20 -64.01 -48.68 75.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.796 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.487 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 40.5 mm -52.67 -52.31 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.766 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -58.1 -47.41 83.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.94 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.47 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.455 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 68.0 t90 -60.93 -57.0 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.414 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.5 mt -54.96 -32.19 61.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.64 -24.97 56.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.27 -43.02 1.77 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.449 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.498 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.907 0.384 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -138.59 79.03 1.71 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 -66.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 35.9 t -132.64 134.64 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 41.4 mt -130.03 115.7 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.501 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -162.48 155.86 20.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.367 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.6 mtm -69.61 154.94 94.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.732 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 -28.11 45.15 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.127 . . . . 0.0 112.351 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.3 p -91.04 -32.3 15.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 158' ' ' VAL . 72.2 t -68.07 -48.36 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.443 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 10.0 mtt180 -54.56 -29.27 50.64 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -77.65 -41.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.157 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.49 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 50.6 t80 -65.48 -48.12 73.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.425 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.23 -45.97 82.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -54.59 -31.85 57.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.306 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.49 -37.67 21.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -84.17 27.67 0.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.951 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.7 20.23 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.957 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.475 HG23 ' HG ' ' A' ' 167' ' ' LEU . 60.8 t -109.01 138.41 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.953 0.501 . . . . 0.0 111.184 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.473 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.1 t0 -116.13 127.1 54.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.454 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 39.1 mm -47.36 -25.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.599 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.455 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 17.5 ptt180 -63.16 -36.98 85.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.076 0.465 . . . . 0.0 110.444 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 1.1 mt -83.26 -10.45 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.48 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 162' ' ' ASP . 2.7 t -114.13 114.03 45.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.925 0.393 . . . . 0.0 111.429 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -77.92 99.17 5.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 141.9 26.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.588 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.21 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.641 0.258 . . . . 0.0 111.027 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.36 120.69 6.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.132 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.55 -86.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.467 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -113.97 36.93 3.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.773 0.321 . . . . 0.0 111.181 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.48 25.93 24.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.645 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -81.58 143.96 31.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.677 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 135' ' ' VAL . 43.8 t -80.58 133.36 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.9 mt -106.89 162.87 13.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.721 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -56.29 -32.63 64.78 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.698 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -64.13 -36.47 84.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.7 m-20 -65.36 -49.65 68.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.741 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.49 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 39.5 mm -52.59 -48.63 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.623 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -59.91 -48.01 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.49 -37.18 77.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.951 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.462 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 76.8 t90 -59.86 -56.99 14.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.475 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.5 mt -56.54 -31.85 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.958 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.72 22.64 7.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.249 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -116.47 -27.62 2.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.581 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.367 -1.24 . . . . 0.0 112.558 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.852 0.358 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.8 58.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -153.8 108.21 3.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 55.8 t -138.02 138.78 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.002 0.43 . . . . 0.0 111.288 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.17 111.95 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.479 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.409 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -169.51 152.4 4.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.106 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 159.98 7.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.96 -25.26 77.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.46 2.107 . . . . 0.0 112.199 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.03 -29.16 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.401 ' CG1' HG13 ' A' ' 158' ' ' VAL . 66.4 t -68.27 -47.91 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.334 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -54.65 -29.46 52.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -77.73 -43.07 32.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.48 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.4 t80 -64.03 -48.24 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.907 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.53 -45.4 83.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -31.87 59.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.177 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.57 -38.17 20.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -83.75 26.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.933 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.93 22.3 19.31 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.027 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.461 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 60.0 t -107.99 137.47 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.988 0.515 . . . . 0.0 111.151 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.471 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 19.4 t0 -116.14 127.42 54.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.433 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 29.3 mm -47.31 -25.74 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.681 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -62.8 -36.23 82.46 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.201 0.525 . . . . 0.0 110.429 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -87.97 -6.86 57.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.783 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.44 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.9 t -114.67 111.92 37.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.78 103.46 5.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.524 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.81 141.1 23.17 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.829 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.22 26.11 9.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 110.772 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -83.87 98.32 2.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.033 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.93 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.4 m-80 -100.41 33.2 2.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.25 26.04 60.43 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.611 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.409 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 8.7 ttp-105 -80.61 140.88 35.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.401 HG13 ' CG1' ' A' ' 135' ' ' VAL . 28.5 t -73.41 138.0 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 111.521 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.7 mt -111.93 161.5 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.697 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -32.69 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.791 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.29 -35.47 80.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 10.0 m-20 -65.4 -48.65 72.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.015 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.48 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 42.4 mm -52.68 -53.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.769 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -58.06 -46.22 85.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.28 77.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.461 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 70.1 t90 -60.01 -56.93 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.516 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.426 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.5 mt -54.78 -32.18 59.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.036 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.24 -25.0 59.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.81 46.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.486 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.4 t30 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.832 0.348 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.13 88.0 3.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -119.6 -3.44 10.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 54.2 t -104.28 138.83 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.924 0.392 . . . . 0.0 111.288 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.98 111.9 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.649 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.431 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -168.98 153.03 5.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.072 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.4 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -58.68 146.86 73.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.644 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.51 -25.03 13.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.575 2.183 . . . . 0.0 112.457 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.8 t -90.71 -34.13 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 158' ' ' VAL . 49.5 t -65.45 -43.5 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.293 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 78.1 mtm-85 -54.74 -30.41 56.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -77.65 -42.25 35.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.3 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.485 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.5 t80 -63.92 -48.09 77.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.922 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.411 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.7 -45.51 82.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.73 59.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.359 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -84.64 -38.58 19.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.212 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.405 ' HE3' ' CE1' ' A' ' 138' ' ' TYR . 19.8 mmtp -83.42 27.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.977 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.85 17.88 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.055 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.46 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 62.0 t -107.71 137.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 122.983 0.513 . . . . 0.0 111.046 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.498 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 18.8 t0 -116.08 126.7 54.11 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.448 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 34.2 mm -47.25 -25.63 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 111.594 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -36.85 84.51 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.187 0.517 . . . . 0.0 110.45 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -86.83 -6.96 58.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.875 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 162' ' ' ASP . 2.8 t -114.8 123.72 70.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 111.479 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.53 101.69 13.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.531 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.405 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -75.97 143.12 29.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.11 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 111.033 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.6 126.26 8.8 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.113 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.623 0.249 . . . . 0.0 111.468 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.03 36.99 3.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 90.95 15.67 55.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.431 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 46.0 ttm-85 -69.56 142.24 53.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 135' ' ' VAL . 46.6 t -78.97 132.26 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.262 0.553 . . . . 0.0 111.468 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.7 mt -107.21 163.48 12.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -55.86 -32.63 63.83 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.779 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.89 -36.57 84.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.12 -49.13 73.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.816 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.485 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 38.7 mm -52.62 -52.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.7 -42.96 84.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.05 78.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.98 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.467 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 65.8 t90 -61.01 -57.06 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.508 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.447 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.6 mt -56.02 -33.62 65.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.952 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.33 -25.02 59.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.258 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.01 -28.13 14.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.521 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.328 -1.262 . . . . 0.0 112.523 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.806 0.336 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -105.93 -35.48 7.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.79 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.01 -45.72 0.72 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.8 t -136.89 160.09 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.008 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.7 mp -93.7 113.03 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.405 ' CA ' ' HG3' ' A' ' 157' ' ' ARG . . . -165.5 148.45 7.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.437 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 4.8 mmm -61.25 153.49 67.59 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.636 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.63 -25.81 76.59 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.548 2.166 . . . . 0.0 112.4 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.2 m -90.82 -32.56 16.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.094 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 86.0 t -65.98 -46.21 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.5 mtp85 -54.58 -27.95 42.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 0.0 109.995 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -77.73 -46.31 22.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.003 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.452 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 54.4 t80 -61.78 -48.0 82.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.734 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -64.4 -44.54 90.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -32.06 59.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.21 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.6 -39.8 18.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -81.98 25.52 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.2 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.01 21.68 18.01 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.464 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 59.9 t -105.79 136.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 122.906 0.483 . . . . 0.0 110.996 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.466 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t70 -116.11 127.03 54.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.8 mm -46.87 -25.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.643 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -62.6 -36.15 81.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.265 0.555 . . . . 0.0 110.526 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.466 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -88.75 -6.23 57.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.424 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.3 t -114.29 121.95 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.305 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -86.83 106.51 17.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.36 137.76 19.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.819 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.23 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.729 0.3 . . . . 0.0 111.03 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 131.88 10.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.081 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.21 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -113.89 30.27 7.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.89 17.34 38.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.669 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.405 ' HG3' ' CA ' ' A' ' 131' ' ' ALA . 24.7 ttm105 -73.79 138.96 44.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.708 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.402 HG13 ' CG1' ' A' ' 135' ' ' VAL . 23.2 t -74.61 135.82 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.171 0.51 . . . . 0.0 111.369 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.6 mt -108.51 163.98 12.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.03 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -33.61 67.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -36.69 84.61 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.3 m-20 -65.14 -47.42 77.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.679 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.452 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 42.7 mm -52.77 -52.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.686 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.05 -41.38 87.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.65 84.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.929 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.466 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 67.5 t90 -59.8 -57.07 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.425 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.9 mt -56.48 -32.27 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.86 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 -25.1 35.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.263 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -90.55 -28.4 16.75 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.567 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.549 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -69.48 170.51 10.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -62.66 -175.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.831 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -79.15 157.87 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 mp -87.86 111.89 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.032 0.444 . . . . 0.0 110.972 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -165.2 149.91 9.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.061 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.95 149.08 97.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.816 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.98 -24.44 32.13 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.63 2.22 . . . . 0.0 112.204 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 77.5 p -91.0 -35.07 14.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.97 -46.13 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 67.0 mtm180 -54.64 -28.78 49.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.962 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -77.78 -44.24 28.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.469 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.3 t80 -63.25 -48.06 79.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.416 ' HB1' ' HB ' ' A' ' 144' ' ' VAL . . . -64.85 -45.38 86.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.98 58.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.297 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -84.71 -37.85 20.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.045 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -84.06 26.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.979 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.88 22.17 18.58 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.131 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.463 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 59.9 t -106.94 137.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.947 0.499 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.499 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t0 -116.07 127.71 55.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.6 mm -47.33 -26.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.687 0.28 . . . . 0.0 111.522 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -63.06 -36.42 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.14 0.495 . . . . 0.0 110.575 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -87.86 -5.28 58.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.959 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.429 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.81 123.54 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-O 120.948 0.404 . . . . 0.0 111.583 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.98 109.02 17.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.374 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.406 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -87.44 139.42 16.0 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.116 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.16 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.682 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -84.14 101.0 2.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.842 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.52 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.597 0.237 . . . . 0.0 111.54 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 153' ' ' GLY . 55.9 m-80 -96.33 29.17 2.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.707 0.289 . . . . 0.0 111.205 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.06 25.98 50.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.768 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.7 ttp-105 -80.87 140.47 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.783 0.325 . . . . 0.0 110.679 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.406 ' HA ' ' CA ' ' A' ' 151' ' ' GLY . 22.0 t -74.64 134.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.177 0.513 . . . . 0.0 111.344 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.8 mt -106.74 163.01 13.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.15 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -56.24 -33.39 65.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -36.67 84.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.2 m-20 -64.79 -47.51 77.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.901 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.469 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 44.5 mm -52.81 -52.78 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.888 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.98 -45.57 86.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.16 78.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.463 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 69.7 t90 -59.7 -57.03 14.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.13 0.491 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.416 ' HG ' ' CG2' ' A' ' 144' ' ' VAL . 1.5 mt -54.41 -32.28 56.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.996 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.33 31.03 2.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -144.12 28.06 1.98 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.518 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.849 0.357 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -83.39 123.39 29.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? 62.26 117.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.407 HG13 ' CG2' ' A' ' 146' ' ' ILE . 3.0 t -100.56 159.55 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.433 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.4 mp -83.19 111.91 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.108 0.48 . . . . 0.0 111.07 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -170.07 152.67 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.294 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.461 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 35.2 mmm -60.89 159.12 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.686 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.72 -27.07 60.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.227 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.6 m -90.97 -32.52 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 132' ' ' MET . 67.7 t -64.92 -46.52 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -54.7 -27.84 43.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -77.78 -43.72 29.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.0 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.461 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.6 t80 -63.54 -48.11 78.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.772 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.405 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . . . -65.18 -45.22 85.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -31.84 58.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.197 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.65 -38.6 19.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.086 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -83.07 27.66 0.55 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.043 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.86 22.34 18.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.093 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.469 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 58.3 t -108.96 137.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 122.961 0.504 . . . . 0.0 111.252 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t0 -116.1 127.74 55.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.407 ' CG2' HG13 ' A' ' 129' ' ' VAL . 34.7 mm -47.1 -26.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.452 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 19.2 ptt85 -64.07 -34.94 79.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 110.639 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 1.0 OUTLIER -85.87 -8.36 58.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.7 t -114.63 121.59 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.942 0.401 . . . . 0.0 111.545 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.58 104.96 15.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.406 ' HA2' ' N ' ' A' ' 158' ' ' VAL . . . -82.07 141.52 21.63 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.01 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 26.1 9.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.761 0.315 . . . . 0.0 110.829 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.05 119.0 5.53 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.58 -82.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -114.08 37.09 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.813 0.34 . . . . 0.0 111.201 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.96 26.0 27.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.569 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.433 ' HG3' HG21 ' A' ' 130' ' ' ILE . 3.2 ttt180 -81.16 138.94 35.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.786 0.327 . . . . 0.0 110.767 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.406 ' N ' ' HA2' ' A' ' 151' ' ' GLY . 13.1 t -77.48 134.54 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 111.341 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -107.17 165.23 11.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.258 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -57.85 -33.97 69.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -36.09 82.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.2 m-20 -65.71 -47.69 74.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.767 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.461 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 45.3 mm -52.9 -52.76 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.839 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.24 -44.81 88.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.42 86.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.054 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.469 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 77.6 t90 -57.92 -57.01 14.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.514 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.5 mt -54.95 -33.14 62.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.975 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.39 -25.09 59.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 126.82 -28.42 4.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.561 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.463 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m120 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.775 0.321 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -174.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.791 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.37 25.59 3.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 56.0 t -138.07 139.74 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.043 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.3 mp -129.99 111.97 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.62 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -170.02 152.54 4.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.098 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.41 160.02 7.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.5 -25.81 80.1 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.235 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.7 t -91.06 -29.2 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG1' HG13 ' A' ' 158' ' ' VAL . 66.0 t -68.02 -48.44 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 5.3 mtp180 -54.62 -29.13 51.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.912 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.64 -41.81 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.237 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.496 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 45.6 t80 -65.16 -48.13 74.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.98 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.77 -46.08 80.08 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.6 -31.81 57.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.362 178.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -84.42 -38.43 20.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.256 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.607 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -83.31 21.91 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.876 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.16 17.77 46.44 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.985 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.465 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 58.7 t -103.94 137.25 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.094 0.558 . . . . 0.0 110.851 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.446 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t0 -116.08 127.43 54.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 28.0 mm -46.13 -26.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.812 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.479 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.1 OUTLIER -64.07 -37.33 87.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -82.98 -8.89 59.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.414 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -114.49 115.15 48.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.863 0.363 . . . . 0.0 111.499 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.5 109.97 6.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.668 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.43 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -71.89 130.99 17.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.676 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 26.19 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.708 0.289 . . . . 0.0 110.935 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -103.38 121.61 7.16 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.325 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.36 -84.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.3 m-80 -109.19 35.72 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.045 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 84.63 26.04 40.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.424 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 31.2 ttm180 -80.97 147.0 30.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.727 0.299 . . . . 0.0 110.831 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.415 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 37.1 t -81.16 132.05 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.267 0.556 . . . . 0.0 111.331 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.0 mt -108.99 165.07 11.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.956 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.419 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 3.3 tptt -55.92 -32.08 63.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -64.65 -37.97 89.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -62.64 -49.74 73.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.61 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.496 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 35.4 mm -52.69 -52.26 28.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.582 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.47 -45.34 94.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.13 81.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 70.9 t90 -58.3 -57.09 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.306 0.574 . . . . 0.0 110.21 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' A' ' 144' ' ' VAL . 9.1 mt -61.07 -31.9 71.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.865 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.44 -24.95 61.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 117.72 -28.1 7.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.493 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.395 -1.225 . . . . 0.0 112.448 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.829 0.347 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -103.67 147.03 27.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 142.1 39.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.42 ' CG1' ' CG2' ' A' ' 146' ' ' ILE . 2.3 t -100.88 158.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.978 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 mp -87.15 116.02 28.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.029 0.443 . . . . 0.0 111.145 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -167.53 148.07 5.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.043 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.1 mtm -63.02 148.72 92.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.751 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -51.49 -26.46 21.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.541 2.161 . . . . 0.0 112.402 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.2 t -90.3 -29.09 18.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.73 -48.25 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.381 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 7.0 mtt85 -54.65 -29.21 51.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.965 0.412 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.63 -44.32 28.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.191 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.467 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.3 t80 -63.63 -48.01 79.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.921 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.403 ' HB2' ' HB ' ' A' ' 144' ' ' VAL . . . -65.24 -45.79 83.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.7 -31.82 58.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.299 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -84.4 -38.75 19.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.32 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -84.3 28.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.917 -179.142 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 21.64 17.55 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.234 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.46 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 56.8 t -106.95 136.69 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 122.852 0.461 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.489 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 32.2 t0 -116.16 126.83 54.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.42 ' CG2' ' CG1' ' A' ' 129' ' ' VAL . 30.2 mm -46.55 -25.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.754 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.77 84.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.209 0.528 . . . . 0.0 110.585 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -87.26 -5.91 58.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.924 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.409 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.7 t -114.77 126.1 72.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.961 0.41 . . . . 0.0 111.397 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.87 105.7 17.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.71 23.21 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.707 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.1 26.04 9.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.9 140.44 14.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 51.49 -90.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.215 . . . . 0.0 111.4 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -114.16 25.7 10.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.34 10.72 30.96 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.824 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -65.66 139.99 58.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 0.0 110.72 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.11 132.83 31.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.445 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.0 mt -104.4 165.09 11.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.208 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -34.16 67.91 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.63 84.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.3 m-20 -64.75 -47.47 78.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.777 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.467 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 42.9 mm -52.89 -52.51 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.725 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -58.44 -41.66 85.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.04 85.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.461 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 67.1 t90 -59.85 -57.04 14.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.417 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.425 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.5 mt -54.65 -32.44 59.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.983 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.09 -25.05 64.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.237 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 134.26 -53.47 0.79 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.556 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.851 0.358 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.11 -55.01 5.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.56 -175.22 1.93 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.727 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.401 ' CG1' ' CG2' ' A' ' 146' ' ' ILE . 2.1 t -94.19 157.08 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.926 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.95 114.67 27.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.064 0.459 . . . . 0.0 111.03 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.41 146.28 3.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.82 160.03 8.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.11 -25.23 65.78 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.563 2.175 . . . . 0.0 112.319 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.02 -31.5 16.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.3 -46.58 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.25 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' O ' ' CB ' ' A' ' 140' ' ' ARG . 4.6 mtp180 -54.71 -29.12 52.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.73 -43.98 29.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.194 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.487 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 47.7 t80 -63.95 -47.99 78.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.929 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.405 ' HB3' ' CD1' ' A' ' 163' ' ' ILE . . . -65.5 -46.94 77.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.79 58.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.235 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.28 -38.14 20.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.312 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.596 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -83.35 19.07 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.766 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.36 14.89 55.84 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.039 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.466 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 61.8 t -100.11 138.29 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 122.98 0.512 . . . . 0.0 110.769 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.499 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 11.2 t70 -116.08 127.99 55.31 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.401 ' CG2' ' CG1' ' A' ' 129' ' ' VAL . 34.8 mm -47.52 -26.13 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.531 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 -62.96 -36.2 82.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 110.575 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -88.12 -6.05 58.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.91 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.437 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.11 122.33 68.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.393 . . . . 0.0 111.365 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -85.66 115.32 23.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.69 136.7 16.94 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.2 26.01 9.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 111.025 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.6 145.5 17.75 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.859 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 48.97 -93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.194 0.198 . . . . 0.0 111.389 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -114.08 29.38 8.05 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.91 18.37 25.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -74.15 137.63 43.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.753 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 21.0 t -74.23 135.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.133 0.492 . . . . 0.0 111.217 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 12.9 mt -108.31 166.76 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -58.23 -33.7 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.93 -35.25 80.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.7 m-20 -66.28 -47.45 73.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.784 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.487 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 43.3 mm -52.8 -52.46 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.577 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.71 -44.82 90.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.47 80.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.976 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.466 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 67.4 t90 -58.4 -56.99 14.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.579 . . . . 0.0 110.357 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.439 ' HG ' HG23 ' A' ' 144' ' ' VAL . 11.2 mt -59.99 -27.42 66.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.094 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.04 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.257 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -88.42 -36.09 8.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.583 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.468 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.816 0.341 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 150.12 41.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -136.28 -172.74 3.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 77.0 t -102.26 135.58 38.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.86 111.97 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.741 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.415 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -166.06 148.35 7.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.229 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.62 150.12 37.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.61 -26.94 13.68 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.607 2.204 . . . . 0.0 112.382 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.98 -29.4 17.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 158' ' ' VAL . 87.0 t -68.93 -51.47 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.421 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.424 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.1 OUTLIER -54.53 -29.62 51.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.884 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -77.66 -41.62 37.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.157 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.499 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.0 t80 -65.29 -48.17 74.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.995 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.45 -46.6 79.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -54.65 -31.67 57.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.489 178.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -84.41 -38.36 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.067 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -83.95 22.62 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.05 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.48 16.46 36.29 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.293 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.466 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 61.3 t -101.23 137.89 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.962 0.505 . . . . 0.0 110.707 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.5 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 34.6 t0 -116.03 127.51 54.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 36.8 mm -47.2 -26.17 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -62.82 -37.0 85.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.171 0.51 . . . . 0.0 110.521 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -86.85 -6.63 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.846 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 166' ' ' TRP . 2.5 t -115.78 119.84 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.925 0.393 . . . . 0.0 111.527 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.63 101.82 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.547 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -79.39 145.45 27.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.864 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.32 25.96 9.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.744 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -86.93 110.1 3.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.076 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.27 -82.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.614 0.245 . . . . 0.0 111.491 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.0 m-80 -104.2 29.16 6.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 111.007 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.94 26.04 23.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.415 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 13.1 ttp-105 -75.78 139.52 41.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.43 ' CG1' HD12 ' A' ' 163' ' ' ILE . 47.4 t -74.21 131.99 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.29 0.567 . . . . 0.0 111.468 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -106.29 163.47 12.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.751 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -55.7 -31.82 62.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.603 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.2 -38.0 89.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.262 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -61.72 -49.9 74.6 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.729 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.499 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 33.6 mm -52.68 -54.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.789 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -56.68 -48.01 78.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.065 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.38 74.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.023 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.466 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 63.8 t90 -59.32 -57.01 14.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.198 0.523 . . . . 0.0 110.324 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.448 ' HG ' HG23 ' A' ' 144' ' ' VAL . 11.4 mt -60.46 -21.71 62.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.232 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.99 -24.97 64.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.142 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 152.36 -68.31 0.32 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.401 -1.221 . . . . 0.0 112.439 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.894 0.378 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.5 108.73 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -106.18 52.31 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.2 158.02 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.5 mp -84.67 112.81 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 111.088 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.4 ' CA ' ' HG3' ' A' ' 157' ' ' ARG . . . -165.54 154.58 12.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.089 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.7 mtp -71.37 149.85 93.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.757 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -51.41 -31.64 39.21 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.53 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 p -85.18 -29.81 24.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 61.2 t -70.8 -46.86 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.531 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.9 mtp180 -54.77 -29.91 55.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.979 0.419 . . . . 0.0 109.946 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -77.77 -44.85 26.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.139 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.473 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 51.7 t80 -62.59 -48.21 80.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.415 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -64.92 -45.35 86.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.62 -31.98 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.372 178.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.67 -38.08 20.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.173 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.41 ' HE3' ' CE1' ' A' ' 138' ' ' TYR . 20.3 mmtp -84.18 26.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.909 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 21.48 16.66 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.181 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.459 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 60.8 t -106.17 137.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 122.926 0.491 . . . . 0.0 110.986 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 59.3 t0 -116.09 127.38 54.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.4 mm -47.01 -26.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.668 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -35.87 81.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.202 0.525 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -88.28 -5.75 58.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.925 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.432 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.78 117.7 56.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 111.379 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.34 112.83 12.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.676 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 156' ' ' GLY . . . -81.22 131.8 10.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.744 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 26.09 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.613 0.244 . . . . 0.0 110.93 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -102.61 124.69 8.26 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.461 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.46 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.0 p30 -113.13 30.62 7.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 151' ' ' GLY . . . 91.64 26.03 21.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.56 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.4 ' HG3' ' CA ' ' A' ' 131' ' ' ALA . 43.5 ttm-85 -81.51 143.83 31.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.802 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.427 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 24.6 t -79.44 132.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.129 0.49 . . . . 0.0 111.322 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.3 mt -105.22 163.98 12.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.083 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.37 -33.22 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.25 -36.2 83.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -65.16 -47.26 77.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.473 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 44.4 mm -52.81 -51.67 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.782 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -58.86 -45.4 90.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.865 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.78 75.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.464 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 64.7 t90 -60.79 -57.05 14.31 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.142 0.496 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.409 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.7 mt -55.69 -33.4 64.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.957 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.72 -24.97 59.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.198 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -80.65 -32.54 33.31 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.496 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.75 0.309 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -123.83 127.49 48.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -174.12 0.88 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.401 ' CG1' ' CG2' ' A' ' 146' ' ' ILE . 2.3 t -98.32 157.65 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.413 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.4 mp -85.34 112.42 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.085 0.469 . . . . 0.0 111.04 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -166.26 147.42 6.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.082 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.89 148.49 91.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.32 -26.47 27.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 p -89.34 -34.94 16.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 158' ' ' VAL . 99.3 t -66.02 -46.76 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 8.9 mtp-105 -54.71 -29.16 52.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.88 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -77.65 -42.99 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.301 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.497 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.8 t80 -64.52 -48.18 76.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.886 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 144' ' ' VAL . . . -64.95 -46.39 81.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.68 -31.76 58.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.413 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -84.46 -37.68 21.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.075 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.419 ' O ' HD23 ' A' ' 167' ' ' LEU . 47.9 mmtt -84.64 22.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.832 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.72 16.62 31.3 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.317 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.464 HG23 ' HG ' ' A' ' 167' ' ' LEU . 61.4 t -101.1 137.73 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 122.761 0.424 . . . . 0.0 110.652 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.6 t0 -116.08 127.25 54.71 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.401 ' CG2' ' CG1' ' A' ' 129' ' ' VAL . 32.7 mm -46.85 -26.38 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.507 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.87 -37.44 86.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 110.527 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -86.51 -6.73 58.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.851 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.422 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.7 126.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.954 0.406 . . . . 0.0 111.546 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -91.92 103.96 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.509 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.49 143.79 29.72 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.814 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.307 . . . . 0.0 110.864 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.37 140.82 15.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.731 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.98 -91.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.541 0.21 . . . . 0.0 111.385 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.13 26.21 10.48 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.743 0.306 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.2 6.83 33.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.818 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.413 ' HG3' HG21 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -60.93 139.75 57.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 135' ' ' VAL . 25.2 t -79.76 131.93 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -104.43 167.16 9.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.306 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HG3' ' CD2' ' A' ' 138' ' ' TYR . 1.3 ttmt -57.54 -35.7 70.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.44 -35.5 79.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.212 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -66.61 -47.94 71.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.497 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 43.2 mm -52.92 -53.58 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.41 -39.86 80.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.32 86.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.462 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 69.1 t90 -57.64 -57.03 14.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.294 0.569 . . . . 0.0 110.274 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 144' ' ' VAL . 11.1 mt -59.23 -30.91 68.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.976 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.98 63.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -120.37 30.56 5.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.558 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.565 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.861 0.363 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.98 34.15 19.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.946 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.34 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 46.0 t -64.93 133.98 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.021 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.404 HG21 ' HG3' ' A' ' 157' ' ' ARG . 4.7 mp -116.49 111.87 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.711 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.4 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.25 155.47 5.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.244 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.403 ' HB2' ' CG2' ' A' ' 135' ' ' VAL . 1.6 mtp -61.65 157.0 51.06 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.397 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.99 -25.43 77.62 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.483 2.122 . . . . 0.0 112.248 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -29.43 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.285 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.447 HG13 HG13 ' A' ' 158' ' ' VAL . 45.6 t -69.3 -46.91 76.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.773 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 8.1 mtp180 -54.56 -30.72 54.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -77.62 -40.97 40.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.281 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.489 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 50.5 t80 -64.66 -48.15 75.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.883 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.7 -45.5 82.53 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.8 58.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.465 178.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.73 -38.33 19.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -83.32 27.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.77 17.7 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.075 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.461 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 58.8 t -107.94 137.14 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 122.935 0.494 . . . . 0.0 111.134 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.492 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.4 t0 -116.07 126.52 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 37.5 mm -46.95 -25.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.606 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.56 -37.56 86.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.0 110.439 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.6 OUTLIER -85.68 -7.87 58.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.795 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -115.04 115.71 50.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.414 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 108.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.636 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.66 134.78 24.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.803 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.21 26.0 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 110.801 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -89.7 101.17 2.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.863 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt 57.36 -84.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.605 0.24 . . . . 0.0 111.33 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.13 9.58 25.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.49 26.01 7.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.691 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.404 ' HG3' HG21 ' A' ' 130' ' ' ILE . 28.8 ttm180 -79.04 145.46 33.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.868 0.366 . . . . 0.0 110.796 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.447 HG13 HG13 ' A' ' 135' ' ' VAL . 17.3 t -80.14 126.48 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.222 0.534 . . . . 0.0 111.227 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.3 mt -105.11 164.66 11.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.185 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -56.05 -33.03 64.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.8 -37.2 86.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.9 m-20 -63.2 -48.91 76.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.759 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.489 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 39.8 mm -52.71 -53.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.715 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.61 -41.91 82.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.78 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.25 83.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.461 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 70.4 t90 -60.12 -56.96 15.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.334 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.446 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.3 mt -54.83 -32.77 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.046 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -99.13 26.24 6.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.87 81.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.594 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.322 -1.266 . . . . 0.0 112.562 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.785 0.326 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -129.79 133.54 47.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.822 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -66.97 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.42 ' CG1' ' CG2' ' A' ' 146' ' ' ILE . 4.1 t -135.54 158.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.914 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.415 HG21 ' HG3' ' A' ' 157' ' ' ARG . 3.3 mp -79.99 111.94 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.092 0.472 . . . . 0.0 111.099 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.403 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.08 147.73 3.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.994 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.3 mtp -59.13 159.96 13.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.681 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.64 -25.52 69.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.499 2.132 . . . . 0.0 112.348 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.3 t -90.97 -33.3 15.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.14 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.426 HG13 HG13 ' A' ' 158' ' ' VAL . 46.4 t -66.32 -44.68 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.361 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 61.3 mtp85 -54.76 -29.95 55.3 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -77.66 -42.43 34.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.156 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.481 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 50.6 t80 -64.21 -47.96 77.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.976 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.0 -45.68 80.71 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.88 58.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.26 178.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.62 -38.73 19.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.626 ' HD2' ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -82.99 27.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.85 -178.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.44 19.94 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.913 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.464 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 57.6 t -108.39 138.01 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 0.0 110.997 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.504 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t70 -116.16 127.02 54.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.42 ' CG2' ' CG1' ' A' ' 129' ' ' VAL . 38.0 mm -46.65 -26.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.667 0.27 . . . . 0.0 111.626 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 mtt85 -63.03 -37.09 85.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.26 0.553 . . . . 0.0 110.64 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -86.9 -5.32 59.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.958 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.42 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.49 118.97 60.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.872 0.367 . . . . 0.0 111.496 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.51 116.31 17.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -82.05 131.65 10.55 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.048 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 25.96 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.663 0.268 . . . . 0.0 110.732 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.12 118.63 6.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.074 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.68 -87.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.631 0.253 . . . . 0.0 111.52 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -99.07 28.14 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.726 0.298 . . . . 0.0 111.04 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.17 26.13 34.86 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.737 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.415 ' HG3' HG21 ' A' ' 130' ' ' ILE . 22.4 ttm180 -78.88 143.55 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.741 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.442 ' HA ' ' HA3' ' A' ' 151' ' ' GLY . 18.0 t -77.79 129.93 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.234 0.54 . . . . 0.0 111.334 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.5 mt -105.44 166.47 10.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.361 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -57.65 -33.69 68.57 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.18 -35.86 82.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -65.67 -47.58 75.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.823 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.481 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 42.0 mm -52.88 -52.27 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.799 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -57.77 -46.3 84.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.83 72.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.018 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.464 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 62.9 t90 -61.55 -57.13 13.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.377 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.419 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.6 mt -56.44 -34.67 67.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.945 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.1 -25.1 40.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -97.96 41.27 2.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.466 -179.929 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.3 p30 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.843 0.354 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.86 169.63 8.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.14 114.24 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 28.1 t -122.94 135.86 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.056 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.407 HG21 ' HG3' ' A' ' 157' ' ' ARG . 3.3 mt -129.56 114.01 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.449 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.407 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -165.94 149.9 7.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.261 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 2.6 mtt -59.9 148.78 75.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.69 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -50.96 -25.22 15.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.474 2.116 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.2 p -90.97 -34.73 15.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.053 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.438 HG13 HG13 ' A' ' 158' ' ' VAL . 54.8 t -65.19 -44.91 95.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.322 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.3 mtp85 -54.67 -30.1 54.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.82 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.71 -41.32 38.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.266 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.495 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 50.2 t80 -65.09 -48.06 75.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.927 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.424 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.73 -46.12 80.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -31.7 58.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.346 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -84.61 -38.76 19.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.279 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -84.16 28.17 0.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.988 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 21.22 16.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.223 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.466 HG23 ' HG ' ' A' ' 167' ' ' LEU . 52.9 t -106.83 137.1 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 122.975 0.51 . . . . 0.0 110.969 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 24.6 t0 -116.03 126.18 53.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.444 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 28.1 mm -46.59 -25.51 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -62.98 -37.07 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.226 0.536 . . . . 0.0 110.465 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -86.73 -5.8 59.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.874 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 166' ' ' TRP . 2.6 t -114.8 124.5 71.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.934 0.397 . . . . 0.0 111.296 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.33 103.64 15.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.51 140.42 21.13 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.847 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.282 . . . . 0.0 110.925 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.61 120.03 6.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.087 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt 57.73 -86.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.549 0.214 . . . . 0.0 111.469 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.65 37.04 2.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 26.09 32.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.635 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.407 ' HG3' HG21 ' A' ' 130' ' ' ILE . 29.0 ttm180 -80.45 142.37 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.438 HG13 HG13 ' A' ' 135' ' ' VAL . 43.5 t -76.97 132.65 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.567 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.5 mt -106.96 163.53 12.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.739 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.405 ' HE2' ' CE1' ' A' ' 138' ' ' TYR . 9.1 tttm -56.18 -32.13 64.06 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.744 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.83 85.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.5 m-20 -64.43 -49.21 72.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.882 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.495 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 40.1 mm -52.53 -51.78 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.88 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -58.46 -47.15 84.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.997 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.6 -34.91 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.465 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 63.4 t90 -61.71 -57.12 13.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 0.0 110.491 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HG ' HG23 ' A' ' 144' ' ' VAL . 2.5 mt -55.61 -23.91 30.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.263 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.65 31.08 1.63 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.608 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.87 -53.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.574 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.358 -1.245 . . . . 0.0 112.535 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.25 38.48 1.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.78 118.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.817 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.449 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 40.1 t -123.76 139.76 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.03 111.94 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.431 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -162.83 154.65 18.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.413 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.4 mtp -65.82 160.02 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.88 -26.42 82.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.51 2.14 . . . . 0.0 112.186 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -91.04 -31.92 16.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 158' ' ' VAL . 45.2 t -70.17 -46.63 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.414 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.8 mtt180 -54.56 -31.94 57.49 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -77.7 -39.94 43.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.462 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.517 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 44.8 t80 -65.89 -48.17 72.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.052 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.413 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -66.32 -46.29 77.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 7.1 tpp85 -54.6 -31.79 57.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.318 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.49 -38.44 20.1 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.414 ' O ' HD23 ' A' ' 167' ' ' LEU . 17.4 mmtp -84.25 27.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.92 19.38 14.52 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.307 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.464 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 60.9 t -104.99 136.71 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 122.954 0.502 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 14.7 t0 -116.04 126.54 53.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.449 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 34.6 mm -45.44 -26.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.41 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -64.94 -35.31 80.75 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.565 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.446 HD11 ' CZ2' ' A' ' 166' ' ' TRP . 0.9 OUTLIER -84.53 -8.17 59.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 178.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.435 HG23 ' CG ' ' A' ' 166' ' ' TRP . 2.2 t -114.83 120.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.503 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -81.94 105.55 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.88 141.42 20.91 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.99 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.02 9.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.777 0.323 . . . . 0.0 110.779 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -89.22 111.41 3.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.847 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt 54.84 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.523 0.201 . . . . 0.0 111.483 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 67.6 m-80 -100.39 36.97 1.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 111.066 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.79 25.98 59.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.568 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -78.17 141.71 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.852 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.427 ' CG1' HD12 ' A' ' 163' ' ' ILE . 42.0 t -75.25 133.06 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 0.0 111.332 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.0 mt -107.24 164.51 12.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.856 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.416 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -55.8 -32.1 63.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.01 -37.65 88.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.6 m-20 -62.62 -49.91 73.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.517 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 32.5 mm -52.79 -53.2 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.598 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.43 -47.94 82.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.808 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.17 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.464 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 65.2 t90 -59.81 -56.68 18.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.242 0.544 . . . . 0.0 110.239 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.44 ' HG ' HG23 ' A' ' 144' ' ' VAL . 9.3 mt -62.32 -31.04 71.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.953 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.86 -25.08 58.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -144.69 55.94 0.55 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.536 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.545 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.816 0.341 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -91.14 -25.85 19.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 64.72 -169.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.411 ' CG1' ' CG2' ' A' ' 146' ' ' ILE . 1.7 t -128.09 157.82 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.3 mp -90.71 116.69 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.017 0.437 . . . . 0.0 111.155 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -169.51 144.01 2.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.088 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.2 mtp -58.95 147.65 72.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.24 -25.91 25.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.49 2.126 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.1 p -87.78 -36.75 17.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 158' ' ' VAL . 48.0 t -67.07 -45.68 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.34 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 59.6 mtm180 -54.74 -29.96 55.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -41.16 38.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.201 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.493 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.8 t80 -65.19 -48.16 74.42 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.836 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 144' ' ' VAL . . . -65.46 -46.29 80.43 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 4.2 tpt85 -54.63 -31.63 57.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.29 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.47 -38.09 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.425 ' O ' HD22 ' A' ' 167' ' ' LEU . 19.2 mmtp -84.09 22.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.937 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.53 35.32 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.224 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.467 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 61.7 t -101.31 137.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 123.041 0.536 . . . . 0.0 110.606 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.489 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.7 t0 -116.04 126.02 53.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 146' ' ' ILE . 33.7 mm -45.69 -26.37 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.803 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -62.94 -37.31 86.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.277 0.56 . . . . 0.0 110.58 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -86.16 -6.01 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.884 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -114.4 123.47 70.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.332 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -86.13 106.34 17.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.534 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.39 136.86 19.43 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.826 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 26.05 9.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.065 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.34 137.96 13.86 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.967 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.1 -90.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.594 0.235 . . . . 0.0 111.472 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -114.05 28.56 8.66 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.93 35.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.683 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -69.87 140.32 53.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.662 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 135' ' ' VAL . 15.0 t -77.35 131.38 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.2 mt -104.54 167.77 9.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.468 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.93 70.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.58 -34.62 78.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.267 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -67.04 -47.29 71.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.756 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.493 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 43.6 mm -52.87 -52.52 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.622 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.48 -44.46 89.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.88 74.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.467 ' CZ3' HG21 ' A' ' 144' ' ' VAL . 56.5 t90 -61.22 -56.26 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.425 HD22 ' O ' ' A' ' 142' ' ' LYS . 4.6 mt -60.75 -34.38 74.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.849 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.65 -23.6 61.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.274 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -52.31 -25.25 18.71 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.7 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 118.36 -1.245 . . . . 0.0 112.472 179.953 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.3 p30 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.789 0.328 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.88 -179.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.908 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -124.71 49.52 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.793 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 146' ' ' ILE . 77.4 t -137.02 135.99 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.063 0.459 . . . . 0.0 111.355 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.6 mp -129.99 111.95 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.471 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' HA ' ' CG ' ' A' ' 157' ' ' ARG . . . -167.33 154.7 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.24 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 3.9 mtp -60.41 155.12 50.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.26 -27.39 56.8 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.656 2.237 . . . . 0.0 112.525 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -91.03 -27.29 18.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.403 ' CG1' HG13 ' A' ' 158' ' ' VAL . 57.6 t -69.89 -47.47 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -54.65 -30.25 54.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.59 33.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.481 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 50.2 t80 -64.42 -48.2 76.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.006 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.415 ' CB ' HD11 ' A' ' 163' ' ' ILE . . . -65.64 -45.98 80.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -54.7 -31.77 58.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.335 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.63 -38.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.4 mmtt -83.29 27.78 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.048 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.02 18.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.057 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.453 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 53.3 t -108.12 136.61 43.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 122.921 0.489 . . . . 0.0 110.964 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.451 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 30.5 t0 -116.18 126.49 53.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.444 ' HB ' ' CG1' ' A' ' 129' ' ' VAL . 29.7 mm -45.93 -26.18 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.803 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -62.39 -36.49 82.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.267 0.556 . . . . 0.0 110.524 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.46 HD13 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.84 -6.8 57.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.834 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 166' ' ' TRP . 2.4 t -113.67 114.73 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.04 100.45 7.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.526 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.23 141.99 27.69 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.68 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.28 26.08 9.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 110.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.99 118.68 5.56 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.325 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.73 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -114.15 28.75 8.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.85 22.13 21.61 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.62 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.416 ' CG ' ' HA ' ' A' ' 131' ' ' ALA . 39.3 ttm180 -76.5 140.99 41.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 110.573 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.403 HG13 ' CG1' ' A' ' 135' ' ' VAL . 40.6 t -74.02 137.99 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.375 0.607 . . . . 0.0 111.539 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.6 mt -113.66 163.08 15.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.638 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.75 -32.52 63.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.809 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -64.28 -36.37 83.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.4 m-20 -64.39 -49.33 72.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.859 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.481 ' HB ' ' CE2' ' A' ' 138' ' ' TYR . 35.5 mm -52.68 -54.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.003 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.16 -47.14 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.983 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.72 -35.74 75.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.149 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.46 ' CZ2' HD13 ' A' ' 148' ' ' LEU . 63.8 t90 -60.99 -57.0 14.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.584 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.419 ' HG ' HG23 ' A' ' 144' ' ' VAL . 1.5 mt -55.18 -32.27 62.05 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.35 -25.03 61.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.194 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.29 69.94 0.74 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.414 -1.215 . . . . 0.0 112.51 179.956 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.492 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.94 0.4 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.32 155.42 7.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.557 ' HB2' HG23 ' A' ' 135' ' ' VAL . 5.5 mtm -61.53 150.69 80.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.8 -26.02 22.72 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -91.04 -27.89 18.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.088 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 158' ' ' VAL . 95.5 t -68.67 -49.44 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.32 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -54.56 -29.4 51.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -77.74 -42.71 33.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.172 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.557 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.4 t80 -64.24 -48.13 76.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.008 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.16 -45.71 83.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 2.4 ttt180 -54.68 -31.82 58.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.386 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -84.58 -38.2 20.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.092 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.797 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.4 mmtt -83.54 26.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.044 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.01 18.23 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.163 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.4 t -107.48 137.76 37.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.001 0.52 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t70 -116.17 127.56 54.9 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.639 HG23 HG21 ' A' ' 158' ' ' VAL . 33.3 mm -47.0 -26.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.592 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -62.7 -36.51 83.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.16 0.505 . . . . 0.0 110.585 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.519 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.67 -6.57 58.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.865 179.574 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.506 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.53 112.28 39.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.1 102.12 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.415 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -69.89 136.21 27.12 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.494 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.624 0.249 . . . . 0.0 111.092 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.23 128.81 9.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.165 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.18 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -111.85 30.15 7.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 93.05 18.59 39.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.741 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.492 ' CB ' HG22 ' A' ' 130' ' ' ILE . 34.7 ttm180 -72.35 141.15 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.311 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 135' ' ' VAL . 25.6 t -76.11 130.56 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.26 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.7 mt -106.26 163.98 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.968 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -56.22 -32.63 64.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.695 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.68 -36.31 83.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.82 -48.98 72.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.774 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.008 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.3 mm -52.59 -53.24 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.755 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.1 -48.07 81.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.948 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.31 72.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.1 t90 -60.36 -57.02 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.384 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.7 -32.21 59.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.045 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.606 HG22 ' CG ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.981 0.42 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.63 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.26 150.34 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.194 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.55 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.6 mtp -57.5 157.71 12.87 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.713 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.78 -26.31 65.62 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.515 2.143 . . . . 0.0 112.178 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.03 -28.06 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.944 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.557 HG11 HG12 ' A' ' 158' ' ' VAL . 89.8 t -69.82 -51.38 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.442 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.63 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 51.5 mtt180 -54.63 -30.2 54.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -77.74 -41.37 37.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.232 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.513 ' CD2' HG21 ' A' ' 163' ' ' ILE . 49.1 t80 -65.33 -48.03 74.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.887 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.057 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.96 -46.08 79.4 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.55 -32.01 57.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.167 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.38 -38.14 20.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.814 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.79 26.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.807 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 22.78 21.01 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.921 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.827 HG22 ' CE3' ' A' ' 166' ' ' TRP . 62.1 t -108.62 137.85 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 122.971 0.508 . . . . 0.0 111.172 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.491 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 62.8 t0 -116.14 127.49 54.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.72 HG23 ' CG2' ' A' ' 158' ' ' VAL . 32.2 mm -47.09 -26.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.532 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -62.79 -36.22 82.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 110.581 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.513 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.96 -5.85 58.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.91 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.494 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.26 117.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.887 0.375 . . . . 0.0 111.507 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.69 103.03 9.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.501 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -82.72 144.84 23.33 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.909 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.29 26.1 9.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.702 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -81.01 94.85 1.6 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.947 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 60.31 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.605 0.24 . . . . 0.0 111.392 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.8 m120 -97.88 27.23 4.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.2 26.08 34.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.606 ' CG ' HG22 ' A' ' 130' ' ' ILE . 33.2 ttp85 -77.89 141.49 39.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' A' ' 146' ' ' ILE . 42.9 t -75.62 133.53 31.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.237 0.542 . . . . 0.0 111.617 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 17.7 mt -106.25 161.07 14.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.685 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -56.11 -32.26 64.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.684 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.15 -36.67 84.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.9 m-20 -64.01 -48.68 75.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.796 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.057 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.5 mm -52.67 -52.31 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.766 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -58.1 -47.41 83.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.94 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.47 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.827 ' CE3' HG22 ' A' ' 144' ' ' VAL . 68.0 t90 -60.93 -57.0 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.96 -32.19 61.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.611 HG22 ' CB ' ' A' ' 157' ' ' ARG . 41.4 mt . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.581 ' HB3' ' CG ' ' A' ' 136' ' ' ARG . . . -162.48 155.86 20.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.367 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.494 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.6 mtm -69.61 154.94 94.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.732 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 -28.11 45.15 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.127 . . . . 0.0 112.351 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.3 p -91.04 -32.3 15.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.652 HG11 HG12 ' A' ' 158' ' ' VAL . 72.2 t -68.07 -48.36 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.443 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.581 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 10.0 mtt180 -54.56 -29.27 50.64 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -77.65 -41.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.157 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.548 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.6 t80 -65.48 -48.12 73.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.059 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.23 -45.97 82.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -54.59 -31.85 57.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.306 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.49 -37.67 21.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.694 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.1 mmtt -84.17 27.67 0.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.951 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.7 20.23 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.957 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.754 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.8 t -109.01 138.41 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.953 0.501 . . . . 0.0 111.184 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.486 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.1 t0 -116.13 127.1 54.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.817 HG23 ' CG2' ' A' ' 158' ' ' VAL . 39.1 mm -47.36 -25.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.599 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.74 ' HG3' HD23 ' A' ' 148' ' ' LEU . 17.5 ptt180 -63.16 -36.98 85.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.076 0.465 . . . . 0.0 110.444 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.74 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.1 mt -83.26 -10.45 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.48 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.586 HG22 ' CD1' ' A' ' 166' ' ' TRP . 2.7 t -114.13 114.03 45.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.925 0.393 . . . . 0.0 111.429 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -77.92 99.17 5.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 141.9 26.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.588 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.21 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.641 0.258 . . . . 0.0 111.027 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.36 120.69 6.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.132 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.55 -86.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.467 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -113.97 36.93 3.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.773 0.321 . . . . 0.0 111.181 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.48 25.93 24.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.645 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.611 ' CB ' HG22 ' A' ' 130' ' ' ILE . 7.1 ttm180 -81.58 143.96 31.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.677 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.817 ' CG2' HG23 ' A' ' 146' ' ' ILE . 43.8 t -80.58 133.36 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.9 mt -106.89 162.87 13.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.721 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -56.29 -32.63 64.78 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.698 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -64.13 -36.47 84.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.7 m-20 -65.36 -49.65 68.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.741 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.059 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.5 mm -52.59 -48.63 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.623 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -59.91 -48.01 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.49 -37.18 77.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.951 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.754 ' CE3' HG22 ' A' ' 144' ' ' VAL . 76.8 t90 -59.86 -56.99 14.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -56.54 -31.85 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.958 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.249 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.472 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.04 0.448 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -169.51 152.4 4.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.106 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.527 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -57.29 159.98 7.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.96 -25.26 77.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.46 2.107 . . . . 0.0 112.199 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.03 -29.16 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.752 HG11 HG12 ' A' ' 158' ' ' VAL . 66.4 t -68.27 -47.91 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.334 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -54.65 -29.46 52.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -77.73 -43.07 32.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.558 ' CD2' HG21 ' A' ' 163' ' ' ILE . 48.4 t80 -64.03 -48.24 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.907 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.03 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.53 -45.4 83.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -31.87 59.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.177 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.57 -38.17 20.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.809 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.5 mmtt -83.75 26.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.933 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.93 22.3 19.31 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.027 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.832 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.0 t -107.99 137.47 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.988 0.515 . . . . 0.0 111.151 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 19.4 t0 -116.14 127.42 54.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.753 HG23 HG21 ' A' ' 158' ' ' VAL . 29.3 mm -47.31 -25.74 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.681 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -62.8 -36.23 82.46 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.201 0.525 . . . . 0.0 110.429 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.526 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.97 -6.86 57.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.783 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.514 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.9 t -114.67 111.92 37.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.78 103.46 5.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.524 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -79.81 141.1 23.17 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.829 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.22 26.11 9.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 110.772 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -83.87 98.32 2.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.033 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.93 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.4 m-80 -100.41 33.2 2.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.25 26.04 60.43 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.611 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.472 ' CB ' HG22 ' A' ' 130' ' ' ILE . 8.7 ttp-105 -80.61 140.88 35.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 146' ' ' ILE . 28.5 t -73.41 138.0 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 111.521 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.7 mt -111.93 161.5 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.697 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -32.69 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.791 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.29 -35.47 80.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 10.0 m-20 -65.4 -48.65 72.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.015 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.03 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.4 mm -52.68 -53.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.769 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -58.06 -46.22 85.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.28 77.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.832 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.1 t90 -60.01 -56.93 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.516 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.78 -32.18 59.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.036 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 121.017 0.437 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.98 153.03 5.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.072 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.542 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -58.68 146.86 73.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.644 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.51 -25.03 13.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.575 2.183 . . . . 0.0 112.457 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.8 t -90.71 -34.13 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 49.5 t -65.45 -43.5 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.293 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.47 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 78.1 mtm-85 -54.74 -30.41 56.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -77.65 -42.25 35.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.3 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.491 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.5 t80 -63.92 -48.09 77.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.922 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.0 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.7 -45.51 82.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.73 59.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.359 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -84.64 -38.58 19.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.212 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.797 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.8 mmtp -83.42 27.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.977 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.85 17.88 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.055 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.826 HG22 ' CE3' ' A' ' 166' ' ' TRP . 62.0 t -107.71 137.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 122.983 0.513 . . . . 0.0 111.046 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.506 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 18.8 t0 -116.08 126.7 54.11 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.741 HG23 ' CG2' ' A' ' 158' ' ' VAL . 34.2 mm -47.25 -25.63 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 111.594 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -36.85 84.51 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.187 0.517 . . . . 0.0 110.45 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.538 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.83 -6.96 58.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.875 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.551 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.8 t -114.8 123.72 70.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 111.479 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.53 101.69 13.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.531 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -75.97 143.12 29.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.11 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 111.033 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.6 126.26 8.8 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.113 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.623 0.249 . . . . 0.0 111.468 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.03 36.99 3.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.95 15.67 55.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.618 ' HA ' HG22 ' A' ' 130' ' ' ILE . 46.0 ttm-85 -69.56 142.24 53.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 146' ' ' ILE . 46.6 t -78.97 132.26 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.262 0.553 . . . . 0.0 111.468 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.467 ' HA ' HG21 ' A' ' 135' ' ' VAL . 12.7 mt -107.21 163.48 12.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -55.86 -32.63 63.83 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.779 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.89 -36.57 84.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.12 -49.13 73.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.816 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.0 HD12 ' HB2' ' A' ' 139' ' ' ALA . 38.7 mm -52.62 -52.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.7 -42.96 84.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.05 78.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.98 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.826 ' CE3' HG22 ' A' ' 144' ' ' VAL . 65.8 t90 -61.01 -57.06 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.508 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.6 mt -56.02 -33.62 65.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.952 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.258 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.7 mp . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.954 0.407 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.5 148.45 7.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.8 mmm -61.25 153.49 67.59 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.636 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.63 -25.81 76.59 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.548 2.166 . . . . 0.0 112.4 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.2 m -90.82 -32.56 16.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.094 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.772 HG11 HG12 ' A' ' 158' ' ' VAL . 86.0 t -65.98 -46.21 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.5 mtp85 -54.58 -27.95 42.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 0.0 109.995 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -77.73 -46.31 22.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.003 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.519 ' CD2' HG21 ' A' ' 163' ' ' ILE . 54.4 t80 -61.78 -48.0 82.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.734 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.991 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.4 -44.54 90.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -32.06 59.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.21 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.6 -39.8 18.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.804 ' O ' HD21 ' A' ' 167' ' ' LEU . 51.7 mmtt -81.98 25.52 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.2 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.01 21.68 18.01 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.838 HG22 ' CE3' ' A' ' 166' ' ' TRP . 59.9 t -105.79 136.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 122.906 0.483 . . . . 0.0 110.996 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t70 -116.11 127.03 54.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 131' ' ' ALA . 25.8 mm -46.87 -25.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.643 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -62.6 -36.15 81.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.265 0.555 . . . . 0.0 110.526 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.549 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.75 -6.23 57.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.487 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.3 t -114.29 121.95 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.305 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -86.83 106.51 17.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.36 137.76 19.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.819 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.23 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.729 0.3 . . . . 0.0 111.03 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 131.88 10.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.081 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.21 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -113.89 30.27 7.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.89 17.34 38.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.669 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.649 ' HA ' HG22 ' A' ' 130' ' ' ILE . 24.7 ttm105 -73.79 138.96 44.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.708 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.772 HG12 HG11 ' A' ' 135' ' ' VAL . 23.2 t -74.61 135.82 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.171 0.51 . . . . 0.0 111.369 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.6 mt -108.51 163.98 12.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.03 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -33.61 67.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -36.69 84.61 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.3 m-20 -65.14 -47.42 77.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.679 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.991 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.7 mm -52.77 -52.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.686 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.05 -41.38 87.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.65 84.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.929 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.838 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.5 t90 -59.8 -57.07 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.425 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.9 mt -56.48 -32.27 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.86 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.263 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.032 0.444 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.2 149.91 9.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.061 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -64.95 149.08 97.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.816 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.98 -24.44 32.13 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.63 2.22 . . . . 0.0 112.204 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 77.5 p -91.0 -35.07 14.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.77 HG11 HG12 ' A' ' 158' ' ' VAL . 92.1 t -65.97 -46.13 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 67.0 mtm180 -54.64 -28.78 49.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.962 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -77.78 -44.24 28.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.556 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.3 t80 -63.25 -48.06 79.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.007 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.85 -45.38 86.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.98 58.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.297 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -84.71 -37.85 20.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.045 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.825 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.1 mmtt -84.06 26.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.979 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.88 22.17 18.58 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.131 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.841 HG22 ' CE3' ' A' ' 166' ' ' TRP . 59.9 t -106.94 137.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.947 0.499 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.505 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t0 -116.07 127.71 55.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.467 HG21 ' HB2' ' A' ' 131' ' ' ALA . 31.6 mm -47.33 -26.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.687 0.28 . . . . 0.0 111.522 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -63.06 -36.42 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.14 0.495 . . . . 0.0 110.575 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.531 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.86 -5.28 58.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.959 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.5 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.81 123.54 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-O 120.948 0.404 . . . . 0.0 111.583 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.98 109.02 17.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.374 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.422 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -87.44 139.42 16.0 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.116 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.16 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.682 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -84.14 101.0 2.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.842 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.52 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.597 0.237 . . . . 0.0 111.54 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 153' ' ' GLY . 55.9 m-80 -96.33 29.17 2.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.707 0.289 . . . . 0.0 111.205 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.06 25.98 50.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.768 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.609 ' HA ' HG22 ' A' ' 130' ' ' ILE . 21.7 ttp-105 -80.87 140.47 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.783 0.325 . . . . 0.0 110.679 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.77 HG12 HG11 ' A' ' 135' ' ' VAL . 22.0 t -74.64 134.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.177 0.513 . . . . 0.0 111.344 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.8 mt -106.74 163.01 13.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.15 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -56.24 -33.39 65.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -36.67 84.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.2 m-20 -64.79 -47.51 77.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.901 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.007 HD12 ' HB2' ' A' ' 139' ' ' ALA . 44.5 mm -52.81 -52.78 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.888 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.98 -45.57 86.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.16 78.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.841 ' CE3' HG22 ' A' ' 144' ' ' VAL . 69.7 t90 -59.7 -57.03 14.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.13 0.491 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.825 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.41 -32.28 56.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.996 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.742 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.108 0.48 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -170.07 152.67 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.294 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.511 ' HB2' HG23 ' A' ' 135' ' ' VAL . 35.2 mmm -60.89 159.12 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.686 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.72 -27.07 60.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.227 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.6 m -90.97 -32.52 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.71 HG11 HG12 ' A' ' 158' ' ' VAL . 67.7 t -64.92 -46.52 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 18.9 mtp180 -54.7 -27.84 43.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -77.78 -43.72 29.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.0 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.581 ' CD2' HG21 ' A' ' 163' ' ' ILE . 53.6 t80 -63.54 -48.11 78.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.772 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.016 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.18 -45.22 85.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.73 -31.84 58.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.197 178.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.65 -38.6 19.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.086 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.843 ' O ' HD21 ' A' ' 167' ' ' LEU . 51.4 mmtt -83.07 27.66 0.55 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.043 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.86 22.34 18.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.093 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.821 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.3 t -108.96 137.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 122.961 0.504 . . . . 0.0 111.252 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.492 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t0 -116.1 127.74 55.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.471 HG21 ' HB2' ' A' ' 131' ' ' ALA . 34.7 mm -47.1 -26.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.701 ' HG3' HD23 ' A' ' 148' ' ' LEU . 19.2 ptt85 -64.07 -34.94 79.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 110.639 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.701 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.0 OUTLIER -85.87 -8.36 58.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.489 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.7 t -114.63 121.59 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.942 0.401 . . . . 0.0 111.545 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.58 104.96 15.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.426 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -82.07 141.52 21.63 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.01 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 26.1 9.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.761 0.315 . . . . 0.0 110.829 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.05 119.0 5.53 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.58 -82.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -114.08 37.09 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.813 0.34 . . . . 0.0 111.201 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.96 26.0 27.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.569 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.742 ' HA ' HG22 ' A' ' 130' ' ' ILE . 3.2 ttt180 -81.16 138.94 35.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.786 0.327 . . . . 0.0 110.767 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.71 HG12 HG11 ' A' ' 135' ' ' VAL . 13.1 t -77.48 134.54 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 111.341 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -107.17 165.23 11.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.258 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -57.85 -33.97 69.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -36.09 82.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.2 m-20 -65.71 -47.69 74.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.767 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.016 HD12 ' HB2' ' A' ' 139' ' ' ALA . 45.3 mm -52.9 -52.76 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.839 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.24 -44.81 88.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.42 86.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.054 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.821 ' CE3' HG22 ' A' ' 144' ' ' VAL . 77.6 t90 -57.92 -57.01 14.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.514 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.843 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.95 -33.14 62.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.975 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.481 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.3 mp . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.975 0.416 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -170.02 152.54 4.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.098 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.537 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -57.41 160.02 7.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.5 -25.81 80.1 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.235 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.7 t -91.06 -29.2 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.771 HG11 HG12 ' A' ' 158' ' ' VAL . 66.0 t -68.02 -48.44 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.499 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 5.3 mtp180 -54.62 -29.13 51.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.912 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.64 -41.81 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.237 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.555 ' CD2' HG21 ' A' ' 163' ' ' ILE . 45.6 t80 -65.16 -48.13 74.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.98 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.058 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.77 -46.08 80.08 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.6 -31.81 57.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.362 178.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -84.42 -38.43 20.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.256 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.71 ' HB3' HD11 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.31 21.91 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.876 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.16 17.77 46.44 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.985 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.775 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.7 t -103.94 137.25 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.094 0.558 . . . . 0.0 110.851 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.456 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t0 -116.08 127.43 54.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.714 HG23 HG21 ' A' ' 158' ' ' VAL . 28.0 mm -46.13 -26.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.812 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.579 ' HG3' HD23 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -64.07 -37.33 87.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -82.98 -8.89 59.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.414 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.514 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.5 t -114.49 115.15 48.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.863 0.363 . . . . 0.0 111.499 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.5 109.97 6.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.668 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -71.89 130.99 17.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.676 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 26.19 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.708 0.289 . . . . 0.0 110.935 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -103.38 121.61 7.16 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.325 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.36 -84.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.3 m-80 -109.19 35.72 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.045 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 84.63 26.04 40.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.481 ' HG3' HG22 ' A' ' 130' ' ' ILE . 31.2 ttm180 -80.97 147.0 30.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.727 0.299 . . . . 0.0 110.831 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.771 HG12 HG11 ' A' ' 135' ' ' VAL . 37.1 t -81.16 132.05 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.267 0.556 . . . . 0.0 111.331 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.0 mt -108.99 165.07 11.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.956 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 3.3 tptt -55.92 -32.08 63.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -64.65 -37.97 89.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -62.64 -49.74 73.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.61 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.058 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.4 mm -52.69 -52.26 28.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.582 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.47 -45.34 94.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.13 81.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.775 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.9 t90 -58.3 -57.09 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.306 0.574 . . . . 0.0 110.21 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 142' ' ' LYS . 9.1 mt -61.07 -31.9 71.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.865 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.567 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.029 0.443 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.697 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -167.53 148.07 5.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.043 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.1 mtm -63.02 148.72 92.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -51.49 -26.46 21.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.541 2.161 . . . . 0.0 112.402 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.2 t -90.3 -29.09 18.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 158' ' ' VAL . 99.3 t -70.73 -48.25 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.381 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.697 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 7.0 mtt85 -54.65 -29.21 51.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.965 0.412 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.63 -44.32 28.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.191 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CD2' HG21 ' A' ' 163' ' ' ILE . 53.3 t80 -63.63 -48.01 79.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.921 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.047 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.24 -45.79 83.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.7 -31.82 58.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.299 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -84.4 -38.75 19.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.32 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.805 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -84.3 28.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.917 -179.142 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 21.64 17.55 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.234 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.827 HG22 ' CE3' ' A' ' 166' ' ' TRP . 56.8 t -106.95 136.69 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 122.852 0.461 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 32.2 t0 -116.16 126.83 54.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.2 mm -46.55 -25.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.754 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.77 84.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.209 0.528 . . . . 0.0 110.585 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.535 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.26 -5.91 58.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.924 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.471 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.7 t -114.77 126.1 72.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.961 0.41 . . . . 0.0 111.397 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.87 105.7 17.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.71 23.21 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.707 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.1 26.04 9.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.9 140.44 14.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 51.49 -90.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.215 . . . . 0.0 111.4 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -114.16 25.7 10.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.34 10.72 30.96 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.824 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.567 ' CB ' HG22 ' A' ' 130' ' ' ILE . 32.6 ttm180 -65.66 139.99 58.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 0.0 110.72 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 135' ' ' VAL . 21.2 t -78.11 132.83 31.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.0 mt -104.4 165.09 11.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.208 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -34.16 67.91 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.63 84.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.3 m-20 -64.75 -47.47 78.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.777 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.047 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.9 mm -52.89 -52.51 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.725 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -58.44 -41.66 85.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.04 85.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.827 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.1 t90 -59.85 -57.04 14.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.417 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.805 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.65 -32.44 59.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.983 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.237 -179.949 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 157' ' ' ARG . 3.9 mp . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.064 0.459 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 136' ' ' ARG . . . -169.41 146.28 3.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.035 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -57.82 160.03 8.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.11 -25.23 65.78 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.563 2.175 . . . . 0.0 112.319 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.02 -31.5 16.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.781 HG11 HG12 ' A' ' 158' ' ' VAL . 60.9 t -67.3 -46.58 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.25 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.464 ' HD2' ' HB3' ' A' ' 131' ' ' ALA . 4.6 mtp180 -54.71 -29.12 52.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.73 -43.98 29.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.194 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.501 ' CD2' HG21 ' A' ' 163' ' ' ILE . 47.7 t80 -63.95 -47.99 78.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.929 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.5 -46.94 77.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.79 58.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.235 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.28 -38.14 20.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.312 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.744 ' HB3' HD11 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.35 19.07 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.766 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.36 14.89 55.84 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.039 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.837 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.8 t -100.11 138.29 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 122.98 0.512 . . . . 0.0 110.769 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.506 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 11.2 t70 -116.08 127.99 55.31 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.443 HG21 ' HB2' ' A' ' 131' ' ' ALA . 34.8 mm -47.52 -26.13 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.531 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 -62.96 -36.2 82.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 110.575 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.533 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.12 -6.05 58.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.91 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.495 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.11 122.33 68.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.393 . . . . 0.0 111.365 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -85.66 115.32 23.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.69 136.7 16.94 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.2 26.01 9.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 111.025 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.6 145.5 17.75 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.859 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 48.97 -93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.194 0.198 . . . . 0.0 111.389 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -114.08 29.38 8.05 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.91 18.37 25.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.621 ' HA ' HG22 ' A' ' 130' ' ' ILE . 5.0 ttm180 -74.15 137.63 43.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.753 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.781 HG12 HG11 ' A' ' 135' ' ' VAL . 21.0 t -74.23 135.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.133 0.492 . . . . 0.0 111.217 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.498 ' HA ' HG21 ' A' ' 135' ' ' VAL . 12.9 mt -108.31 166.76 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -58.23 -33.7 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.93 -35.25 80.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.7 m-20 -66.28 -47.45 73.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.784 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.3 mm -52.8 -52.46 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.577 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.71 -44.82 90.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.47 80.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.976 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.837 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.4 t90 -58.4 -56.99 14.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.579 . . . . 0.0 110.357 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.2 mt -59.99 -27.42 66.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.094 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.257 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.551 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.5 mp . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.505 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -166.06 148.35 7.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.229 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.541 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -56.62 150.12 37.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.61 -26.94 13.68 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.607 2.204 . . . . 0.0 112.382 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.98 -29.4 17.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 87.0 t -68.93 -51.47 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.421 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -54.53 -29.62 51.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.884 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -77.66 -41.62 37.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.157 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.0 t80 -65.29 -48.17 74.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.995 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.45 -46.6 79.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -54.65 -31.67 57.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.489 178.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -84.41 -38.36 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.067 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.704 ' HB3' HD11 ' A' ' 167' ' ' LEU . 49.8 mmtt -83.95 22.62 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.05 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.48 16.46 36.29 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.293 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.818 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.3 t -101.23 137.89 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.962 0.505 . . . . 0.0 110.707 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 34.6 t0 -116.03 127.51 54.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.832 HG23 ' CG2' ' A' ' 158' ' ' VAL . 36.8 mm -47.2 -26.17 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -62.82 -37.0 85.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.171 0.51 . . . . 0.0 110.521 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.525 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.85 -6.63 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.846 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.507 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -115.78 119.84 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.925 0.393 . . . . 0.0 111.527 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.63 101.82 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.547 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -79.39 145.45 27.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.864 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.32 25.96 9.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.744 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -86.93 110.1 3.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.076 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.27 -82.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.614 0.245 . . . . 0.0 111.491 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.5 m120 -104.2 29.16 6.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 111.007 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.94 26.04 23.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.551 ' CB ' HG22 ' A' ' 130' ' ' ILE . 13.1 ttp-105 -75.78 139.52 41.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.832 ' CG2' HG23 ' A' ' 146' ' ' ILE . 47.4 t -74.21 131.99 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.29 0.567 . . . . 0.0 111.468 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -106.29 163.47 12.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.751 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -55.7 -31.82 62.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.603 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.2 -38.0 89.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.262 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -61.72 -49.9 74.6 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.729 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 33.6 mm -52.68 -54.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.789 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -56.68 -48.01 78.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.065 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.38 74.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.023 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.818 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.8 t90 -59.32 -57.01 14.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.198 0.523 . . . . 0.0 110.324 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.704 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.4 mt -60.46 -21.71 62.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.232 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.142 179.963 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.039 0.447 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.54 154.58 12.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.089 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.5 ' HB2' HG23 ' A' ' 135' ' ' VAL . 6.7 mtp -71.37 149.85 93.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.757 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -51.41 -31.64 39.21 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.53 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 p -85.18 -29.81 24.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.785 HG11 HG12 ' A' ' 158' ' ' VAL . 61.2 t -70.8 -46.86 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.531 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.9 mtp180 -54.77 -29.91 55.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.979 0.419 . . . . 0.0 109.946 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -77.77 -44.85 26.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.139 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.54 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.7 t80 -62.59 -48.21 80.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.92 -45.35 86.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.62 -31.98 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.372 178.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.67 -38.08 20.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.173 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.799 ' O ' HD21 ' A' ' 167' ' ' LEU . 20.3 mmtp -84.18 26.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.909 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 21.48 16.66 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.181 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.836 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.8 t -106.17 137.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 122.926 0.491 . . . . 0.0 110.986 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.488 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 59.3 t0 -116.09 127.38 54.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 131' ' ' ALA . 31.4 mm -47.01 -26.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.668 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -35.87 81.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.202 0.525 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.542 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.28 -5.75 58.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.925 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.489 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.78 117.7 56.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 111.379 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.34 112.83 12.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.676 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -81.22 131.8 10.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.744 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 26.09 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.613 0.244 . . . . 0.0 110.93 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -102.61 124.69 8.26 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.461 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.46 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.0 p30 -113.13 30.62 7.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 91.64 26.03 21.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.56 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.598 ' HA ' HG22 ' A' ' 130' ' ' ILE . 43.5 ttm-85 -81.51 143.83 31.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.802 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.785 HG12 HG11 ' A' ' 135' ' ' VAL . 24.6 t -79.44 132.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.129 0.49 . . . . 0.0 111.322 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.3 mt -105.22 163.98 12.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.083 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.37 -33.22 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.25 -36.2 83.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -65.16 -47.26 77.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 44.4 mm -52.81 -51.67 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.782 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -58.86 -45.4 90.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.865 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.78 75.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.836 ' CE3' HG22 ' A' ' 144' ' ' VAL . 64.7 t90 -60.79 -57.05 14.31 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.142 0.496 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.7 mt -55.69 -33.4 64.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.957 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.198 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 121.085 0.469 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -166.26 147.42 6.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.082 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.479 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.6 OUTLIER -62.89 148.49 91.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.32 -26.47 27.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 p -89.34 -34.94 16.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.69 HG11 HG12 ' A' ' 158' ' ' VAL . 99.3 t -66.02 -46.76 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.651 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 8.9 mtp-105 -54.71 -29.16 52.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.88 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -77.65 -42.99 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.301 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.8 t80 -64.52 -48.18 76.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.886 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.027 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.95 -46.39 81.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.68 -31.76 58.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.413 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -84.46 -37.68 21.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.075 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.731 ' HB3' HD11 ' A' ' 167' ' ' LEU . 47.9 mmtt -84.64 22.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.832 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.72 16.62 31.3 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.317 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.4 t -101.1 137.73 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 122.761 0.424 . . . . 0.0 110.652 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.513 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.6 t0 -116.08 127.25 54.71 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.406 HG21 ' HB2' ' A' ' 131' ' ' ALA . 32.7 mm -46.85 -26.38 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.507 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.87 -37.44 86.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 110.527 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.537 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.51 -6.73 58.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.851 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.509 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.8 t -114.7 126.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.954 0.406 . . . . 0.0 111.546 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -91.92 103.96 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.509 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -76.49 143.79 29.72 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.814 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.307 . . . . 0.0 110.864 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.37 140.82 15.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.731 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.98 -91.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.541 0.21 . . . . 0.0 111.385 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.13 26.21 10.48 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.743 0.306 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.2 6.83 33.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.818 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.609 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -60.93 139.75 57.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.69 HG12 HG11 ' A' ' 135' ' ' VAL . 25.2 t -79.76 131.93 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.563 ' HA ' HG21 ' A' ' 135' ' ' VAL . 13.5 mt -104.43 167.16 9.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.306 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.451 ' HE2' ' CG ' ' A' ' 138' ' ' TYR . 1.3 ttmt -57.54 -35.7 70.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.44 -35.5 79.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.212 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -66.61 -47.94 71.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.027 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.2 mm -52.92 -53.58 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.41 -39.86 80.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.32 86.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 69.1 t90 -57.64 -57.03 14.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.294 0.569 . . . . 0.0 110.274 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.731 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.1 mt -59.23 -30.91 68.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.976 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.507 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.7 mp . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.058 0.456 . . . . 0.0 110.711 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.439 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.25 155.47 5.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.244 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.56 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.6 mtp -61.65 157.0 51.06 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.397 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.99 -25.43 77.62 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.483 2.122 . . . . 0.0 112.248 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -29.43 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.285 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.758 HG11 HG12 ' A' ' 158' ' ' VAL . 45.6 t -69.3 -46.91 76.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.773 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 8.1 mtp180 -54.56 -30.72 54.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -77.62 -40.97 40.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.281 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.51 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.5 t80 -64.66 -48.15 75.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.883 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.036 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.7 -45.5 82.53 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.8 58.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.465 178.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.73 -38.33 19.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.715 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.0 mmtt -83.32 27.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.77 17.7 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.075 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.809 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.8 t -107.94 137.14 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 122.935 0.494 . . . . 0.0 111.134 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.4 t0 -116.07 126.52 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.732 HG23 HG21 ' A' ' 158' ' ' VAL . 37.5 mm -46.95 -25.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.606 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.56 -37.56 86.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.0 110.439 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.52 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -85.68 -7.87 58.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.795 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.599 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.5 t -115.04 115.71 50.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.414 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 108.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.636 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -70.66 134.78 24.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.803 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.21 26.0 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 110.801 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -89.7 101.17 2.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.863 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt 57.36 -84.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.605 0.24 . . . . 0.0 111.33 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.13 9.58 25.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.49 26.01 7.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.691 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.507 ' HG3' HG22 ' A' ' 130' ' ' ILE . 28.8 ttm180 -79.04 145.46 33.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.868 0.366 . . . . 0.0 110.796 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.758 HG12 HG11 ' A' ' 135' ' ' VAL . 17.3 t -80.14 126.48 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.222 0.534 . . . . 0.0 111.227 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.3 mt -105.11 164.66 11.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.185 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -56.05 -33.03 64.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.8 -37.2 86.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.9 m-20 -63.2 -48.91 76.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.759 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.036 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.8 mm -52.71 -53.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.715 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.61 -41.91 82.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.78 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.25 83.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.809 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.4 t90 -60.12 -56.96 15.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.334 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.715 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.3 mt -54.83 -32.77 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.046 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -179.936 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 157' ' ' ARG . 3.3 mp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.092 0.472 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.08 147.73 3.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.994 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.487 ' HB2' HG23 ' A' ' 135' ' ' VAL . 8.3 mtp -59.13 159.96 13.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.681 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.64 -25.52 69.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.499 2.132 . . . . 0.0 112.348 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.3 t -90.97 -33.3 15.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.14 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.651 HG11 HG12 ' A' ' 158' ' ' VAL . 46.4 t -66.32 -44.68 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.361 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 61.3 mtp85 -54.76 -29.95 55.3 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -77.66 -42.43 34.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.156 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.6 t80 -64.21 -47.96 77.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.976 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.023 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.0 -45.68 80.71 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.88 58.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.26 178.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.62 -38.73 19.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.834 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -82.99 27.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.85 -178.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.44 19.94 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.913 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.833 HG22 ' CE3' ' A' ' 166' ' ' TRP . 57.6 t -108.39 138.01 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 0.0 110.997 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t70 -116.16 127.02 54.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 131' ' ' ALA . 38.0 mm -46.65 -26.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.667 0.27 . . . . 0.0 111.626 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 mtt85 -63.03 -37.09 85.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.26 0.553 . . . . 0.0 110.64 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.9 -5.32 59.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.958 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.49 118.97 60.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.872 0.367 . . . . 0.0 111.496 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.51 116.31 17.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -82.05 131.65 10.55 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.048 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 25.96 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.663 0.268 . . . . 0.0 110.732 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.12 118.63 6.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.074 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.68 -87.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.631 0.253 . . . . 0.0 111.52 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -99.07 28.14 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.726 0.298 . . . . 0.0 111.04 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.17 26.13 34.86 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.737 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 130' ' ' ILE . 22.4 ttm180 -78.88 143.55 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.741 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.651 HG12 HG11 ' A' ' 135' ' ' VAL . 18.0 t -77.79 129.93 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.234 0.54 . . . . 0.0 111.334 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' HA ' HG21 ' A' ' 135' ' ' VAL . 16.5 mt -105.44 166.47 10.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.361 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -57.65 -33.69 68.57 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.18 -35.86 82.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -65.67 -47.58 75.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.823 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.0 mm -52.88 -52.27 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.799 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -57.77 -46.3 84.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.83 72.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.018 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.833 ' CE3' HG22 ' A' ' 144' ' ' VAL . 62.9 t90 -61.55 -57.13 13.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.377 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.834 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.6 mt -56.44 -34.67 67.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.945 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 157' ' ' ARG . 3.3 mt . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.878 0.371 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.479 ' HB2' HD12 ' A' ' 146' ' ' ILE . . . -165.94 149.9 7.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.261 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.517 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.6 mtt -59.9 148.78 75.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.69 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -50.96 -25.22 15.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.474 2.116 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.2 p -90.97 -34.73 15.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.053 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.676 HG11 HG12 ' A' ' 158' ' ' VAL . 54.8 t -65.19 -44.91 95.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.322 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 22.3 mtp85 -54.67 -30.1 54.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.82 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.71 -41.32 38.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.266 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.512 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.2 t80 -65.09 -48.06 75.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.927 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.012 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.73 -46.12 80.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.69 -31.7 58.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.346 178.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -84.61 -38.76 19.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.279 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.814 ' O ' HD21 ' A' ' 167' ' ' LEU . 16.5 mmtp -84.16 28.17 0.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.988 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 21.22 16.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.223 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.818 HG22 ' CE3' ' A' ' 166' ' ' TRP . 52.9 t -106.83 137.1 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 122.975 0.51 . . . . 0.0 110.969 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.493 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 24.6 t0 -116.03 126.18 53.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.729 HG23 HG21 ' A' ' 158' ' ' VAL . 28.1 mm -46.59 -25.51 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -62.98 -37.07 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.226 0.536 . . . . 0.0 110.465 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.545 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.73 -5.8 59.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.874 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.452 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.6 t -114.8 124.5 71.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.934 0.397 . . . . 0.0 111.296 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.33 103.64 15.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -81.51 140.42 21.13 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.847 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.282 . . . . 0.0 110.925 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.61 120.03 6.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.087 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt 57.73 -86.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.549 0.214 . . . . 0.0 111.469 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.65 37.04 2.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 26.09 32.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.635 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.584 ' CB ' HG22 ' A' ' 130' ' ' ILE . 29.0 ttm180 -80.45 142.37 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.729 HG21 HG23 ' A' ' 146' ' ' ILE . 43.5 t -76.97 132.65 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.567 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.5 mt -106.96 163.53 12.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.739 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HE2' ' CE1' ' A' ' 138' ' ' TYR . 9.1 tttm -56.18 -32.13 64.06 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.744 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.83 85.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.5 m-20 -64.43 -49.21 72.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.882 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.012 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.1 mm -52.53 -51.78 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.88 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -58.46 -47.15 84.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.997 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.6 -34.91 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.818 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.4 t90 -61.71 -57.12 13.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 0.0 110.491 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 142' ' ' LYS . 2.5 mt -55.61 -23.91 30.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.263 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.608 -179.806 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.514 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 CA--C 1.522 -0.135 0 CA-C-O 120.958 0.409 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.717 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -162.83 154.65 18.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.413 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.4 mtp -65.82 160.02 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.88 -26.42 82.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.51 2.14 . . . . 0.0 112.186 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -91.04 -31.92 16.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 45.2 t -70.17 -46.63 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.414 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.717 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 4.8 mtt180 -54.56 -31.94 57.49 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -77.7 -39.94 43.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.462 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CD2' HG21 ' A' ' 163' ' ' ILE . 44.8 t80 -65.89 -48.17 72.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.052 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.025 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.32 -46.29 77.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 7.1 tpp85 -54.6 -31.79 57.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.318 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.49 -38.44 20.1 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.68 ' HB3' HD11 ' A' ' 167' ' ' LEU . 17.4 mmtp -84.25 27.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.92 19.38 14.52 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.307 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.765 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.9 t -104.99 136.71 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 122.954 0.502 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.428 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 14.7 t0 -116.04 126.54 53.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.773 HG23 ' CG2' ' A' ' 158' ' ' VAL . 34.6 mm -45.44 -26.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -64.94 -35.31 80.75 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.565 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.45 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.9 OUTLIER -84.53 -8.17 59.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 178.696 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.45 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.2 t -114.83 120.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.503 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -81.94 105.55 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -82.88 141.42 20.91 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.99 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.02 9.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.777 0.323 . . . . 0.0 110.779 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -89.22 111.41 3.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.847 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt 54.84 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.523 0.201 . . . . 0.0 111.483 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 34.6 m120 -100.39 36.97 1.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 111.066 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.79 25.98 59.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.568 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.514 ' CB ' HG22 ' A' ' 130' ' ' ILE . 22.5 ttm180 -78.17 141.71 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.852 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.773 ' CG2' HG23 ' A' ' 146' ' ' ILE . 42.0 t -75.25 133.06 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 0.0 111.332 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.0 mt -107.24 164.51 12.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.856 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -55.8 -32.1 63.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.01 -37.65 88.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.456 ' CB ' HG13 ' A' ' 158' ' ' VAL . 4.6 m-20 -62.62 -49.91 73.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.025 HD12 ' HB2' ' A' ' 139' ' ' ALA . 32.5 mm -52.79 -53.2 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.598 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.43 -47.94 82.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.808 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.17 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.765 ' CE3' HG22 ' A' ' 144' ' ' VAL . 65.2 t90 -59.81 -56.68 18.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.242 0.544 . . . . 0.0 110.239 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.68 HD11 ' HB3' ' A' ' 142' ' ' LYS . 9.3 mt -62.32 -31.04 71.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.953 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.54 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.3 mp . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.017 0.437 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -169.51 144.01 2.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.088 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.2 mtp -58.95 147.65 72.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.24 -25.91 25.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.49 2.126 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.1 p -87.78 -36.75 17.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.647 HG11 HG12 ' A' ' 158' ' ' VAL . 48.0 t -67.07 -45.68 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.34 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.603 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 59.6 mtm180 -54.74 -29.96 55.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -41.16 38.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.201 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CD2' HG21 ' A' ' 163' ' ' ILE . 48.8 t80 -65.19 -48.16 74.42 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.836 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.46 -46.29 80.43 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 4.2 tpt85 -54.63 -31.63 57.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.29 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.47 -38.09 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.664 ' HB3' HD11 ' A' ' 167' ' ' LEU . 19.2 mmtp -84.09 22.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.937 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.53 35.32 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.224 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.7 t -101.31 137.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 123.041 0.536 . . . . 0.0 110.606 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.7 t0 -116.04 126.02 53.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.7 mm -45.69 -26.37 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.803 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -62.94 -37.31 86.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.277 0.56 . . . . 0.0 110.58 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.536 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.16 -6.01 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.884 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.438 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -114.4 123.47 70.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.332 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -86.13 106.34 17.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.534 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -77.39 136.86 19.43 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.826 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 26.05 9.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.065 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.34 137.96 13.86 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.967 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.1 -90.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.594 0.235 . . . . 0.0 111.472 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -114.05 28.56 8.66 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.93 35.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.683 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.54 ' CB ' HG22 ' A' ' 130' ' ' ILE . 7.5 ttm180 -69.87 140.32 53.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.662 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.647 HG12 HG11 ' A' ' 135' ' ' VAL . 15.0 t -77.35 131.38 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.544 ' HA ' HG21 ' A' ' 135' ' ' VAL . 13.2 mt -104.54 167.77 9.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.468 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.93 70.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.58 -34.62 78.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.267 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -67.04 -47.29 71.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.756 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.6 mm -52.87 -52.52 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.622 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.48 -44.46 89.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.88 74.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 56.5 t90 -61.22 -56.26 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 142' ' ' LYS . 4.6 mt -60.75 -34.38 74.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.849 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.274 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.513 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.976 0.417 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.461 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.33 154.7 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.24 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.9 mtp -60.41 155.12 50.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.26 -27.39 56.8 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.656 2.237 . . . . 0.0 112.525 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -91.03 -27.29 18.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.776 HG11 HG12 ' A' ' 158' ' ' VAL . 57.6 t -69.89 -47.47 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 74.7 mtm180 -54.65 -30.25 54.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.59 33.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.574 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.2 t80 -64.42 -48.2 76.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.006 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 1.022 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.64 -45.98 80.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 2.4 tpt180 -54.7 -31.77 58.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.335 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.63 -38.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.809 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.4 mmtt -83.29 27.78 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.048 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.02 18.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.057 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.82 HG22 ' CE3' ' A' ' 166' ' ' TRP . 53.3 t -108.12 136.61 43.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 122.921 0.489 . . . . 0.0 110.964 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.454 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 30.5 t0 -116.18 126.49 53.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.757 HG23 HG21 ' A' ' 158' ' ' VAL . 29.7 mm -45.93 -26.18 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.803 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -62.39 -36.49 82.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.267 0.556 . . . . 0.0 110.524 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.533 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.84 -6.8 57.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.834 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.46 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.4 t -113.67 114.73 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.04 100.45 7.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.526 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -76.23 141.99 27.69 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.68 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.28 26.08 9.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 110.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.99 118.68 5.56 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.325 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.73 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -114.15 28.75 8.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 95.85 22.13 21.61 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.62 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.513 ' CB ' HG22 ' A' ' 130' ' ' ILE . 39.3 ttm180 -76.5 140.99 41.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 110.573 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.776 HG12 HG11 ' A' ' 135' ' ' VAL . 40.6 t -74.02 137.99 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.375 0.607 . . . . 0.0 111.539 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.6 mt -113.66 163.08 15.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.638 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.75 -32.52 63.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.809 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -64.28 -36.37 83.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.4 m-20 -64.39 -49.33 72.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.859 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.022 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.5 mm -52.68 -54.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.003 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.16 -47.14 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.983 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.72 -35.74 75.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.149 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.82 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.8 t90 -60.99 -57.0 14.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.584 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -55.18 -32.27 62.05 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.194 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.807 0.337 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.12 -28.83 8.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 173.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.837 HG13 ' HB ' ' A' ' 146' ' ' ILE . 73.2 t -94.06 136.41 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.179 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.492 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp -129.98 111.97 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.596 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.32 155.42 7.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.557 ' HB2' HG23 ' A' ' 135' ' ' VAL . 5.5 mtm -61.53 150.69 80.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.8 -26.02 22.72 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -91.04 -27.89 18.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.088 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 158' ' ' VAL . 95.5 t -68.67 -49.44 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.32 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -54.56 -29.4 51.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -77.74 -42.71 33.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.172 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.557 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.4 t80 -64.24 -48.13 76.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.008 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.16 -45.71 83.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 2.4 ttt180 -54.68 -31.82 58.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.386 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -84.58 -38.2 20.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.092 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.797 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.4 mmtt -83.54 26.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.044 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.01 18.23 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.163 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.4 t -107.48 137.76 37.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.001 0.52 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t70 -116.17 127.56 54.9 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.837 ' HB ' HG13 ' A' ' 129' ' ' VAL . 33.3 mm -47.0 -26.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.592 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -62.7 -36.51 83.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.16 0.505 . . . . 0.0 110.585 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.519 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.67 -6.57 58.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.865 179.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.506 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.53 112.28 39.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.1 102.12 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.415 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -69.89 136.21 27.12 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.494 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.624 0.249 . . . . 0.0 111.092 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.23 128.81 9.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.165 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.18 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -111.85 30.15 7.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 93.05 18.59 39.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.741 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.492 ' CB ' HG22 ' A' ' 130' ' ' ILE . 34.7 ttm180 -72.35 141.15 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.311 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 135' ' ' VAL . 25.6 t -76.11 130.56 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.26 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.7 mt -106.26 163.98 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.968 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -56.22 -32.63 64.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.695 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.68 -36.31 83.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.82 -48.98 72.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.774 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.008 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.3 mm -52.59 -53.24 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.755 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.1 -48.07 81.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.948 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.31 72.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.1 t90 -60.36 -57.02 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.384 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.7 -32.21 59.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.045 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.97 -25.06 64.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.28 -32.45 7.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.504 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.414 -1.215 . . . . 0.0 112.479 179.948 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.848 0.356 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -91.73 151.06 20.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.408 ' HB3' ' NH1' ' A' ' 128' ' ' ARG . 5.6 mtp-105 -97.98 -33.19 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.834 HG13 ' HB ' ' A' ' 146' ' ' ILE . 74.2 t -94.41 141.38 15.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.606 HG22 ' CG ' ' A' ' 157' ' ' ARG . 4.6 mp -130.05 112.72 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.63 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.26 150.34 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.194 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.55 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.6 mtp -57.5 157.71 12.87 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.713 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.78 -26.31 65.62 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.515 2.143 . . . . 0.0 112.178 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.03 -28.06 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.944 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.557 HG11 HG12 ' A' ' 158' ' ' VAL . 89.8 t -69.82 -51.38 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.442 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.63 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 51.5 mtt180 -54.63 -30.2 54.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -77.74 -41.37 37.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.232 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.513 ' CD2' HG21 ' A' ' 163' ' ' ILE . 49.1 t80 -65.33 -48.03 74.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.887 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.057 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.96 -46.08 79.4 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.55 -32.01 57.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.167 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.38 -38.14 20.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.814 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.79 26.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.807 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 22.78 21.01 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.921 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.827 HG22 ' CE3' ' A' ' 166' ' ' TRP . 62.1 t -108.62 137.85 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 122.971 0.508 . . . . 0.0 111.172 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.491 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 62.8 t0 -116.14 127.49 54.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.834 ' HB ' HG13 ' A' ' 129' ' ' VAL . 32.2 mm -47.09 -26.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.532 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -62.79 -36.22 82.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 110.581 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.513 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.96 -5.85 58.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.91 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.494 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.26 117.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.887 0.375 . . . . 0.0 111.507 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.69 103.03 9.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.501 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -82.72 144.84 23.33 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.909 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.29 26.1 9.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.702 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -81.01 94.85 1.6 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.947 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 60.31 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.605 0.24 . . . . 0.0 111.392 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.8 m120 -97.88 27.23 4.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.2 26.08 34.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.606 ' CG ' HG22 ' A' ' 130' ' ' ILE . 33.2 ttp85 -77.89 141.49 39.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' A' ' 146' ' ' ILE . 42.9 t -75.62 133.53 31.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.237 0.542 . . . . 0.0 111.617 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 17.7 mt -106.25 161.07 14.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.685 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -56.11 -32.26 64.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.684 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.15 -36.67 84.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.9 m-20 -64.01 -48.68 75.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.796 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.057 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.5 mm -52.67 -52.31 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.766 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -58.1 -47.41 83.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.94 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.47 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.827 ' CE3' HG22 ' A' ' 144' ' ' VAL . 68.0 t90 -60.93 -57.0 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.96 -32.19 61.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.64 -24.97 56.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.27 -43.02 1.77 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.449 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.498 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.907 0.384 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -138.59 79.03 1.71 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 -66.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.785 HG13 ' HB ' ' A' ' 146' ' ' ILE . 35.9 t -132.64 134.64 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.611 HG22 ' CB ' ' A' ' 157' ' ' ARG . 41.4 mt -130.03 115.7 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.501 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.581 ' HB3' ' CG ' ' A' ' 136' ' ' ARG . . . -162.48 155.86 20.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.367 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.494 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.6 mtm -69.61 154.94 94.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.732 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 -28.11 45.15 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.127 . . . . 0.0 112.351 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.3 p -91.04 -32.3 15.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.652 HG11 HG12 ' A' ' 158' ' ' VAL . 72.2 t -68.07 -48.36 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.443 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.581 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 10.0 mtt180 -54.56 -29.27 50.64 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -77.65 -41.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.157 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.548 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.6 t80 -65.48 -48.12 73.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.059 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.23 -45.97 82.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -54.59 -31.85 57.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.306 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.49 -37.67 21.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.694 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.1 mmtt -84.17 27.67 0.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.951 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.7 20.23 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.957 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.754 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.8 t -109.01 138.41 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.953 0.501 . . . . 0.0 111.184 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.486 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.1 t0 -116.13 127.1 54.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.817 HG23 ' CG2' ' A' ' 158' ' ' VAL . 39.1 mm -47.36 -25.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.599 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.74 ' HG3' HD23 ' A' ' 148' ' ' LEU . 17.5 ptt180 -63.16 -36.98 85.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.076 0.465 . . . . 0.0 110.444 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.74 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.1 mt -83.26 -10.45 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.48 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.586 HG22 ' CD1' ' A' ' 166' ' ' TRP . 2.7 t -114.13 114.03 45.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.925 0.393 . . . . 0.0 111.429 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -77.92 99.17 5.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 141.9 26.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.588 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.21 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.641 0.258 . . . . 0.0 111.027 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.36 120.69 6.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.132 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.55 -86.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.467 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -113.97 36.93 3.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.773 0.321 . . . . 0.0 111.181 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.48 25.93 24.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.645 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.611 ' CB ' HG22 ' A' ' 130' ' ' ILE . 7.1 ttm180 -81.58 143.96 31.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.677 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.817 ' CG2' HG23 ' A' ' 146' ' ' ILE . 43.8 t -80.58 133.36 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.9 mt -106.89 162.87 13.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.721 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -56.29 -32.63 64.78 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.698 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -64.13 -36.47 84.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.7 m-20 -65.36 -49.65 68.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.741 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.059 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.5 mm -52.59 -48.63 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.623 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -59.91 -48.01 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.49 -37.18 77.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.951 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.754 ' CE3' HG22 ' A' ' 144' ' ' VAL . 76.8 t90 -59.86 -56.99 14.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -56.54 -31.85 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.958 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.72 22.64 7.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.249 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -116.47 -27.62 2.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.581 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.367 -1.24 . . . . 0.0 112.558 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.852 0.358 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.8 58.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -153.8 108.21 3.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.801 HG13 ' HB ' ' A' ' 146' ' ' ILE . 55.8 t -138.02 138.78 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.002 0.43 . . . . 0.0 111.288 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.472 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp -130.17 111.95 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.479 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -169.51 152.4 4.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.106 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.527 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -57.29 159.98 7.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.96 -25.26 77.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.46 2.107 . . . . 0.0 112.199 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.03 -29.16 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.752 HG11 HG12 ' A' ' 158' ' ' VAL . 66.4 t -68.27 -47.91 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.334 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -54.65 -29.46 52.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -77.73 -43.07 32.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.558 ' CD2' HG21 ' A' ' 163' ' ' ILE . 48.4 t80 -64.03 -48.24 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.907 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.03 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.53 -45.4 83.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -31.87 59.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.177 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.57 -38.17 20.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.809 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.5 mmtt -83.75 26.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.933 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.93 22.3 19.31 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.027 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.832 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.0 t -107.99 137.47 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.988 0.515 . . . . 0.0 111.151 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 19.4 t0 -116.14 127.42 54.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.801 ' HB ' HG13 ' A' ' 129' ' ' VAL . 29.3 mm -47.31 -25.74 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.681 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -62.8 -36.23 82.46 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.201 0.525 . . . . 0.0 110.429 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.526 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.97 -6.86 57.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.783 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.514 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.9 t -114.67 111.92 37.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.78 103.46 5.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.524 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -79.81 141.1 23.17 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.829 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.22 26.11 9.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 110.772 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -83.87 98.32 2.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.033 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.93 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.4 m-80 -100.41 33.2 2.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.25 26.04 60.43 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.611 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.472 ' CB ' HG22 ' A' ' 130' ' ' ILE . 8.7 ttp-105 -80.61 140.88 35.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 146' ' ' ILE . 28.5 t -73.41 138.0 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 111.521 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.7 mt -111.93 161.5 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.697 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -32.69 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.791 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.29 -35.47 80.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 10.0 m-20 -65.4 -48.65 72.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.015 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.03 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.4 mm -52.68 -53.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.769 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -58.06 -46.22 85.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.28 77.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.832 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.1 t90 -60.01 -56.93 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.516 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.78 -32.18 59.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.036 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.24 -25.0 59.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.81 46.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.486 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.4 t30 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.832 0.348 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.13 88.0 3.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -119.6 -3.44 10.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.834 HG13 ' HB ' ' A' ' 146' ' ' ILE . 54.2 t -104.28 138.83 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.924 0.392 . . . . 0.0 111.288 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp -129.98 111.9 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.649 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.98 153.03 5.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.072 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.542 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -58.68 146.86 73.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.644 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.51 -25.03 13.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.575 2.183 . . . . 0.0 112.457 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.8 t -90.71 -34.13 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 49.5 t -65.45 -43.5 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.293 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.47 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 78.1 mtm-85 -54.74 -30.41 56.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -77.65 -42.25 35.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.3 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.491 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.5 t80 -63.92 -48.09 77.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.922 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.0 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.7 -45.51 82.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.73 59.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.359 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -84.64 -38.58 19.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.212 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.797 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.8 mmtp -83.42 27.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.977 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.85 17.88 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.055 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.826 HG22 ' CE3' ' A' ' 166' ' ' TRP . 62.0 t -107.71 137.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 122.983 0.513 . . . . 0.0 111.046 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.506 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 18.8 t0 -116.08 126.7 54.11 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.834 ' HB ' HG13 ' A' ' 129' ' ' VAL . 34.2 mm -47.25 -25.63 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 111.594 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -36.85 84.51 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.187 0.517 . . . . 0.0 110.45 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.538 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.83 -6.96 58.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.875 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.551 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.8 t -114.8 123.72 70.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 111.479 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.53 101.69 13.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.531 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -75.97 143.12 29.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.11 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 111.033 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.6 126.26 8.8 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.113 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.623 0.249 . . . . 0.0 111.468 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.03 36.99 3.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.95 15.67 55.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.618 ' HA ' HG22 ' A' ' 130' ' ' ILE . 46.0 ttm-85 -69.56 142.24 53.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 146' ' ' ILE . 46.6 t -78.97 132.26 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.262 0.553 . . . . 0.0 111.468 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.467 ' HA ' HG21 ' A' ' 135' ' ' VAL . 12.7 mt -107.21 163.48 12.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -55.86 -32.63 63.83 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.779 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.89 -36.57 84.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.12 -49.13 73.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.816 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.0 HD12 ' HB2' ' A' ' 139' ' ' ALA . 38.7 mm -52.62 -52.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.7 -42.96 84.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.05 78.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.98 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.826 ' CE3' HG22 ' A' ' 144' ' ' VAL . 65.8 t90 -61.01 -57.06 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.508 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.6 mt -56.02 -33.62 65.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.952 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.33 -25.02 59.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.258 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.01 -28.13 14.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.521 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.328 -1.262 . . . . 0.0 112.523 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.538 ' N ' HD21 ' A' ' 126' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.806 0.336 . . . . 0.0 111.187 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -105.93 -35.48 7.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.79 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.01 -45.72 0.72 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.467 HG21 ' HG3' ' A' ' 147' ' ' ARG . 1.8 t -136.89 160.09 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.7 mp -93.7 113.03 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.5 148.45 7.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.8 mmm -61.25 153.49 67.59 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.636 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.63 -25.81 76.59 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.548 2.166 . . . . 0.0 112.4 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.2 m -90.82 -32.56 16.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.094 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.772 HG11 HG12 ' A' ' 158' ' ' VAL . 86.0 t -65.98 -46.21 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.5 mtp85 -54.58 -27.95 42.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 0.0 109.995 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -77.73 -46.31 22.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.003 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.519 ' CD2' HG21 ' A' ' 163' ' ' ILE . 54.4 t80 -61.78 -48.0 82.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.734 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.991 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.4 -44.54 90.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -32.06 59.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.21 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.6 -39.8 18.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.804 ' O ' HD21 ' A' ' 167' ' ' LEU . 51.7 mmtt -81.98 25.52 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.2 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.01 21.68 18.01 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.838 HG22 ' CE3' ' A' ' 166' ' ' TRP . 59.9 t -105.79 136.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 122.906 0.483 . . . . 0.0 110.996 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t70 -116.11 127.03 54.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 131' ' ' ALA . 25.8 mm -46.87 -25.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.643 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.467 ' HG3' HG21 ' A' ' 129' ' ' VAL . 26.2 mtt-85 -62.6 -36.15 81.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.265 0.555 . . . . 0.0 110.526 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.549 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.75 -6.23 57.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.487 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.3 t -114.29 121.95 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.305 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -86.83 106.51 17.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.36 137.76 19.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.819 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.23 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.729 0.3 . . . . 0.0 111.03 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 131.88 10.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.081 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.21 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -113.89 30.27 7.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.89 17.34 38.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.669 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.649 ' HA ' HG22 ' A' ' 130' ' ' ILE . 24.7 ttm105 -73.79 138.96 44.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.708 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.772 HG12 HG11 ' A' ' 135' ' ' VAL . 23.2 t -74.61 135.82 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.171 0.51 . . . . 0.0 111.369 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.6 mt -108.51 163.98 12.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.03 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -33.61 67.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -36.69 84.61 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.3 m-20 -65.14 -47.42 77.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.679 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.991 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.7 mm -52.77 -52.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.686 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.05 -41.38 87.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.65 84.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.929 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.838 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.5 t90 -59.8 -57.07 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.425 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.9 mt -56.48 -32.27 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.86 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 -25.1 35.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.263 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -90.55 -28.4 16.75 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.567 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.549 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -69.48 170.51 10.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -62.66 -175.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.831 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.471 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.0 t -79.15 157.87 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.046 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp -87.86 111.89 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.032 0.444 . . . . 0.0 110.972 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.2 149.91 9.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.061 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -64.95 149.08 97.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.816 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.98 -24.44 32.13 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.63 2.22 . . . . 0.0 112.204 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 77.5 p -91.0 -35.07 14.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.77 HG11 HG12 ' A' ' 158' ' ' VAL . 92.1 t -65.97 -46.13 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 67.0 mtm180 -54.64 -28.78 49.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.962 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -77.78 -44.24 28.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.556 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.3 t80 -63.25 -48.06 79.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.007 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.85 -45.38 86.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.98 58.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.297 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -84.71 -37.85 20.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.045 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.825 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.1 mmtt -84.06 26.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.979 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.88 22.17 18.58 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.131 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.841 HG22 ' CE3' ' A' ' 166' ' ' TRP . 59.9 t -106.94 137.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.947 0.499 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.505 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t0 -116.07 127.71 55.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.471 HG22 ' CG1' ' A' ' 129' ' ' VAL . 31.6 mm -47.33 -26.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.687 0.28 . . . . 0.0 111.522 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -63.06 -36.42 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.14 0.495 . . . . 0.0 110.575 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.531 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.86 -5.28 58.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.959 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.5 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.81 123.54 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-O 120.948 0.404 . . . . 0.0 111.583 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.98 109.02 17.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.374 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.422 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -87.44 139.42 16.0 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.116 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.16 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.682 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -84.14 101.0 2.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.842 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.52 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.597 0.237 . . . . 0.0 111.54 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 153' ' ' GLY . 55.9 m-80 -96.33 29.17 2.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.707 0.289 . . . . 0.0 111.205 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.06 25.98 50.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.768 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.609 ' HA ' HG22 ' A' ' 130' ' ' ILE . 21.7 ttp-105 -80.87 140.47 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.783 0.325 . . . . 0.0 110.679 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.77 HG12 HG11 ' A' ' 135' ' ' VAL . 22.0 t -74.64 134.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.177 0.513 . . . . 0.0 111.344 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.8 mt -106.74 163.01 13.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.15 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -56.24 -33.39 65.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -36.67 84.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.2 m-20 -64.79 -47.51 77.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.901 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.007 HD12 ' HB2' ' A' ' 139' ' ' ALA . 44.5 mm -52.81 -52.78 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.888 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.98 -45.57 86.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.16 78.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.841 ' CE3' HG22 ' A' ' 144' ' ' VAL . 69.7 t90 -59.7 -57.03 14.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.13 0.491 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.825 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.41 -32.28 56.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.996 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.33 31.03 2.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -144.12 28.06 1.98 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.518 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.849 0.357 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -83.39 123.39 29.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? 62.26 117.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.489 ' CG1' HG22 ' A' ' 146' ' ' ILE . 3.0 t -100.56 159.55 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.742 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -83.19 111.91 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.108 0.48 . . . . 0.0 111.07 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -170.07 152.67 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.294 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.511 ' HB2' HG23 ' A' ' 135' ' ' VAL . 35.2 mmm -60.89 159.12 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.686 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.72 -27.07 60.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.227 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.6 m -90.97 -32.52 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.71 HG11 HG12 ' A' ' 158' ' ' VAL . 67.7 t -64.92 -46.52 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 18.9 mtp180 -54.7 -27.84 43.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -77.78 -43.72 29.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.0 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.581 ' CD2' HG21 ' A' ' 163' ' ' ILE . 53.6 t80 -63.54 -48.11 78.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.772 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.016 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.18 -45.22 85.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.73 -31.84 58.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.197 178.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.65 -38.6 19.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.086 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.843 ' O ' HD21 ' A' ' 167' ' ' LEU . 51.4 mmtt -83.07 27.66 0.55 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.043 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.86 22.34 18.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.093 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.821 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.3 t -108.96 137.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 122.961 0.504 . . . . 0.0 111.252 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.492 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t0 -116.1 127.74 55.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.489 HG22 ' CG1' ' A' ' 129' ' ' VAL . 34.7 mm -47.1 -26.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.701 ' HG3' HD23 ' A' ' 148' ' ' LEU . 19.2 ptt85 -64.07 -34.94 79.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 110.639 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.701 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.0 OUTLIER -85.87 -8.36 58.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.489 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.7 t -114.63 121.59 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.942 0.401 . . . . 0.0 111.545 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.58 104.96 15.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.426 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -82.07 141.52 21.63 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.01 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 26.1 9.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.761 0.315 . . . . 0.0 110.829 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.05 119.0 5.53 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.58 -82.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -114.08 37.09 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.813 0.34 . . . . 0.0 111.201 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.96 26.0 27.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.569 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.742 ' HA ' HG22 ' A' ' 130' ' ' ILE . 3.2 ttt180 -81.16 138.94 35.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.786 0.327 . . . . 0.0 110.767 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.71 HG12 HG11 ' A' ' 135' ' ' VAL . 13.1 t -77.48 134.54 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 111.341 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -107.17 165.23 11.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.258 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -57.85 -33.97 69.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -36.09 82.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.2 m-20 -65.71 -47.69 74.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.767 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.016 HD12 ' HB2' ' A' ' 139' ' ' ALA . 45.3 mm -52.9 -52.76 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.839 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.24 -44.81 88.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.42 86.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.054 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.821 ' CE3' HG22 ' A' ' 144' ' ' VAL . 77.6 t90 -57.92 -57.01 14.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.514 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.843 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.95 -33.14 62.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.975 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.39 -25.09 59.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 126.82 -28.42 4.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.561 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.463 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m120 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.775 0.321 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -174.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.791 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.37 25.59 3.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.8 HG13 ' HB ' ' A' ' 146' ' ' ILE . 56.0 t -138.07 139.74 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.043 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.481 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.3 mp -129.99 111.97 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.62 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -170.02 152.54 4.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.098 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.537 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -57.41 160.02 7.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.5 -25.81 80.1 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.235 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.7 t -91.06 -29.2 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.771 HG11 HG12 ' A' ' 158' ' ' VAL . 66.0 t -68.02 -48.44 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.499 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 5.3 mtp180 -54.62 -29.13 51.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.912 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.64 -41.81 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.237 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.555 ' CD2' HG21 ' A' ' 163' ' ' ILE . 45.6 t80 -65.16 -48.13 74.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.98 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.058 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.77 -46.08 80.08 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.6 -31.81 57.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.362 178.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -84.42 -38.43 20.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.256 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.71 ' HB3' HD11 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.31 21.91 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.876 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.16 17.77 46.44 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.985 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.775 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.7 t -103.94 137.25 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.094 0.558 . . . . 0.0 110.851 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.456 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t0 -116.08 127.43 54.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.8 ' HB ' HG13 ' A' ' 129' ' ' VAL . 28.0 mm -46.13 -26.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.812 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.579 ' HG3' HD23 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -64.07 -37.33 87.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -82.98 -8.89 59.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.414 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.514 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.5 t -114.49 115.15 48.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.863 0.363 . . . . 0.0 111.499 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.5 109.97 6.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.668 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -71.89 130.99 17.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.676 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 26.19 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.708 0.289 . . . . 0.0 110.935 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -103.38 121.61 7.16 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.325 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.36 -84.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.3 m-80 -109.19 35.72 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.045 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 84.63 26.04 40.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.481 ' HG3' HG22 ' A' ' 130' ' ' ILE . 31.2 ttm180 -80.97 147.0 30.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.727 0.299 . . . . 0.0 110.831 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.771 HG12 HG11 ' A' ' 135' ' ' VAL . 37.1 t -81.16 132.05 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.267 0.556 . . . . 0.0 111.331 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.0 mt -108.99 165.07 11.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.956 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 3.3 tptt -55.92 -32.08 63.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -64.65 -37.97 89.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -62.64 -49.74 73.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.61 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.058 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.4 mm -52.69 -52.26 28.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.582 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.47 -45.34 94.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.13 81.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.775 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.9 t90 -58.3 -57.09 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.306 0.574 . . . . 0.0 110.21 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 142' ' ' LYS . 9.1 mt -61.07 -31.9 71.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.865 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.44 -24.95 61.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 117.72 -28.1 7.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.493 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.395 -1.225 . . . . 0.0 112.448 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.829 0.347 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -103.67 147.03 27.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 142.1 39.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.494 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.3 t -100.88 158.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.978 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.567 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp -87.15 116.02 28.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.029 0.443 . . . . 0.0 111.145 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.697 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -167.53 148.07 5.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.043 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.1 mtm -63.02 148.72 92.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -51.49 -26.46 21.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.541 2.161 . . . . 0.0 112.402 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.2 t -90.3 -29.09 18.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 158' ' ' VAL . 99.3 t -70.73 -48.25 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.381 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.697 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 7.0 mtt85 -54.65 -29.21 51.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.965 0.412 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.63 -44.32 28.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.191 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CD2' HG21 ' A' ' 163' ' ' ILE . 53.3 t80 -63.63 -48.01 79.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.921 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.047 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.24 -45.79 83.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.7 -31.82 58.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.299 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -84.4 -38.75 19.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.32 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.805 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -84.3 28.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.917 -179.142 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 21.64 17.55 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.234 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.827 HG22 ' CE3' ' A' ' 166' ' ' TRP . 56.8 t -106.95 136.69 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 122.852 0.461 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 32.2 t0 -116.16 126.83 54.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.494 HG22 ' CG1' ' A' ' 129' ' ' VAL . 30.2 mm -46.55 -25.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.754 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.77 84.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.209 0.528 . . . . 0.0 110.585 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.535 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.26 -5.91 58.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.924 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.471 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.7 t -114.77 126.1 72.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.961 0.41 . . . . 0.0 111.397 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.87 105.7 17.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.71 23.21 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.707 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.1 26.04 9.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.9 140.44 14.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 51.49 -90.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.215 . . . . 0.0 111.4 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -114.16 25.7 10.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.34 10.72 30.96 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.824 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.567 ' CB ' HG22 ' A' ' 130' ' ' ILE . 32.6 ttm180 -65.66 139.99 58.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 0.0 110.72 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 135' ' ' VAL . 21.2 t -78.11 132.83 31.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.0 mt -104.4 165.09 11.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.208 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -34.16 67.91 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.63 84.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.3 m-20 -64.75 -47.47 78.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.777 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.047 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.9 mm -52.89 -52.51 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.725 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -58.44 -41.66 85.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.04 85.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.827 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.1 t90 -59.85 -57.04 14.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.417 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.805 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.65 -32.44 59.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.983 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.09 -25.05 64.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.237 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 134.26 -53.47 0.79 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.556 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.851 0.358 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.11 -55.01 5.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.56 -175.22 1.93 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.727 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.487 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.1 t -94.19 157.08 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.926 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 157' ' ' ARG . 3.9 mp -88.95 114.67 27.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.064 0.459 . . . . 0.0 111.03 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 136' ' ' ARG . . . -169.41 146.28 3.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.035 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -57.82 160.03 8.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.11 -25.23 65.78 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.563 2.175 . . . . 0.0 112.319 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.02 -31.5 16.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.781 HG11 HG12 ' A' ' 158' ' ' VAL . 60.9 t -67.3 -46.58 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.25 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.464 ' HD2' ' HB3' ' A' ' 131' ' ' ALA . 4.6 mtp180 -54.71 -29.12 52.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.73 -43.98 29.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.194 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.501 ' CD2' HG21 ' A' ' 163' ' ' ILE . 47.7 t80 -63.95 -47.99 78.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.929 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.5 -46.94 77.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.79 58.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.235 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.28 -38.14 20.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.312 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.744 ' HB3' HD11 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.35 19.07 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.766 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.36 14.89 55.84 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.039 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.837 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.8 t -100.11 138.29 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 122.98 0.512 . . . . 0.0 110.769 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.506 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 11.2 t70 -116.08 127.99 55.31 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.487 HG22 ' CG1' ' A' ' 129' ' ' VAL . 34.8 mm -47.52 -26.13 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.531 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.47 ' HG3' HG21 ' A' ' 129' ' ' VAL . 18.8 mtt85 -62.96 -36.2 82.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 110.575 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.533 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.12 -6.05 58.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.91 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.495 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.11 122.33 68.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.393 . . . . 0.0 111.365 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -85.66 115.32 23.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.69 136.7 16.94 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.2 26.01 9.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 111.025 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.6 145.5 17.75 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.859 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 48.97 -93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.194 0.198 . . . . 0.0 111.389 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -114.08 29.38 8.05 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.91 18.37 25.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.621 ' HA ' HG22 ' A' ' 130' ' ' ILE . 5.0 ttm180 -74.15 137.63 43.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.753 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.781 HG12 HG11 ' A' ' 135' ' ' VAL . 21.0 t -74.23 135.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.133 0.492 . . . . 0.0 111.217 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.498 ' HA ' HG21 ' A' ' 135' ' ' VAL . 12.9 mt -108.31 166.76 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -58.23 -33.7 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.93 -35.25 80.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.7 m-20 -66.28 -47.45 73.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.784 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.3 mm -52.8 -52.46 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.577 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.71 -44.82 90.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.47 80.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.976 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.837 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.4 t90 -58.4 -56.99 14.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.579 . . . . 0.0 110.357 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.2 mt -59.99 -27.42 66.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.094 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.04 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.257 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -88.42 -36.09 8.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.583 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.468 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.816 0.341 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 150.12 41.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -136.28 -172.74 3.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.851 HG13 ' HB ' ' A' ' 146' ' ' ILE . 77.0 t -102.26 135.58 38.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.551 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.5 mp -127.86 111.97 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.741 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.505 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -166.06 148.35 7.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.229 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.541 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -56.62 150.12 37.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.61 -26.94 13.68 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.607 2.204 . . . . 0.0 112.382 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.98 -29.4 17.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 87.0 t -68.93 -51.47 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.421 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -54.53 -29.62 51.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.884 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -77.66 -41.62 37.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.157 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.0 t80 -65.29 -48.17 74.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.995 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.45 -46.6 79.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -54.65 -31.67 57.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.489 178.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -84.41 -38.36 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.067 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.704 ' HB3' HD11 ' A' ' 167' ' ' LEU . 49.8 mmtt -83.95 22.62 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.05 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.48 16.46 36.29 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.293 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.818 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.3 t -101.23 137.89 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.962 0.505 . . . . 0.0 110.707 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 34.6 t0 -116.03 127.51 54.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.851 ' HB ' HG13 ' A' ' 129' ' ' VAL . 36.8 mm -47.2 -26.17 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -62.82 -37.0 85.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.171 0.51 . . . . 0.0 110.521 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.525 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.85 -6.63 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.846 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.507 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -115.78 119.84 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.925 0.393 . . . . 0.0 111.527 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.63 101.82 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.547 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -79.39 145.45 27.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.864 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.32 25.96 9.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.744 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -86.93 110.1 3.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.076 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.27 -82.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.614 0.245 . . . . 0.0 111.491 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 153' ' ' GLY . 8.5 m120 -104.2 29.16 6.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 111.007 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.94 26.04 23.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.551 ' CB ' HG22 ' A' ' 130' ' ' ILE . 13.1 ttp-105 -75.78 139.52 41.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.832 ' CG2' HG23 ' A' ' 146' ' ' ILE . 47.4 t -74.21 131.99 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.29 0.567 . . . . 0.0 111.468 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -106.29 163.47 12.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.751 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -55.7 -31.82 62.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.603 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.2 -38.0 89.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.262 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -61.72 -49.9 74.6 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.729 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 33.6 mm -52.68 -54.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.789 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -56.68 -48.01 78.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.065 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.38 74.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.023 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.818 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.8 t90 -59.32 -57.01 14.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.198 0.523 . . . . 0.0 110.324 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.704 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.4 mt -60.46 -21.71 62.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.232 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.99 -24.97 64.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.142 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 152.36 -68.31 0.32 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.401 -1.221 . . . . 0.0 112.439 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.894 0.378 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.5 108.73 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -106.18 52.31 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.482 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.8 t -132.2 158.02 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp -84.67 112.81 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 111.088 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.54 154.58 12.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.089 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.5 ' HB2' HG23 ' A' ' 135' ' ' VAL . 6.7 mtp -71.37 149.85 93.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.757 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -51.41 -31.64 39.21 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.53 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 p -85.18 -29.81 24.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.785 HG11 HG12 ' A' ' 158' ' ' VAL . 61.2 t -70.8 -46.86 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.531 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.9 mtp180 -54.77 -29.91 55.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.979 0.419 . . . . 0.0 109.946 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -77.77 -44.85 26.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.139 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.54 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.7 t80 -62.59 -48.21 80.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.92 -45.35 86.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.62 -31.98 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.372 178.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.67 -38.08 20.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.173 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.799 ' O ' HD21 ' A' ' 167' ' ' LEU . 20.3 mmtp -84.18 26.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.909 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 21.48 16.66 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.181 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.836 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.8 t -106.17 137.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 122.926 0.491 . . . . 0.0 110.986 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.488 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 59.3 t0 -116.09 127.38 54.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.482 HG22 ' CG1' ' A' ' 129' ' ' VAL . 31.4 mm -47.01 -26.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.668 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -35.87 81.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.202 0.525 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.542 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.28 -5.75 58.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.925 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.489 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.78 117.7 56.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 111.379 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.34 112.83 12.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.676 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -81.22 131.8 10.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.744 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 26.09 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.613 0.244 . . . . 0.0 110.93 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -102.61 124.69 8.26 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.461 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.46 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.0 p30 -113.13 30.62 7.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 91.64 26.03 21.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.56 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.598 ' HA ' HG22 ' A' ' 130' ' ' ILE . 43.5 ttm-85 -81.51 143.83 31.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.802 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.785 HG12 HG11 ' A' ' 135' ' ' VAL . 24.6 t -79.44 132.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.129 0.49 . . . . 0.0 111.322 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.3 mt -105.22 163.98 12.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.083 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.37 -33.22 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.25 -36.2 83.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -65.16 -47.26 77.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 44.4 mm -52.81 -51.67 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.782 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -58.86 -45.4 90.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.865 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.78 75.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.836 ' CE3' HG22 ' A' ' 144' ' ' VAL . 64.7 t90 -60.79 -57.05 14.31 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.142 0.496 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.7 mt -55.69 -33.4 64.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.957 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.72 -24.97 59.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.198 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -80.65 -32.54 33.31 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.496 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.75 0.309 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -123.83 127.49 48.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -174.12 0.88 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.487 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.3 t -98.32 157.65 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -85.34 112.42 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.085 0.469 . . . . 0.0 111.04 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -166.26 147.42 6.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.082 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.479 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.6 OUTLIER -62.89 148.49 91.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.32 -26.47 27.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 p -89.34 -34.94 16.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.69 HG11 HG12 ' A' ' 158' ' ' VAL . 99.3 t -66.02 -46.76 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.651 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 8.9 mtp-105 -54.71 -29.16 52.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.88 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -77.65 -42.99 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.301 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.8 t80 -64.52 -48.18 76.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.886 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.027 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.95 -46.39 81.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.68 -31.76 58.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.413 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -84.46 -37.68 21.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.075 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.731 ' HB3' HD11 ' A' ' 167' ' ' LEU . 47.9 mmtt -84.64 22.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.832 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.72 16.62 31.3 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.317 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.4 t -101.1 137.73 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 122.761 0.424 . . . . 0.0 110.652 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.513 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.6 t0 -116.08 127.25 54.71 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.487 HG22 ' CG1' ' A' ' 129' ' ' VAL . 32.7 mm -46.85 -26.38 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.507 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.87 -37.44 86.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 110.527 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.537 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.51 -6.73 58.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.851 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.509 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.8 t -114.7 126.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.954 0.406 . . . . 0.0 111.546 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -91.92 103.96 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.509 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -76.49 143.79 29.72 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.814 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.307 . . . . 0.0 110.864 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.37 140.82 15.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.731 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.98 -91.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.541 0.21 . . . . 0.0 111.385 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.13 26.21 10.48 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.743 0.306 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.2 6.83 33.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.818 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.609 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -60.93 139.75 57.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.69 HG12 HG11 ' A' ' 135' ' ' VAL . 25.2 t -79.76 131.93 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.563 ' HA ' HG21 ' A' ' 135' ' ' VAL . 13.5 mt -104.43 167.16 9.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.306 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.451 ' HE2' ' CG ' ' A' ' 138' ' ' TYR . 1.3 ttmt -57.54 -35.7 70.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.44 -35.5 79.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.212 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -66.61 -47.94 71.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.027 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.2 mm -52.92 -53.58 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.41 -39.86 80.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.32 86.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 69.1 t90 -57.64 -57.03 14.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.294 0.569 . . . . 0.0 110.274 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.731 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.1 mt -59.23 -30.91 68.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.976 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.98 63.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -120.37 30.56 5.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.558 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.565 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.861 0.363 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.98 34.15 19.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.946 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.34 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.733 HG13 ' HB ' ' A' ' 146' ' ' ILE . 46.0 t -64.93 133.98 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.021 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.507 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.7 mp -116.49 111.87 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.711 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.439 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.25 155.47 5.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.244 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.56 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.6 mtp -61.65 157.0 51.06 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.397 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.99 -25.43 77.62 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.483 2.122 . . . . 0.0 112.248 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -29.43 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.285 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.758 HG11 HG12 ' A' ' 158' ' ' VAL . 45.6 t -69.3 -46.91 76.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.773 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 8.1 mtp180 -54.56 -30.72 54.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -77.62 -40.97 40.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.281 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.51 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.5 t80 -64.66 -48.15 75.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.883 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.036 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.7 -45.5 82.53 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.8 58.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.465 178.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.73 -38.33 19.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.715 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.0 mmtt -83.32 27.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.77 17.7 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.075 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.809 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.8 t -107.94 137.14 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 122.935 0.494 . . . . 0.0 111.134 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.4 t0 -116.07 126.52 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.733 ' HB ' HG13 ' A' ' 129' ' ' VAL . 37.5 mm -46.95 -25.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.606 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.56 -37.56 86.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.0 110.439 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.52 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -85.68 -7.87 58.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.795 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.599 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.5 t -115.04 115.71 50.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.414 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 108.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.636 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -70.66 134.78 24.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.803 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.21 26.0 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 110.801 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -89.7 101.17 2.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.863 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt 57.36 -84.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.605 0.24 . . . . 0.0 111.33 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.13 9.58 25.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.49 26.01 7.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.691 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.507 ' HG3' HG22 ' A' ' 130' ' ' ILE . 28.8 ttm180 -79.04 145.46 33.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.868 0.366 . . . . 0.0 110.796 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.758 HG12 HG11 ' A' ' 135' ' ' VAL . 17.3 t -80.14 126.48 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.222 0.534 . . . . 0.0 111.227 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.3 mt -105.11 164.66 11.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.185 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -56.05 -33.03 64.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.8 -37.2 86.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.9 m-20 -63.2 -48.91 76.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.759 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.036 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.8 mm -52.71 -53.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.715 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.61 -41.91 82.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.78 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.25 83.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.809 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.4 t90 -60.12 -56.96 15.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.334 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.715 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.3 mt -54.83 -32.77 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.046 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -99.13 26.24 6.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.87 81.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.594 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.322 -1.266 . . . . 0.0 112.562 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.785 0.326 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -129.79 133.54 47.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.822 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -66.97 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.51 ' CG1' HG22 ' A' ' 146' ' ' ILE . 4.1 t -135.54 158.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.914 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 157' ' ' ARG . 3.3 mp -79.99 111.94 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.092 0.472 . . . . 0.0 111.099 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.08 147.73 3.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.994 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.487 ' HB2' HG23 ' A' ' 135' ' ' VAL . 8.3 mtp -59.13 159.96 13.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.681 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.64 -25.52 69.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.499 2.132 . . . . 0.0 112.348 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.3 t -90.97 -33.3 15.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.14 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.651 HG11 HG12 ' A' ' 158' ' ' VAL . 46.4 t -66.32 -44.68 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.361 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 61.3 mtp85 -54.76 -29.95 55.3 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -77.66 -42.43 34.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.156 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.6 t80 -64.21 -47.96 77.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.976 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.023 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.0 -45.68 80.71 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.88 58.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.26 178.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.62 -38.73 19.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.834 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -82.99 27.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.85 -178.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.44 19.94 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.913 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.833 HG22 ' CE3' ' A' ' 166' ' ' TRP . 57.6 t -108.39 138.01 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 0.0 110.997 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t70 -116.16 127.02 54.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.51 HG22 ' CG1' ' A' ' 129' ' ' VAL . 38.0 mm -46.65 -26.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.667 0.27 . . . . 0.0 111.626 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 mtt85 -63.03 -37.09 85.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.26 0.553 . . . . 0.0 110.64 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.9 -5.32 59.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.958 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.49 118.97 60.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.872 0.367 . . . . 0.0 111.496 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.51 116.31 17.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -82.05 131.65 10.55 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.048 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 25.96 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.663 0.268 . . . . 0.0 110.732 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.12 118.63 6.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.074 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.68 -87.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.631 0.253 . . . . 0.0 111.52 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -99.07 28.14 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.726 0.298 . . . . 0.0 111.04 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.17 26.13 34.86 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.737 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 130' ' ' ILE . 22.4 ttm180 -78.88 143.55 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.741 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.651 HG12 HG11 ' A' ' 135' ' ' VAL . 18.0 t -77.79 129.93 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.234 0.54 . . . . 0.0 111.334 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' HA ' HG21 ' A' ' 135' ' ' VAL . 16.5 mt -105.44 166.47 10.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.361 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -57.65 -33.69 68.57 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.18 -35.86 82.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -65.67 -47.58 75.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.823 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.0 mm -52.88 -52.27 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.799 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -57.77 -46.3 84.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.83 72.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.018 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.833 ' CE3' HG22 ' A' ' 144' ' ' VAL . 62.9 t90 -61.55 -57.13 13.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.377 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.834 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.6 mt -56.44 -34.67 67.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.945 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.1 -25.1 40.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -97.96 41.27 2.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.466 -179.929 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.3 p30 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.843 0.354 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.86 169.63 8.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.14 114.24 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.744 HG13 ' HB ' ' A' ' 146' ' ' ILE . 28.1 t -122.94 135.86 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.056 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 157' ' ' ARG . 3.3 mt -129.56 114.01 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.449 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.479 ' HB2' HD12 ' A' ' 146' ' ' ILE . . . -165.94 149.9 7.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.261 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.517 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.6 mtt -59.9 148.78 75.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.69 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -50.96 -25.22 15.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.474 2.116 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.2 p -90.97 -34.73 15.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.053 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.676 HG11 HG12 ' A' ' 158' ' ' VAL . 54.8 t -65.19 -44.91 95.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.322 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 22.3 mtp85 -54.67 -30.1 54.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.82 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.71 -41.32 38.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.266 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.512 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.2 t80 -65.09 -48.06 75.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.927 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.012 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.73 -46.12 80.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.69 -31.7 58.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.346 178.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -84.61 -38.76 19.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.279 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.814 ' O ' HD21 ' A' ' 167' ' ' LEU . 16.5 mmtp -84.16 28.17 0.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.988 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 21.22 16.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.223 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.818 HG22 ' CE3' ' A' ' 166' ' ' TRP . 52.9 t -106.83 137.1 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 122.975 0.51 . . . . 0.0 110.969 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.493 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 24.6 t0 -116.03 126.18 53.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.744 ' HB ' HG13 ' A' ' 129' ' ' VAL . 28.1 mm -46.59 -25.51 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -62.98 -37.07 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.226 0.536 . . . . 0.0 110.465 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.545 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.73 -5.8 59.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.874 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.452 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.6 t -114.8 124.5 71.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.934 0.397 . . . . 0.0 111.296 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.33 103.64 15.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -81.51 140.42 21.13 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.847 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.282 . . . . 0.0 110.925 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.61 120.03 6.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.087 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt 57.73 -86.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.549 0.214 . . . . 0.0 111.469 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.65 37.04 2.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 26.09 32.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.635 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.584 ' CB ' HG22 ' A' ' 130' ' ' ILE . 29.0 ttm180 -80.45 142.37 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.729 HG21 HG23 ' A' ' 146' ' ' ILE . 43.5 t -76.97 132.65 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.567 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.5 mt -106.96 163.53 12.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.739 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HE2' ' CE1' ' A' ' 138' ' ' TYR . 9.1 tttm -56.18 -32.13 64.06 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.744 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.83 85.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.5 m-20 -64.43 -49.21 72.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.882 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.012 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.1 mm -52.53 -51.78 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.88 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -58.46 -47.15 84.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.997 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.6 -34.91 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.818 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.4 t90 -61.71 -57.12 13.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 0.0 110.491 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 142' ' ' LYS . 2.5 mt -55.61 -23.91 30.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.263 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.65 31.08 1.63 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.608 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.87 -53.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.574 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.358 -1.245 . . . . 0.0 112.535 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.25 38.48 1.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.78 118.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.817 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.771 HG13 ' HB ' ' A' ' 146' ' ' ILE . 40.1 t -123.76 139.76 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.514 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp -130.03 111.94 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.431 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.717 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -162.83 154.65 18.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.413 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.4 mtp -65.82 160.02 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.88 -26.42 82.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.51 2.14 . . . . 0.0 112.186 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -91.04 -31.92 16.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 45.2 t -70.17 -46.63 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.414 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.717 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 4.8 mtt180 -54.56 -31.94 57.49 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -77.7 -39.94 43.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.462 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CD2' HG21 ' A' ' 163' ' ' ILE . 44.8 t80 -65.89 -48.17 72.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.052 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.025 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.32 -46.29 77.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 7.1 tpp85 -54.6 -31.79 57.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.318 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.49 -38.44 20.1 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.68 ' HB3' HD11 ' A' ' 167' ' ' LEU . 17.4 mmtp -84.25 27.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.92 19.38 14.52 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.307 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.765 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.9 t -104.99 136.71 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 122.954 0.502 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.428 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 14.7 t0 -116.04 126.54 53.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.773 HG23 ' CG2' ' A' ' 158' ' ' VAL . 34.6 mm -45.44 -26.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -64.94 -35.31 80.75 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.565 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.45 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.9 OUTLIER -84.53 -8.17 59.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 178.696 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.45 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.2 t -114.83 120.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.503 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -81.94 105.55 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -82.88 141.42 20.91 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.99 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.02 9.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.777 0.323 . . . . 0.0 110.779 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -89.22 111.41 3.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.847 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt 54.84 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.523 0.201 . . . . 0.0 111.483 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 34.6 m120 -100.39 36.97 1.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 111.066 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.79 25.98 59.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.568 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.514 ' CB ' HG22 ' A' ' 130' ' ' ILE . 22.5 ttm180 -78.17 141.71 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.852 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.773 ' CG2' HG23 ' A' ' 146' ' ' ILE . 42.0 t -75.25 133.06 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 0.0 111.332 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.0 mt -107.24 164.51 12.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.856 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -55.8 -32.1 63.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.01 -37.65 88.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.456 ' CB ' HG13 ' A' ' 158' ' ' VAL . 4.6 m-20 -62.62 -49.91 73.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.025 HD12 ' HB2' ' A' ' 139' ' ' ALA . 32.5 mm -52.79 -53.2 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.598 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.43 -47.94 82.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.808 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.17 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.765 ' CE3' HG22 ' A' ' 144' ' ' VAL . 65.2 t90 -59.81 -56.68 18.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.242 0.544 . . . . 0.0 110.239 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.68 HD11 ' HB3' ' A' ' 142' ' ' LYS . 9.3 mt -62.32 -31.04 71.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.953 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.86 -25.08 58.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -144.69 55.94 0.55 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.536 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.545 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.816 0.341 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -91.14 -25.85 19.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 64.72 -169.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.5 ' CG1' HG22 ' A' ' 146' ' ' ILE . 1.7 t -128.09 157.82 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.54 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.3 mp -90.71 116.69 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.017 0.437 . . . . 0.0 111.155 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -169.51 144.01 2.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.088 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.2 mtp -58.95 147.65 72.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.24 -25.91 25.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.49 2.126 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.1 p -87.78 -36.75 17.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.647 HG11 HG12 ' A' ' 158' ' ' VAL . 48.0 t -67.07 -45.68 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.34 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.603 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 59.6 mtm180 -54.74 -29.96 55.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -41.16 38.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.201 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CD2' HG21 ' A' ' 163' ' ' ILE . 48.8 t80 -65.19 -48.16 74.42 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.836 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.46 -46.29 80.43 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 4.2 tpt85 -54.63 -31.63 57.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.29 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.47 -38.09 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.664 ' HB3' HD11 ' A' ' 167' ' ' LEU . 19.2 mmtp -84.09 22.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.937 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.53 35.32 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.224 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.7 t -101.31 137.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 123.041 0.536 . . . . 0.0 110.606 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.7 t0 -116.04 126.02 53.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.5 HG22 ' CG1' ' A' ' 129' ' ' VAL . 33.7 mm -45.69 -26.37 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.803 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -62.94 -37.31 86.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.277 0.56 . . . . 0.0 110.58 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.536 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.16 -6.01 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.884 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.438 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -114.4 123.47 70.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.332 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -86.13 106.34 17.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.534 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -77.39 136.86 19.43 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.826 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 26.05 9.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.065 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.34 137.96 13.86 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.967 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.1 -90.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.594 0.235 . . . . 0.0 111.472 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -114.05 28.56 8.66 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.93 35.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.683 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.54 ' CB ' HG22 ' A' ' 130' ' ' ILE . 7.5 ttm180 -69.87 140.32 53.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.662 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.647 HG12 HG11 ' A' ' 135' ' ' VAL . 15.0 t -77.35 131.38 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.544 ' HA ' HG21 ' A' ' 135' ' ' VAL . 13.2 mt -104.54 167.77 9.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.468 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.93 70.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.58 -34.62 78.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.267 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -67.04 -47.29 71.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.756 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.6 mm -52.87 -52.52 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.622 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.48 -44.46 89.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.88 74.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 56.5 t90 -61.22 -56.26 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 142' ' ' LYS . 4.6 mt -60.75 -34.38 74.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.849 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.65 -23.6 61.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.274 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -52.31 -25.25 18.71 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.7 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 118.36 -1.245 . . . . 0.0 112.472 179.953 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.3 p30 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.789 0.328 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.88 -179.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.908 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -124.71 49.52 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.793 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.868 HG13 ' HB ' ' A' ' 146' ' ' ILE . 77.4 t -137.02 135.99 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.063 0.459 . . . . 0.0 111.355 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.513 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp -129.99 111.95 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.471 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.461 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.33 154.7 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.24 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.9 mtp -60.41 155.12 50.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.26 -27.39 56.8 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.656 2.237 . . . . 0.0 112.525 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -91.03 -27.29 18.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.776 HG11 HG12 ' A' ' 158' ' ' VAL . 57.6 t -69.89 -47.47 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 74.7 mtm180 -54.65 -30.25 54.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.59 33.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.574 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.2 t80 -64.42 -48.2 76.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.006 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 1.022 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.64 -45.98 80.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 2.4 tpt180 -54.7 -31.77 58.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.335 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.63 -38.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.809 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.4 mmtt -83.29 27.78 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.048 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.02 18.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.057 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.82 HG22 ' CE3' ' A' ' 166' ' ' TRP . 53.3 t -108.12 136.61 43.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 122.921 0.489 . . . . 0.0 110.964 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.454 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 30.5 t0 -116.18 126.49 53.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.868 ' HB ' HG13 ' A' ' 129' ' ' VAL . 29.7 mm -45.93 -26.18 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.803 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -62.39 -36.49 82.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.267 0.556 . . . . 0.0 110.524 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.533 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.84 -6.8 57.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.834 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.46 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.4 t -113.67 114.73 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.04 100.45 7.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.526 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -76.23 141.99 27.69 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.68 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.28 26.08 9.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 110.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.99 118.68 5.56 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.325 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.73 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -114.15 28.75 8.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 95.85 22.13 21.61 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.62 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.513 ' CB ' HG22 ' A' ' 130' ' ' ILE . 39.3 ttm180 -76.5 140.99 41.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 110.573 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.776 HG12 HG11 ' A' ' 135' ' ' VAL . 40.6 t -74.02 137.99 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.375 0.607 . . . . 0.0 111.539 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.6 mt -113.66 163.08 15.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.638 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.75 -32.52 63.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.809 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -64.28 -36.37 83.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.4 m-20 -64.39 -49.33 72.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.859 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.022 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.5 mm -52.68 -54.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.003 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.16 -47.14 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.983 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.72 -35.74 75.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.149 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.82 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.8 t90 -60.99 -57.0 14.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.584 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -55.18 -32.27 62.05 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.35 -25.03 61.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.194 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.29 69.94 0.74 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.414 -1.215 . . . . 0.0 112.51 179.956 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.492 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.94 0.4 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.32 155.42 7.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.557 ' HB2' HG23 ' A' ' 135' ' ' VAL . 5.5 mtm -61.53 150.69 80.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.8 -26.02 22.72 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -91.04 -27.89 18.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.088 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 158' ' ' VAL . 95.5 t -68.67 -49.44 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.32 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -54.56 -29.4 51.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -77.74 -42.71 33.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.172 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.557 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.4 t80 -64.24 -48.13 76.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.008 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.16 -45.71 83.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 2.4 ttt180 -54.68 -31.82 58.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.386 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -84.58 -38.2 20.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.092 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.797 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.4 mmtt -83.54 26.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.044 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.01 18.23 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.163 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.4 t -107.48 137.76 37.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.001 0.52 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t70 -116.17 127.56 54.9 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.639 HG23 HG21 ' A' ' 158' ' ' VAL . 33.3 mm -47.0 -26.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.592 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -62.7 -36.51 83.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.16 0.505 . . . . 0.0 110.585 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.519 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.67 -6.57 58.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.865 179.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.506 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.53 112.28 39.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.1 102.12 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.415 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -69.89 136.21 27.12 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.494 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.624 0.249 . . . . 0.0 111.092 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.23 128.81 9.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.165 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.18 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -111.85 30.15 7.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 93.05 18.59 39.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.741 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.492 ' CB ' HG22 ' A' ' 130' ' ' ILE . 34.7 ttm180 -72.35 141.15 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.311 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 135' ' ' VAL . 25.6 t -76.11 130.56 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.26 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.7 mt -106.26 163.98 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.968 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -56.22 -32.63 64.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.695 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.68 -36.31 83.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.82 -48.98 72.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.774 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.008 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.3 mm -52.59 -53.24 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.755 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.1 -48.07 81.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.948 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.31 72.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.1 t90 -60.36 -57.02 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.384 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.7 -32.21 59.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.045 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.606 HG22 ' CG ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.981 0.42 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.63 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.26 150.34 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.194 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.55 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.6 mtp -57.5 157.71 12.87 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.713 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.78 -26.31 65.62 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.515 2.143 . . . . 0.0 112.178 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.03 -28.06 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.944 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.557 HG11 HG12 ' A' ' 158' ' ' VAL . 89.8 t -69.82 -51.38 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.442 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.63 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 51.5 mtt180 -54.63 -30.2 54.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -77.74 -41.37 37.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.232 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.513 ' CD2' HG21 ' A' ' 163' ' ' ILE . 49.1 t80 -65.33 -48.03 74.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.887 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.057 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.96 -46.08 79.4 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.55 -32.01 57.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.167 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.38 -38.14 20.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.814 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.79 26.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.807 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 22.78 21.01 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.921 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.827 HG22 ' CE3' ' A' ' 166' ' ' TRP . 62.1 t -108.62 137.85 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 122.971 0.508 . . . . 0.0 111.172 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.491 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 62.8 t0 -116.14 127.49 54.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.72 HG23 ' CG2' ' A' ' 158' ' ' VAL . 32.2 mm -47.09 -26.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.532 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -62.79 -36.22 82.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 110.581 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.513 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.96 -5.85 58.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.91 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.494 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.26 117.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.887 0.375 . . . . 0.0 111.507 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.69 103.03 9.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.501 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -82.72 144.84 23.33 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.909 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.29 26.1 9.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.702 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -81.01 94.85 1.6 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.947 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 60.31 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.605 0.24 . . . . 0.0 111.392 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 23.8 m-80 -97.88 27.23 4.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.2 26.08 34.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.606 ' CG ' HG22 ' A' ' 130' ' ' ILE . 33.2 ttp85 -77.89 141.49 39.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' A' ' 146' ' ' ILE . 42.9 t -75.62 133.53 31.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.237 0.542 . . . . 0.0 111.617 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 17.7 mt -106.25 161.07 14.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.685 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -56.11 -32.26 64.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.684 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.15 -36.67 84.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.9 m-20 -64.01 -48.68 75.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.796 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.057 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.5 mm -52.67 -52.31 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.766 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -58.1 -47.41 83.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.94 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.47 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.827 ' CE3' HG22 ' A' ' 144' ' ' VAL . 68.0 t90 -60.93 -57.0 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.96 -32.19 61.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.611 HG22 ' CB ' ' A' ' 157' ' ' ARG . 41.4 mt . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.581 ' HB3' ' CG ' ' A' ' 136' ' ' ARG . . . -162.48 155.86 20.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.367 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.494 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.6 mtm -69.61 154.94 94.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.732 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 -28.11 45.15 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.127 . . . . 0.0 112.351 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.3 p -91.04 -32.3 15.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.652 HG11 HG12 ' A' ' 158' ' ' VAL . 72.2 t -68.07 -48.36 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.443 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.581 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 10.0 mtt180 -54.56 -29.27 50.64 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -77.65 -41.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.157 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.548 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.6 t80 -65.48 -48.12 73.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.059 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.23 -45.97 82.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -54.59 -31.85 57.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.306 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.49 -37.67 21.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.694 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.1 mmtt -84.17 27.67 0.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.951 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.7 20.23 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.957 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.754 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.8 t -109.01 138.41 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.953 0.501 . . . . 0.0 111.184 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.486 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.1 t0 -116.13 127.1 54.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.817 HG23 ' CG2' ' A' ' 158' ' ' VAL . 39.1 mm -47.36 -25.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.599 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.74 ' HG3' HD23 ' A' ' 148' ' ' LEU . 17.5 ptt180 -63.16 -36.98 85.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.076 0.465 . . . . 0.0 110.444 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.74 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.1 mt -83.26 -10.45 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.48 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.586 HG22 ' CD1' ' A' ' 166' ' ' TRP . 2.7 t -114.13 114.03 45.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.925 0.393 . . . . 0.0 111.429 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -77.92 99.17 5.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 141.9 26.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.588 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.21 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.641 0.258 . . . . 0.0 111.027 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.36 120.69 6.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.132 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.55 -86.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.467 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -113.97 36.93 3.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.773 0.321 . . . . 0.0 111.181 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.48 25.93 24.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.645 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.611 ' CB ' HG22 ' A' ' 130' ' ' ILE . 7.1 ttm180 -81.58 143.96 31.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.677 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.817 ' CG2' HG23 ' A' ' 146' ' ' ILE . 43.8 t -80.58 133.36 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.9 mt -106.89 162.87 13.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.721 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -56.29 -32.63 64.78 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.698 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -64.13 -36.47 84.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.7 m-20 -65.36 -49.65 68.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.741 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.059 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.5 mm -52.59 -48.63 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.623 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -59.91 -48.01 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.49 -37.18 77.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.951 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.754 ' CE3' HG22 ' A' ' 144' ' ' VAL . 76.8 t90 -59.86 -56.99 14.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -56.54 -31.85 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.958 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.249 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.472 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 121.04 0.448 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -169.51 152.4 4.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.106 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.527 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -57.29 159.98 7.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.96 -25.26 77.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.46 2.107 . . . . 0.0 112.199 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.03 -29.16 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.752 HG11 HG12 ' A' ' 158' ' ' VAL . 66.4 t -68.27 -47.91 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.334 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -54.65 -29.46 52.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -77.73 -43.07 32.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.558 ' CD2' HG21 ' A' ' 163' ' ' ILE . 48.4 t80 -64.03 -48.24 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.907 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.03 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.53 -45.4 83.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -31.87 59.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.177 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.57 -38.17 20.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.809 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.5 mmtt -83.75 26.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.933 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.93 22.3 19.31 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.027 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.832 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.0 t -107.99 137.47 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.988 0.515 . . . . 0.0 111.151 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 19.4 t0 -116.14 127.42 54.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.753 HG23 HG21 ' A' ' 158' ' ' VAL . 29.3 mm -47.31 -25.74 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.681 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -62.8 -36.23 82.46 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.201 0.525 . . . . 0.0 110.429 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.526 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.97 -6.86 57.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.783 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.514 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.9 t -114.67 111.92 37.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.78 103.46 5.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.524 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -79.81 141.1 23.17 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.829 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.22 26.11 9.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 110.772 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -83.87 98.32 2.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.033 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.93 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.4 m-80 -100.41 33.2 2.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.25 26.04 60.43 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.611 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.472 ' CB ' HG22 ' A' ' 130' ' ' ILE . 8.7 ttp-105 -80.61 140.88 35.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 146' ' ' ILE . 28.5 t -73.41 138.0 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 111.521 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.7 mt -111.93 161.5 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.697 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -32.69 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.791 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.29 -35.47 80.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 10.0 m-20 -65.4 -48.65 72.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.015 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.03 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.4 mm -52.68 -53.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.769 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -58.06 -46.22 85.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.28 77.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.832 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.1 t90 -60.01 -56.93 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.516 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.78 -32.18 59.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.036 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 121.017 0.437 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.98 153.03 5.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.072 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.542 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -58.68 146.86 73.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.644 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.51 -25.03 13.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.575 2.183 . . . . 0.0 112.457 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.8 t -90.71 -34.13 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 49.5 t -65.45 -43.5 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.293 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.47 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 78.1 mtm-85 -54.74 -30.41 56.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -77.65 -42.25 35.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.3 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.491 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.5 t80 -63.92 -48.09 77.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.922 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.0 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.7 -45.51 82.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.73 59.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.359 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -84.64 -38.58 19.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.212 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.797 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.8 mmtp -83.42 27.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.977 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.85 17.88 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.055 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.826 HG22 ' CE3' ' A' ' 166' ' ' TRP . 62.0 t -107.71 137.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 122.983 0.513 . . . . 0.0 111.046 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.506 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 18.8 t0 -116.08 126.7 54.11 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.741 HG23 ' CG2' ' A' ' 158' ' ' VAL . 34.2 mm -47.25 -25.63 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 111.594 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -36.85 84.51 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.187 0.517 . . . . 0.0 110.45 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.538 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.83 -6.96 58.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.875 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.551 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.8 t -114.8 123.72 70.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 111.479 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.53 101.69 13.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.531 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -75.97 143.12 29.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.11 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 111.033 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.6 126.26 8.8 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.113 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.623 0.249 . . . . 0.0 111.468 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.03 36.99 3.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.95 15.67 55.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.618 ' HA ' HG22 ' A' ' 130' ' ' ILE . 46.0 ttm-85 -69.56 142.24 53.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 146' ' ' ILE . 46.6 t -78.97 132.26 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.262 0.553 . . . . 0.0 111.468 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.467 ' HA ' HG21 ' A' ' 135' ' ' VAL . 12.7 mt -107.21 163.48 12.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -55.86 -32.63 63.83 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.779 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.89 -36.57 84.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.12 -49.13 73.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.816 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.0 HD12 ' HB2' ' A' ' 139' ' ' ALA . 38.7 mm -52.62 -52.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.7 -42.96 84.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.05 78.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.98 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.826 ' CE3' HG22 ' A' ' 144' ' ' VAL . 65.8 t90 -61.01 -57.06 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.508 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.6 mt -56.02 -33.62 65.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.952 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.258 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.7 mp . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.954 0.407 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.5 148.45 7.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.8 mmm -61.25 153.49 67.59 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.636 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.63 -25.81 76.59 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.548 2.166 . . . . 0.0 112.4 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.2 m -90.82 -32.56 16.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.094 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.772 HG11 HG12 ' A' ' 158' ' ' VAL . 86.0 t -65.98 -46.21 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.5 mtp85 -54.58 -27.95 42.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 0.0 109.995 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -77.73 -46.31 22.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.003 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.519 ' CD2' HG21 ' A' ' 163' ' ' ILE . 54.4 t80 -61.78 -48.0 82.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.734 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.991 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.4 -44.54 90.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -32.06 59.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.21 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.6 -39.8 18.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.804 ' O ' HD21 ' A' ' 167' ' ' LEU . 51.7 mmtt -81.98 25.52 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.2 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.01 21.68 18.01 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.838 HG22 ' CE3' ' A' ' 166' ' ' TRP . 59.9 t -105.79 136.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 122.906 0.483 . . . . 0.0 110.996 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t70 -116.11 127.03 54.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 131' ' ' ALA . 25.8 mm -46.87 -25.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.643 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -62.6 -36.15 81.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.265 0.555 . . . . 0.0 110.526 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.549 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.75 -6.23 57.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.487 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.3 t -114.29 121.95 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.305 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -86.83 106.51 17.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.36 137.76 19.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.819 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.23 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.729 0.3 . . . . 0.0 111.03 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 131.88 10.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.081 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.21 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -113.89 30.27 7.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.89 17.34 38.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.669 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.649 ' HA ' HG22 ' A' ' 130' ' ' ILE . 24.7 ttm105 -73.79 138.96 44.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.708 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.772 HG12 HG11 ' A' ' 135' ' ' VAL . 23.2 t -74.61 135.82 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.171 0.51 . . . . 0.0 111.369 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.6 mt -108.51 163.98 12.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.03 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -33.61 67.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -36.69 84.61 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.3 m-20 -65.14 -47.42 77.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.679 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.991 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.7 mm -52.77 -52.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.686 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.05 -41.38 87.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.65 84.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.929 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.838 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.5 t90 -59.8 -57.07 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.425 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.9 mt -56.48 -32.27 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.86 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.263 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.032 0.444 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.2 149.91 9.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.061 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -64.95 149.08 97.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.816 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.98 -24.44 32.13 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.63 2.22 . . . . 0.0 112.204 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 77.5 p -91.0 -35.07 14.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.77 HG11 HG12 ' A' ' 158' ' ' VAL . 92.1 t -65.97 -46.13 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 67.0 mtm180 -54.64 -28.78 49.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.962 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -77.78 -44.24 28.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.556 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.3 t80 -63.25 -48.06 79.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.007 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.85 -45.38 86.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.98 58.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.297 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -84.71 -37.85 20.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.045 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.825 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.1 mmtt -84.06 26.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.979 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.88 22.17 18.58 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.131 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.841 HG22 ' CE3' ' A' ' 166' ' ' TRP . 59.9 t -106.94 137.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.947 0.499 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.505 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t0 -116.07 127.71 55.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.467 HG21 ' HB2' ' A' ' 131' ' ' ALA . 31.6 mm -47.33 -26.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.687 0.28 . . . . 0.0 111.522 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -63.06 -36.42 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.14 0.495 . . . . 0.0 110.575 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.531 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.86 -5.28 58.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.959 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.5 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.81 123.54 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-O 120.948 0.404 . . . . 0.0 111.583 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.98 109.02 17.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.374 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.422 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -87.44 139.42 16.0 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.116 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.16 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.682 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -84.14 101.0 2.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.842 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.52 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.597 0.237 . . . . 0.0 111.54 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 153' ' ' GLY . 55.9 m-80 -96.33 29.17 2.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.707 0.289 . . . . 0.0 111.205 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.06 25.98 50.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.768 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.609 ' HA ' HG22 ' A' ' 130' ' ' ILE . 21.7 ttp-105 -80.87 140.47 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.783 0.325 . . . . 0.0 110.679 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.77 HG12 HG11 ' A' ' 135' ' ' VAL . 22.0 t -74.64 134.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.177 0.513 . . . . 0.0 111.344 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.8 mt -106.74 163.01 13.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.15 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -56.24 -33.39 65.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -36.67 84.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.2 m-20 -64.79 -47.51 77.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.901 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.007 HD12 ' HB2' ' A' ' 139' ' ' ALA . 44.5 mm -52.81 -52.78 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.888 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.98 -45.57 86.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.16 78.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.841 ' CE3' HG22 ' A' ' 144' ' ' VAL . 69.7 t90 -59.7 -57.03 14.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.13 0.491 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.825 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.41 -32.28 56.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.996 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.742 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.108 0.48 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -170.07 152.67 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.294 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.511 ' HB2' HG23 ' A' ' 135' ' ' VAL . 35.2 mmm -60.89 159.12 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.686 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.72 -27.07 60.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.227 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.6 m -90.97 -32.52 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.71 HG11 HG12 ' A' ' 158' ' ' VAL . 67.7 t -64.92 -46.52 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 18.9 mtp180 -54.7 -27.84 43.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -77.78 -43.72 29.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.0 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.581 ' CD2' HG21 ' A' ' 163' ' ' ILE . 53.6 t80 -63.54 -48.11 78.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.772 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.016 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.18 -45.22 85.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.73 -31.84 58.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.197 178.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.65 -38.6 19.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.086 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.843 ' O ' HD21 ' A' ' 167' ' ' LEU . 51.4 mmtt -83.07 27.66 0.55 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.043 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.86 22.34 18.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.093 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.821 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.3 t -108.96 137.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 122.961 0.504 . . . . 0.0 111.252 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.492 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t0 -116.1 127.74 55.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.471 HG21 ' HB2' ' A' ' 131' ' ' ALA . 34.7 mm -47.1 -26.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.701 ' HG3' HD23 ' A' ' 148' ' ' LEU . 19.2 ptt85 -64.07 -34.94 79.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 110.639 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.701 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.0 OUTLIER -85.87 -8.36 58.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.489 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.7 t -114.63 121.59 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.942 0.401 . . . . 0.0 111.545 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.58 104.96 15.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.426 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -82.07 141.52 21.63 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.01 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 26.1 9.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.761 0.315 . . . . 0.0 110.829 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.05 119.0 5.53 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.58 -82.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -114.08 37.09 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.813 0.34 . . . . 0.0 111.201 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.96 26.0 27.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.569 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.742 ' HA ' HG22 ' A' ' 130' ' ' ILE . 3.2 ttt180 -81.16 138.94 35.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.786 0.327 . . . . 0.0 110.767 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.71 HG12 HG11 ' A' ' 135' ' ' VAL . 13.1 t -77.48 134.54 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 111.341 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -107.17 165.23 11.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.258 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -57.85 -33.97 69.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -36.09 82.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.2 m-20 -65.71 -47.69 74.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.767 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.016 HD12 ' HB2' ' A' ' 139' ' ' ALA . 45.3 mm -52.9 -52.76 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.839 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.24 -44.81 88.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.42 86.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.054 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.821 ' CE3' HG22 ' A' ' 144' ' ' VAL . 77.6 t90 -57.92 -57.01 14.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.514 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.843 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.95 -33.14 62.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.975 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 -179.935 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.481 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.3 mp . . . . . 0 N--CA 1.456 -0.172 0 CA-C-O 120.975 0.416 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -170.02 152.54 4.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.098 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.537 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -57.41 160.02 7.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.5 -25.81 80.1 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.235 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.7 t -91.06 -29.2 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.771 HG11 HG12 ' A' ' 158' ' ' VAL . 66.0 t -68.02 -48.44 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.499 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 5.3 mtp180 -54.62 -29.13 51.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.912 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.64 -41.81 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.237 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.555 ' CD2' HG21 ' A' ' 163' ' ' ILE . 45.6 t80 -65.16 -48.13 74.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.98 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.058 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.77 -46.08 80.08 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.6 -31.81 57.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.362 178.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -84.42 -38.43 20.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.256 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.71 ' HB3' HD11 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.31 21.91 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.876 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.16 17.77 46.44 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.985 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.775 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.7 t -103.94 137.25 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.094 0.558 . . . . 0.0 110.851 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.456 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t0 -116.08 127.43 54.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.714 HG23 HG21 ' A' ' 158' ' ' VAL . 28.0 mm -46.13 -26.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.812 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.579 ' HG3' HD23 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -64.07 -37.33 87.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -82.98 -8.89 59.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.414 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.514 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.5 t -114.49 115.15 48.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.863 0.363 . . . . 0.0 111.499 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.5 109.97 6.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.668 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -71.89 130.99 17.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.676 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 26.19 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.708 0.289 . . . . 0.0 110.935 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -103.38 121.61 7.16 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.325 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.36 -84.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.3 m-80 -109.19 35.72 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.045 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 84.63 26.04 40.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.481 ' HG3' HG22 ' A' ' 130' ' ' ILE . 31.2 ttm180 -80.97 147.0 30.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.727 0.299 . . . . 0.0 110.831 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.771 HG12 HG11 ' A' ' 135' ' ' VAL . 37.1 t -81.16 132.05 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.267 0.556 . . . . 0.0 111.331 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.0 mt -108.99 165.07 11.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.956 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 3.3 tptt -55.92 -32.08 63.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -64.65 -37.97 89.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -62.64 -49.74 73.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.61 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.058 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.4 mm -52.69 -52.26 28.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.582 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.47 -45.34 94.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.13 81.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.775 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.9 t90 -58.3 -57.09 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.306 0.574 . . . . 0.0 110.21 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 142' ' ' LYS . 9.1 mt -61.07 -31.9 71.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.865 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.567 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.029 0.443 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.697 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -167.53 148.07 5.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.043 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.1 mtm -63.02 148.72 92.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -51.49 -26.46 21.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.541 2.161 . . . . 0.0 112.402 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.2 t -90.3 -29.09 18.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 158' ' ' VAL . 99.3 t -70.73 -48.25 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.381 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.697 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 7.0 mtt85 -54.65 -29.21 51.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.965 0.412 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.63 -44.32 28.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.191 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CD2' HG21 ' A' ' 163' ' ' ILE . 53.3 t80 -63.63 -48.01 79.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.921 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.047 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.24 -45.79 83.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.7 -31.82 58.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.299 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -84.4 -38.75 19.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.32 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.805 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -84.3 28.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.917 -179.142 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 21.64 17.55 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.234 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.827 HG22 ' CE3' ' A' ' 166' ' ' TRP . 56.8 t -106.95 136.69 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 122.852 0.461 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 32.2 t0 -116.16 126.83 54.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.2 mm -46.55 -25.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.754 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.77 84.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.209 0.528 . . . . 0.0 110.585 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.535 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.26 -5.91 58.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.924 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.471 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.7 t -114.77 126.1 72.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.961 0.41 . . . . 0.0 111.397 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.87 105.7 17.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.71 23.21 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.707 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.1 26.04 9.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.9 140.44 14.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 51.49 -90.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.215 . . . . 0.0 111.4 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -114.16 25.7 10.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.34 10.72 30.96 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.824 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.567 ' CB ' HG22 ' A' ' 130' ' ' ILE . 32.6 ttm180 -65.66 139.99 58.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 0.0 110.72 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 135' ' ' VAL . 21.2 t -78.11 132.83 31.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.0 mt -104.4 165.09 11.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.208 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -34.16 67.91 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.63 84.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.3 m-20 -64.75 -47.47 78.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.777 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.047 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.9 mm -52.89 -52.51 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.725 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -58.44 -41.66 85.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.04 85.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.827 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.1 t90 -59.85 -57.04 14.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.417 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.805 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.65 -32.44 59.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.983 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.237 -179.949 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 157' ' ' ARG . 3.9 mp . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.064 0.459 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 136' ' ' ARG . . . -169.41 146.28 3.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.035 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -57.82 160.03 8.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.11 -25.23 65.78 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.563 2.175 . . . . 0.0 112.319 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.02 -31.5 16.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.781 HG11 HG12 ' A' ' 158' ' ' VAL . 60.9 t -67.3 -46.58 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.25 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.464 ' HD2' ' HB3' ' A' ' 131' ' ' ALA . 4.6 mtp180 -54.71 -29.12 52.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.73 -43.98 29.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.194 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.501 ' CD2' HG21 ' A' ' 163' ' ' ILE . 47.7 t80 -63.95 -47.99 78.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.929 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.5 -46.94 77.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.79 58.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.235 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.28 -38.14 20.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.312 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.744 ' HB3' HD11 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.35 19.07 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.766 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.36 14.89 55.84 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.039 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.837 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.8 t -100.11 138.29 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 122.98 0.512 . . . . 0.0 110.769 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.506 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 11.2 t70 -116.08 127.99 55.31 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.443 HG21 ' HB2' ' A' ' 131' ' ' ALA . 34.8 mm -47.52 -26.13 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.531 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 -62.96 -36.2 82.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 110.575 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.533 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.12 -6.05 58.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.91 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.495 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.11 122.33 68.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.393 . . . . 0.0 111.365 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -85.66 115.32 23.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.69 136.7 16.94 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.2 26.01 9.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 111.025 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.6 145.5 17.75 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.859 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 48.97 -93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.194 0.198 . . . . 0.0 111.389 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -114.08 29.38 8.05 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.91 18.37 25.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.621 ' HA ' HG22 ' A' ' 130' ' ' ILE . 5.0 ttm180 -74.15 137.63 43.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.753 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.781 HG12 HG11 ' A' ' 135' ' ' VAL . 21.0 t -74.23 135.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.133 0.492 . . . . 0.0 111.217 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.498 ' HA ' HG21 ' A' ' 135' ' ' VAL . 12.9 mt -108.31 166.76 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -58.23 -33.7 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.93 -35.25 80.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.7 m-20 -66.28 -47.45 73.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.784 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.3 mm -52.8 -52.46 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.577 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.71 -44.82 90.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.47 80.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.976 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.837 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.4 t90 -58.4 -56.99 14.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.579 . . . . 0.0 110.357 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.2 mt -59.99 -27.42 66.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.094 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.257 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.551 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.5 mp . . . . . 0 CA--C 1.522 -0.125 0 CA-C-O 120.976 0.417 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.505 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -166.06 148.35 7.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.229 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.541 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -56.62 150.12 37.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.61 -26.94 13.68 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.607 2.204 . . . . 0.0 112.382 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.98 -29.4 17.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 87.0 t -68.93 -51.47 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.421 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -54.53 -29.62 51.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.884 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -77.66 -41.62 37.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.157 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.0 t80 -65.29 -48.17 74.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.995 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.45 -46.6 79.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -54.65 -31.67 57.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.489 178.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -84.41 -38.36 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.067 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.704 ' HB3' HD11 ' A' ' 167' ' ' LEU . 49.8 mmtt -83.95 22.62 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.05 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.48 16.46 36.29 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.293 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.818 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.3 t -101.23 137.89 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.962 0.505 . . . . 0.0 110.707 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 34.6 t0 -116.03 127.51 54.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.832 HG23 ' CG2' ' A' ' 158' ' ' VAL . 36.8 mm -47.2 -26.17 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -62.82 -37.0 85.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.171 0.51 . . . . 0.0 110.521 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.525 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.85 -6.63 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.846 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.507 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -115.78 119.84 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.925 0.393 . . . . 0.0 111.527 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.63 101.82 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.547 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -79.39 145.45 27.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.864 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.32 25.96 9.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.744 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -86.93 110.1 3.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.076 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.27 -82.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.614 0.245 . . . . 0.0 111.491 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.0 m-80 -104.2 29.16 6.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 111.007 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.94 26.04 23.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.551 ' CB ' HG22 ' A' ' 130' ' ' ILE . 13.1 ttp-105 -75.78 139.52 41.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.832 ' CG2' HG23 ' A' ' 146' ' ' ILE . 47.4 t -74.21 131.99 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.29 0.567 . . . . 0.0 111.468 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -106.29 163.47 12.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.751 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -55.7 -31.82 62.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.603 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.2 -38.0 89.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.262 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -61.72 -49.9 74.6 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.729 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 33.6 mm -52.68 -54.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.789 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -56.68 -48.01 78.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.065 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.38 74.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.023 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.818 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.8 t90 -59.32 -57.01 14.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.198 0.523 . . . . 0.0 110.324 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.704 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.4 mt -60.46 -21.71 62.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.232 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.142 179.963 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.039 0.447 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.54 154.58 12.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.089 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.5 ' HB2' HG23 ' A' ' 135' ' ' VAL . 6.7 mtp -71.37 149.85 93.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.757 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -51.41 -31.64 39.21 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.53 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 p -85.18 -29.81 24.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.785 HG11 HG12 ' A' ' 158' ' ' VAL . 61.2 t -70.8 -46.86 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.531 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.9 mtp180 -54.77 -29.91 55.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.979 0.419 . . . . 0.0 109.946 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -77.77 -44.85 26.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.139 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.54 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.7 t80 -62.59 -48.21 80.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.92 -45.35 86.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.62 -31.98 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.372 178.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.67 -38.08 20.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.173 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.799 ' O ' HD21 ' A' ' 167' ' ' LEU . 20.3 mmtp -84.18 26.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.909 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 21.48 16.66 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.181 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.836 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.8 t -106.17 137.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 122.926 0.491 . . . . 0.0 110.986 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.488 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 59.3 t0 -116.09 127.38 54.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.468 HG21 ' HB2' ' A' ' 131' ' ' ALA . 31.4 mm -47.01 -26.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.668 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -35.87 81.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.202 0.525 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.542 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.28 -5.75 58.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.925 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.489 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.78 117.7 56.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 111.379 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.34 112.83 12.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.676 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -81.22 131.8 10.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.744 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 26.09 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.613 0.244 . . . . 0.0 110.93 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -102.61 124.69 8.26 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.461 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.46 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.0 p30 -113.13 30.62 7.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 91.64 26.03 21.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.56 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.598 ' HA ' HG22 ' A' ' 130' ' ' ILE . 43.5 ttm-85 -81.51 143.83 31.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.802 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.785 HG12 HG11 ' A' ' 135' ' ' VAL . 24.6 t -79.44 132.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.129 0.49 . . . . 0.0 111.322 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.3 mt -105.22 163.98 12.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.083 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.37 -33.22 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.25 -36.2 83.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -65.16 -47.26 77.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 44.4 mm -52.81 -51.67 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.782 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -58.86 -45.4 90.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.865 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.78 75.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.836 ' CE3' HG22 ' A' ' 144' ' ' VAL . 64.7 t90 -60.79 -57.05 14.31 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.142 0.496 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.7 mt -55.69 -33.4 64.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.957 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.198 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 121.085 0.469 . . . . 0.0 111.04 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -166.26 147.42 6.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.082 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.479 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.6 OUTLIER -62.89 148.49 91.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.32 -26.47 27.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 p -89.34 -34.94 16.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.69 HG11 HG12 ' A' ' 158' ' ' VAL . 99.3 t -66.02 -46.76 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.651 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 8.9 mtp-105 -54.71 -29.16 52.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.88 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -77.65 -42.99 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.301 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.8 t80 -64.52 -48.18 76.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.886 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.027 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.95 -46.39 81.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.68 -31.76 58.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.413 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -84.46 -37.68 21.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.075 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.731 ' HB3' HD11 ' A' ' 167' ' ' LEU . 47.9 mmtt -84.64 22.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.832 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.72 16.62 31.3 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.317 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.4 t -101.1 137.73 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 122.761 0.424 . . . . 0.0 110.652 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.513 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.6 t0 -116.08 127.25 54.71 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.406 HG21 ' HB2' ' A' ' 131' ' ' ALA . 32.7 mm -46.85 -26.38 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.507 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.87 -37.44 86.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 110.527 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.537 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.51 -6.73 58.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.851 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.509 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.8 t -114.7 126.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.954 0.406 . . . . 0.0 111.546 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -91.92 103.96 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.509 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -76.49 143.79 29.72 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.814 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.307 . . . . 0.0 110.864 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.37 140.82 15.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.731 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.98 -91.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.541 0.21 . . . . 0.0 111.385 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.13 26.21 10.48 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.743 0.306 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.2 6.83 33.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.818 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.609 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -60.93 139.75 57.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.69 HG12 HG11 ' A' ' 135' ' ' VAL . 25.2 t -79.76 131.93 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.563 ' HA ' HG21 ' A' ' 135' ' ' VAL . 13.5 mt -104.43 167.16 9.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.306 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.451 ' HE2' ' CG ' ' A' ' 138' ' ' TYR . 1.3 ttmt -57.54 -35.7 70.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.44 -35.5 79.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.212 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -66.61 -47.94 71.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.027 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.2 mm -52.92 -53.58 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.41 -39.86 80.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.32 86.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 69.1 t90 -57.64 -57.03 14.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.294 0.569 . . . . 0.0 110.274 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.731 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.1 mt -59.23 -30.91 68.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.976 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.507 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.7 mp . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.058 0.456 . . . . 0.0 110.711 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.439 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.25 155.47 5.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.244 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.56 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.6 mtp -61.65 157.0 51.06 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.397 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.99 -25.43 77.62 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.483 2.122 . . . . 0.0 112.248 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -29.43 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.285 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.758 HG11 HG12 ' A' ' 158' ' ' VAL . 45.6 t -69.3 -46.91 76.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.773 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 8.1 mtp180 -54.56 -30.72 54.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -77.62 -40.97 40.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.281 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.51 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.5 t80 -64.66 -48.15 75.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.883 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.036 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.7 -45.5 82.53 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.8 58.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.465 178.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.73 -38.33 19.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.715 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.0 mmtt -83.32 27.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.77 17.7 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.075 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.809 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.8 t -107.94 137.14 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 122.935 0.494 . . . . 0.0 111.134 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.4 t0 -116.07 126.52 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.732 HG23 HG21 ' A' ' 158' ' ' VAL . 37.5 mm -46.95 -25.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.606 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.56 -37.56 86.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.0 110.439 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.52 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -85.68 -7.87 58.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.795 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.599 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.5 t -115.04 115.71 50.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.414 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 108.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.636 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -70.66 134.78 24.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.803 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.21 26.0 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 110.801 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -89.7 101.17 2.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.863 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt 57.36 -84.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.605 0.24 . . . . 0.0 111.33 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.13 9.58 25.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.49 26.01 7.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.691 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.507 ' HG3' HG22 ' A' ' 130' ' ' ILE . 28.8 ttm180 -79.04 145.46 33.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.868 0.366 . . . . 0.0 110.796 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.758 HG12 HG11 ' A' ' 135' ' ' VAL . 17.3 t -80.14 126.48 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.222 0.534 . . . . 0.0 111.227 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.3 mt -105.11 164.66 11.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.185 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -56.05 -33.03 64.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.8 -37.2 86.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.9 m-20 -63.2 -48.91 76.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.759 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.036 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.8 mm -52.71 -53.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.715 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.61 -41.91 82.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.78 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.25 83.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.809 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.4 t90 -60.12 -56.96 15.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.334 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.715 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.3 mt -54.83 -32.77 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.046 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -179.936 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 157' ' ' ARG . 3.3 mp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.092 0.472 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.08 147.73 3.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.994 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.487 ' HB2' HG23 ' A' ' 135' ' ' VAL . 8.3 mtp -59.13 159.96 13.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.681 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.64 -25.52 69.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.499 2.132 . . . . 0.0 112.348 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.3 t -90.97 -33.3 15.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.14 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.651 HG11 HG12 ' A' ' 158' ' ' VAL . 46.4 t -66.32 -44.68 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.361 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 61.3 mtp85 -54.76 -29.95 55.3 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -77.66 -42.43 34.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.156 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.6 t80 -64.21 -47.96 77.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.976 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.023 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.0 -45.68 80.71 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.88 58.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.26 178.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.62 -38.73 19.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.834 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -82.99 27.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.85 -178.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.44 19.94 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.913 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.833 HG22 ' CE3' ' A' ' 166' ' ' TRP . 57.6 t -108.39 138.01 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 0.0 110.997 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t70 -116.16 127.02 54.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 131' ' ' ALA . 38.0 mm -46.65 -26.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.667 0.27 . . . . 0.0 111.626 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 mtt85 -63.03 -37.09 85.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.26 0.553 . . . . 0.0 110.64 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.9 -5.32 59.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.958 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.49 118.97 60.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.872 0.367 . . . . 0.0 111.496 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.51 116.31 17.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -82.05 131.65 10.55 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.048 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 25.96 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.663 0.268 . . . . 0.0 110.732 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.12 118.63 6.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.074 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.68 -87.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.631 0.253 . . . . 0.0 111.52 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -99.07 28.14 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.726 0.298 . . . . 0.0 111.04 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.17 26.13 34.86 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.737 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 130' ' ' ILE . 22.4 ttm180 -78.88 143.55 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.741 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.651 HG12 HG11 ' A' ' 135' ' ' VAL . 18.0 t -77.79 129.93 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.234 0.54 . . . . 0.0 111.334 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.468 ' HA ' HG21 ' A' ' 135' ' ' VAL . 16.5 mt -105.44 166.47 10.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.361 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -57.65 -33.69 68.57 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.18 -35.86 82.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -65.67 -47.58 75.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.823 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.0 mm -52.88 -52.27 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.799 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -57.77 -46.3 84.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.83 72.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.018 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.833 ' CE3' HG22 ' A' ' 144' ' ' VAL . 62.9 t90 -61.55 -57.13 13.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.377 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.834 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.6 mt -56.44 -34.67 67.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.945 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 157' ' ' ARG . 3.3 mt . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.878 0.371 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.479 ' HB2' HD12 ' A' ' 146' ' ' ILE . . . -165.94 149.9 7.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.261 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.517 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.6 mtt -59.9 148.78 75.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.69 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -50.96 -25.22 15.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.474 2.116 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.2 p -90.97 -34.73 15.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.053 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.676 HG11 HG12 ' A' ' 158' ' ' VAL . 54.8 t -65.19 -44.91 95.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.322 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 22.3 mtp85 -54.67 -30.1 54.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.82 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.71 -41.32 38.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.266 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.512 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.2 t80 -65.09 -48.06 75.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.927 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.012 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.73 -46.12 80.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.69 -31.7 58.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.346 178.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -84.61 -38.76 19.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.279 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.814 ' O ' HD21 ' A' ' 167' ' ' LEU . 16.5 mmtp -84.16 28.17 0.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.988 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 21.22 16.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.223 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.818 HG22 ' CE3' ' A' ' 166' ' ' TRP . 52.9 t -106.83 137.1 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 122.975 0.51 . . . . 0.0 110.969 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.493 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 24.6 t0 -116.03 126.18 53.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.729 HG23 HG21 ' A' ' 158' ' ' VAL . 28.1 mm -46.59 -25.51 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -62.98 -37.07 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.226 0.536 . . . . 0.0 110.465 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.545 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.73 -5.8 59.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.874 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.452 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.6 t -114.8 124.5 71.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.934 0.397 . . . . 0.0 111.296 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.33 103.64 15.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -81.51 140.42 21.13 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.847 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.282 . . . . 0.0 110.925 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.61 120.03 6.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.087 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt 57.73 -86.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.549 0.214 . . . . 0.0 111.469 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.65 37.04 2.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 26.09 32.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.635 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.584 ' CB ' HG22 ' A' ' 130' ' ' ILE . 29.0 ttm180 -80.45 142.37 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.729 HG21 HG23 ' A' ' 146' ' ' ILE . 43.5 t -76.97 132.65 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.567 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.5 mt -106.96 163.53 12.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.739 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HE2' ' CE1' ' A' ' 138' ' ' TYR . 9.1 tttm -56.18 -32.13 64.06 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.744 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.83 85.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.5 m-20 -64.43 -49.21 72.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.882 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.012 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.1 mm -52.53 -51.78 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.88 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -58.46 -47.15 84.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.997 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.6 -34.91 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.818 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.4 t90 -61.71 -57.12 13.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 0.0 110.491 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 142' ' ' LYS . 2.5 mt -55.61 -23.91 30.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.263 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.608 -179.806 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.514 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 CA--C 1.522 -0.135 0 CA-C-O 120.958 0.409 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.717 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -162.83 154.65 18.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.413 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.4 mtp -65.82 160.02 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.88 -26.42 82.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.51 2.14 . . . . 0.0 112.186 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -91.04 -31.92 16.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 45.2 t -70.17 -46.63 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.414 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.717 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 4.8 mtt180 -54.56 -31.94 57.49 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -77.7 -39.94 43.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.462 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CD2' HG21 ' A' ' 163' ' ' ILE . 44.8 t80 -65.89 -48.17 72.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.052 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.025 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.32 -46.29 77.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 7.1 tpp85 -54.6 -31.79 57.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.318 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.49 -38.44 20.1 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.68 ' HB3' HD11 ' A' ' 167' ' ' LEU . 17.4 mmtp -84.25 27.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.92 19.38 14.52 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.307 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.765 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.9 t -104.99 136.71 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 122.954 0.502 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.428 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 14.7 t0 -116.04 126.54 53.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.773 HG23 ' CG2' ' A' ' 158' ' ' VAL . 34.6 mm -45.44 -26.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -64.94 -35.31 80.75 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.565 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.45 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.9 OUTLIER -84.53 -8.17 59.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 178.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.45 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.2 t -114.83 120.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.503 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -81.94 105.55 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -82.88 141.42 20.91 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.99 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.02 9.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.777 0.323 . . . . 0.0 110.779 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -89.22 111.41 3.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.847 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt 54.84 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.523 0.201 . . . . 0.0 111.483 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 67.6 m-80 -100.39 36.97 1.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 111.066 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.79 25.98 59.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.568 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.514 ' CB ' HG22 ' A' ' 130' ' ' ILE . 22.5 ttm180 -78.17 141.71 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.852 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.773 ' CG2' HG23 ' A' ' 146' ' ' ILE . 42.0 t -75.25 133.06 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 0.0 111.332 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.0 mt -107.24 164.51 12.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.856 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -55.8 -32.1 63.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.01 -37.65 88.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.456 ' CB ' HG13 ' A' ' 158' ' ' VAL . 4.6 m-20 -62.62 -49.91 73.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.025 HD12 ' HB2' ' A' ' 139' ' ' ALA . 32.5 mm -52.79 -53.2 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.598 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.43 -47.94 82.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.808 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.17 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.765 ' CE3' HG22 ' A' ' 144' ' ' VAL . 65.2 t90 -59.81 -56.68 18.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.242 0.544 . . . . 0.0 110.239 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.68 HD11 ' HB3' ' A' ' 142' ' ' LYS . 9.3 mt -62.32 -31.04 71.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.953 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.977 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.54 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.3 mp . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.017 0.437 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -169.51 144.01 2.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.088 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.2 mtp -58.95 147.65 72.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.24 -25.91 25.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.49 2.126 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.1 p -87.78 -36.75 17.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.647 HG11 HG12 ' A' ' 158' ' ' VAL . 48.0 t -67.07 -45.68 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.34 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.603 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 59.6 mtm180 -54.74 -29.96 55.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -41.16 38.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.201 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CD2' HG21 ' A' ' 163' ' ' ILE . 48.8 t80 -65.19 -48.16 74.42 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.836 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.46 -46.29 80.43 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 4.2 tpt85 -54.63 -31.63 57.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.29 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.47 -38.09 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.664 ' HB3' HD11 ' A' ' 167' ' ' LEU . 19.2 mmtp -84.09 22.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.937 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.53 35.32 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.224 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.7 t -101.31 137.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 123.041 0.536 . . . . 0.0 110.606 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.7 t0 -116.04 126.02 53.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.7 mm -45.69 -26.37 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.803 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -62.94 -37.31 86.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.277 0.56 . . . . 0.0 110.58 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.536 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.16 -6.01 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.884 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.438 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -114.4 123.47 70.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.332 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -86.13 106.34 17.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.534 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -77.39 136.86 19.43 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.826 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 26.05 9.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.065 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.34 137.96 13.86 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.967 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.1 -90.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.594 0.235 . . . . 0.0 111.472 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -114.05 28.56 8.66 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.93 35.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.683 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.54 ' CB ' HG22 ' A' ' 130' ' ' ILE . 7.5 ttm180 -69.87 140.32 53.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.662 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.647 HG12 HG11 ' A' ' 135' ' ' VAL . 15.0 t -77.35 131.38 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.544 ' HA ' HG21 ' A' ' 135' ' ' VAL . 13.2 mt -104.54 167.77 9.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.468 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.93 70.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.58 -34.62 78.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.267 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -67.04 -47.29 71.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.756 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.6 mm -52.87 -52.52 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.622 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.48 -44.46 89.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.88 74.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 56.5 t90 -61.22 -56.26 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 142' ' ' LYS . 4.6 mt -60.75 -34.38 74.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.849 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.274 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.513 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp . . . . . 0 N--CA 1.456 -0.161 0 CA-C-O 120.976 0.417 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.461 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.33 154.7 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.24 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.9 mtp -60.41 155.12 50.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.26 -27.39 56.8 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.656 2.237 . . . . 0.0 112.525 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -91.03 -27.29 18.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.776 HG11 HG12 ' A' ' 158' ' ' VAL . 57.6 t -69.89 -47.47 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 74.7 mtm180 -54.65 -30.25 54.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.59 33.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.574 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.2 t80 -64.42 -48.2 76.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.006 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 1.022 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.64 -45.98 80.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 2.4 tpt180 -54.7 -31.77 58.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.335 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.63 -38.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.809 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.4 mmtt -83.29 27.78 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.048 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.02 18.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.057 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.82 HG22 ' CE3' ' A' ' 166' ' ' TRP . 53.3 t -108.12 136.61 43.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 122.921 0.489 . . . . 0.0 110.964 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.454 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 30.5 t0 -116.18 126.49 53.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.757 HG23 HG21 ' A' ' 158' ' ' VAL . 29.7 mm -45.93 -26.18 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.803 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -62.39 -36.49 82.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.267 0.556 . . . . 0.0 110.524 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.533 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.84 -6.8 57.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.834 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.46 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.4 t -113.67 114.73 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.04 100.45 7.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.526 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -76.23 141.99 27.69 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.68 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.28 26.08 9.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 110.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.99 118.68 5.56 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.325 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.73 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -114.15 28.75 8.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 95.85 22.13 21.61 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.62 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.513 ' CB ' HG22 ' A' ' 130' ' ' ILE . 39.3 ttm180 -76.5 140.99 41.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 110.573 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.776 HG12 HG11 ' A' ' 135' ' ' VAL . 40.6 t -74.02 137.99 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.375 0.607 . . . . 0.0 111.539 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.6 mt -113.66 163.08 15.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.638 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.75 -32.52 63.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.809 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -64.28 -36.37 83.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.4 m-20 -64.39 -49.33 72.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.859 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.022 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.5 mm -52.68 -54.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.003 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.16 -47.14 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.983 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.72 -35.74 75.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.149 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.82 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.8 t90 -60.99 -57.0 14.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.584 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -55.18 -32.27 62.05 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.194 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.807 0.337 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.12 -28.83 8.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 173.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.857 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.837 HG13 ' HB ' ' A' ' 146' ' ' ILE . 73.2 t -94.06 136.41 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.179 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.492 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp -129.98 111.97 22.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.596 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.32 155.42 7.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.187 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.557 ' HB2' HG23 ' A' ' 135' ' ' VAL . 5.5 mtm -61.53 150.69 80.24 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.812 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.8 -26.02 22.72 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.536 2.157 . . . . 0.0 112.291 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 m -91.04 -27.89 18.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.088 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.694 HG11 HG12 ' A' ' 158' ' ' VAL . 95.5 t -68.67 -49.44 64.6 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.32 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -54.56 -29.4 51.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -77.74 -42.71 33.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.172 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.557 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.4 t80 -64.24 -48.13 76.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.828 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.008 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.16 -45.71 83.83 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 2.4 ttt180 -54.68 -31.82 58.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.386 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -84.58 -38.2 20.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.092 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.797 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.4 mmtt -83.54 26.72 0.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.044 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 22.01 18.23 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.163 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.4 t -107.48 137.76 37.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.001 0.52 . . . . 0.0 111.096 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t70 -116.17 127.56 54.9 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.837 ' HB ' HG13 ' A' ' 129' ' ' VAL . 33.3 mm -47.0 -26.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.592 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 52.4 mtt85 -62.7 -36.51 83.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.16 0.505 . . . . 0.0 110.585 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.519 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.67 -6.57 58.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.865 179.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.506 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.53 112.28 39.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.1 102.12 6.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.415 ' O ' ' HA2' ' A' ' 156' ' ' GLY . . . -69.89 136.21 27.12 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.494 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.09 9.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.624 0.249 . . . . 0.0 111.092 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.23 128.81 9.67 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.55 -0.834 . . . . 0.0 113.165 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 55.18 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -111.85 30.15 7.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 93.05 18.59 39.27 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.741 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.492 ' CB ' HG22 ' A' ' 130' ' ' ILE . 34.7 ttm180 -72.35 141.15 48.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.752 0.311 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.694 HG12 HG11 ' A' ' 135' ' ' VAL . 25.6 t -76.11 130.56 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.26 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.7 mt -106.26 163.98 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.968 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -56.22 -32.63 64.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.695 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.68 -36.31 83.85 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.82 -48.98 72.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.774 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.008 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.3 mm -52.59 -53.24 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.755 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -58.1 -48.07 81.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.948 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.14 -36.31 72.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.1 t90 -60.36 -57.02 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.384 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.7 -32.21 59.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.045 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.97 -25.06 64.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.28 -32.45 7.57 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.504 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.414 -1.215 . . . . 0.0 112.479 179.948 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.848 0.356 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -91.73 151.06 20.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.408 ' HB3' ' NH1' ' A' ' 128' ' ' ARG . 5.6 mtp-105 -97.98 -33.19 11.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.834 HG13 ' HB ' ' A' ' 146' ' ' ILE . 74.2 t -94.41 141.38 15.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.606 HG22 ' CG ' ' A' ' 157' ' ' ARG . 4.6 mp -130.05 112.72 24.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.63 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -169.26 150.34 4.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.194 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.55 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.6 mtp -57.5 157.71 12.87 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.713 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.78 -26.31 65.62 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.515 2.143 . . . . 0.0 112.178 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.03 -28.06 18.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.944 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.557 HG11 HG12 ' A' ' 158' ' ' VAL . 89.8 t -69.82 -51.38 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.442 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.63 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 51.5 mtt180 -54.63 -30.2 54.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -77.74 -41.37 37.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.232 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.513 ' CD2' HG21 ' A' ' 163' ' ' ILE . 49.1 t80 -65.33 -48.03 74.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.887 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.057 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.96 -46.08 79.4 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.55 -32.01 57.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.167 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.38 -38.14 20.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.814 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.79 26.86 0.67 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.807 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 22.78 21.01 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.921 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.827 HG22 ' CE3' ' A' ' 166' ' ' TRP . 62.1 t -108.62 137.85 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 122.971 0.508 . . . . 0.0 111.172 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.491 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 62.8 t0 -116.14 127.49 54.86 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.834 ' HB ' HG13 ' A' ' 129' ' ' VAL . 32.2 mm -47.09 -26.25 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.532 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -62.79 -36.22 82.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.125 0.488 . . . . 0.0 110.581 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.513 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.96 -5.85 58.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.91 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.494 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.26 117.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.887 0.375 . . . . 0.0 111.507 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -79.69 103.03 9.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.501 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -82.72 144.84 23.33 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.909 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.29 26.1 9.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 0.0 110.702 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -81.01 94.85 1.6 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.947 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt 60.31 -79.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.605 0.24 . . . . 0.0 111.392 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 153' ' ' GLY . 23.8 m-80 -97.88 27.23 4.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 111.057 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.2 26.08 34.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.606 ' CG ' HG22 ' A' ' 130' ' ' ILE . 33.2 ttp85 -77.89 141.49 39.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.35 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.72 ' CG2' HG23 ' A' ' 146' ' ' ILE . 42.9 t -75.62 133.53 31.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.237 0.542 . . . . 0.0 111.617 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 17.7 mt -106.25 161.07 14.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.685 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -56.11 -32.26 64.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.684 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -65.15 -36.67 84.95 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.9 m-20 -64.01 -48.68 75.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.796 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.057 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.5 mm -52.67 -52.31 28.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.766 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -58.1 -47.41 83.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.94 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.47 72.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.827 ' CE3' HG22 ' A' ' 144' ' ' VAL . 68.0 t90 -60.93 -57.0 14.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.96 -32.19 61.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.026 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.64 -24.97 56.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.204 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.27 -43.02 1.77 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.449 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.498 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.907 0.384 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -138.59 79.03 1.71 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.31 -66.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.937 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.785 HG13 ' HB ' ' A' ' 146' ' ' ILE . 35.9 t -132.64 134.64 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.611 HG22 ' CB ' ' A' ' 157' ' ' ARG . 41.4 mt -130.03 115.7 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.501 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.581 ' HB3' ' CG ' ' A' ' 136' ' ' ARG . . . -162.48 155.86 20.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.367 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.494 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.6 mtm -69.61 154.94 94.36 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.732 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.67 -28.11 45.15 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.491 2.127 . . . . 0.0 112.351 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.3 p -91.04 -32.3 15.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.652 HG11 HG12 ' A' ' 158' ' ' VAL . 72.2 t -68.07 -48.36 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.443 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.581 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 10.0 mtt180 -54.56 -29.27 50.64 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -77.65 -41.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.157 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.548 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.6 t80 -65.48 -48.12 73.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.059 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.23 -45.97 82.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -54.59 -31.85 57.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.306 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.49 -37.67 21.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.148 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.694 ' O ' HD21 ' A' ' 167' ' ' LEU . 46.1 mmtt -84.17 27.67 0.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.951 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.89 22.7 20.23 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.957 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.754 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.8 t -109.01 138.41 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 122.953 0.501 . . . . 0.0 111.184 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.486 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.1 t0 -116.13 127.1 54.55 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.817 HG23 ' CG2' ' A' ' 158' ' ' VAL . 39.1 mm -47.36 -25.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.599 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.74 ' HG3' HD23 ' A' ' 148' ' ' LEU . 17.5 ptt180 -63.16 -36.98 85.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.076 0.465 . . . . 0.0 110.444 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.74 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.1 mt -83.26 -10.45 58.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.48 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.586 HG22 ' CD1' ' A' ' 166' ' ' TRP . 2.7 t -114.13 114.03 45.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.925 0.393 . . . . 0.0 111.429 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -77.92 99.17 5.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.04 141.9 26.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.588 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.21 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.641 0.258 . . . . 0.0 111.027 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.36 120.69 6.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.132 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.55 -86.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.628 0.251 . . . . 0.0 111.467 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -113.97 36.93 3.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.773 0.321 . . . . 0.0 111.181 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.48 25.93 24.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.645 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.611 ' CB ' HG22 ' A' ' 130' ' ' ILE . 7.1 ttm180 -81.58 143.96 31.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 0.0 110.677 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.817 ' CG2' HG23 ' A' ' 146' ' ' ILE . 43.8 t -80.58 133.36 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.9 mt -106.89 162.87 13.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.721 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -56.29 -32.63 64.78 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.698 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -64.13 -36.47 84.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.7 m-20 -65.36 -49.65 68.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.741 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.059 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.5 mm -52.59 -48.63 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.623 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -59.91 -48.01 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.852 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.49 -37.18 77.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.951 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.754 ' CE3' HG22 ' A' ' 144' ' ' VAL . 76.8 t90 -59.86 -56.99 14.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.694 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -56.54 -31.85 64.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.958 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.72 22.64 7.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.249 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -116.47 -27.62 2.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.581 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.367 -1.24 . . . . 0.0 112.558 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.852 0.358 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.8 58.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -153.8 108.21 3.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.801 HG13 ' HB ' ' A' ' 146' ' ' ILE . 55.8 t -138.02 138.78 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.002 0.43 . . . . 0.0 111.288 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.472 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp -130.17 111.95 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.479 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -169.51 152.4 4.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.106 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.527 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -57.29 159.98 7.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.96 -25.26 77.73 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.46 2.107 . . . . 0.0 112.199 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.03 -29.16 17.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.03 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.752 HG11 HG12 ' A' ' 158' ' ' VAL . 66.4 t -68.27 -47.91 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.334 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.3 mtp85 -54.65 -29.46 52.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -77.73 -43.07 32.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.558 ' CD2' HG21 ' A' ' 163' ' ' ILE . 48.4 t80 -64.03 -48.24 77.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.907 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.03 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.53 -45.4 83.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.74 -31.87 59.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.177 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -84.57 -38.17 20.28 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.084 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.809 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.5 mmtt -83.75 26.73 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.933 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.93 22.3 19.31 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.027 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.832 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.0 t -107.99 137.47 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.988 0.515 . . . . 0.0 111.151 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.48 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 19.4 t0 -116.14 127.42 54.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.801 ' HB ' HG13 ' A' ' 129' ' ' VAL . 29.3 mm -47.31 -25.74 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.681 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -62.8 -36.23 82.46 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.201 0.525 . . . . 0.0 110.429 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.526 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.97 -6.86 57.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.783 179.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.514 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.9 t -114.67 111.92 37.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.78 103.46 5.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.524 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.413 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -79.81 141.1 23.17 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.829 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.22 26.11 9.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.73 0.3 . . . . 0.0 110.772 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -83.87 98.32 2.12 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.854 -0.689 . . . . 0.0 113.033 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.93 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 153' ' ' GLY . 5.4 m-80 -100.41 33.2 2.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.25 26.04 60.43 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.611 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.472 ' CB ' HG22 ' A' ' 130' ' ' ILE . 8.7 ttp-105 -80.61 140.88 35.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.814 0.34 . . . . 0.0 110.828 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.753 HG21 HG23 ' A' ' 146' ' ' ILE . 28.5 t -73.41 138.0 22.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.244 0.545 . . . . 0.0 111.521 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.7 mt -111.93 161.5 16.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.697 178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -32.69 64.73 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.791 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.29 -35.47 80.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 10.0 m-20 -65.4 -48.65 72.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.015 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.03 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.4 mm -52.68 -53.59 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.769 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -58.06 -46.22 85.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.903 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.14 -36.28 77.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.832 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.1 t90 -60.01 -56.93 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.516 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.78 -32.18 59.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.036 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.24 -25.0 59.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.206 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.81 46.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.34 -1.256 . . . . 0.0 112.486 -179.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.4 t30 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.832 0.348 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.13 88.0 3.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 mtm-85 -119.6 -3.44 10.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.834 HG13 ' HB ' ' A' ' 146' ' ' ILE . 54.2 t -104.28 138.83 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.924 0.392 . . . . 0.0 111.288 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.6 mp -129.98 111.9 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.649 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -168.98 153.03 5.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.072 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.542 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -58.68 146.86 73.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.644 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.51 -25.03 13.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.575 2.183 . . . . 0.0 112.457 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.8 t -90.71 -34.13 15.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.088 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 49.5 t -65.45 -43.5 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.293 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.47 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 78.1 mtm-85 -54.74 -30.41 56.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -77.65 -42.25 35.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.3 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.491 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 53.5 t80 -63.92 -48.09 77.95 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.922 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.0 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.7 -45.51 82.5 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.82 -31.73 59.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.359 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -84.64 -38.58 19.66 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.212 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.797 ' O ' HD21 ' A' ' 167' ' ' LEU . 19.8 mmtp -83.42 27.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.977 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.85 17.88 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.055 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.826 HG22 ' CE3' ' A' ' 166' ' ' TRP . 62.0 t -107.71 137.27 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 122.983 0.513 . . . . 0.0 111.046 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.506 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 18.8 t0 -116.08 126.7 54.11 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.834 ' HB ' HG13 ' A' ' 129' ' ' VAL . 34.2 mm -47.25 -25.63 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 111.594 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -36.85 84.51 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.187 0.517 . . . . 0.0 110.45 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.538 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.83 -6.96 58.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.875 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.551 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.8 t -114.8 123.72 70.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.897 0.38 . . . . 0.0 111.479 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.53 101.69 13.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.531 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 158' ' ' VAL . . . -75.97 143.12 29.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.777 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.28 26.11 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.73 0.3 . . . . 0.0 111.033 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.6 126.26 8.8 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.113 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.05 -87.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.623 0.249 . . . . 0.0 111.468 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.03 36.99 3.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.788 0.328 . . . . 0.0 111.116 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 90.95 15.67 55.82 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.73 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.618 ' HA ' HG22 ' A' ' 130' ' ' ILE . 46.0 ttm-85 -69.56 142.24 53.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 0.0 110.799 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 146' ' ' ILE . 46.6 t -78.97 132.26 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.262 0.553 . . . . 0.0 111.468 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.467 ' HA ' HG21 ' A' ' 135' ' ' VAL . 12.7 mt -107.21 163.48 12.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.638 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -55.86 -32.63 63.83 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.779 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.89 -36.57 84.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -64.12 -49.13 73.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.816 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.0 HD12 ' HB2' ' A' ' 139' ' ' ALA . 38.7 mm -52.62 -52.2 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.781 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -57.7 -42.96 84.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.885 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.05 78.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.98 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.826 ' CE3' HG22 ' A' ' 144' ' ' VAL . 65.8 t90 -61.01 -57.06 14.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.508 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.6 mt -56.02 -33.62 65.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.952 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.33 -25.02 59.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.258 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.01 -28.13 14.98 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.521 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.328 -1.262 . . . . 0.0 112.523 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.806 0.336 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -105.93 -35.48 7.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.79 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.01 -45.72 0.72 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.467 HG21 ' HG3' ' A' ' 147' ' ' ARG . 1.8 t -136.89 160.09 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.7 mp -93.7 113.03 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.83 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.5 148.45 7.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.276 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.546 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.8 mmm -61.25 153.49 67.59 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.636 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.63 -25.81 76.59 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.548 2.166 . . . . 0.0 112.4 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.2 m -90.82 -32.56 16.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.094 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.772 HG11 HG12 ' A' ' 158' ' ' VAL . 86.0 t -65.98 -46.21 88.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.302 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.5 mtp85 -54.58 -27.95 42.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 0.0 109.995 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -77.73 -46.31 22.16 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.003 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.519 ' CD2' HG21 ' A' ' 163' ' ' ILE . 54.4 t80 -61.78 -48.0 82.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.734 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.991 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.4 -44.54 90.93 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -32.06 59.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.21 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -84.6 -39.8 18.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.168 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.804 ' O ' HD21 ' A' ' 167' ' ' LEU . 51.7 mmtt -81.98 25.52 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.2 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.01 21.68 18.01 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.217 -0.992 . . . . 0.0 112.071 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.838 HG22 ' CE3' ' A' ' 166' ' ' TRP . 59.9 t -105.79 136.47 39.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 122.906 0.483 . . . . 0.0 110.996 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t70 -116.11 127.03 54.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.56 HG21 ' HB2' ' A' ' 131' ' ' ALA . 25.8 mm -46.87 -25.84 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.643 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.467 ' HG3' HG21 ' A' ' 129' ' ' VAL . 26.2 mtt-85 -62.6 -36.15 81.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.265 0.555 . . . . 0.0 110.526 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.549 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.75 -6.23 57.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.903 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.487 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.3 t -114.29 121.95 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 111.305 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -86.83 106.51 17.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.494 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.36 137.76 19.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.819 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.23 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.729 0.3 . . . . 0.0 111.03 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.11 131.88 10.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.081 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 54.21 -86.8 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -113.89 30.27 7.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 111.011 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.89 17.34 38.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.669 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.649 ' HA ' HG22 ' A' ' 130' ' ' ILE . 24.7 ttm105 -73.79 138.96 44.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.708 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.772 HG12 HG11 ' A' ' 135' ' ' VAL . 23.2 t -74.61 135.82 26.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.171 0.51 . . . . 0.0 111.369 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.6 mt -108.51 163.98 12.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.03 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -33.61 67.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -36.69 84.61 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.3 m-20 -65.14 -47.42 77.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.679 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.991 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.7 mm -52.77 -52.23 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.686 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.05 -41.38 87.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.636 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.65 84.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.929 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.838 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.5 t90 -59.8 -57.07 14.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.425 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.804 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.9 mt -56.48 -32.27 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.86 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 -25.1 35.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.263 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -90.55 -28.4 16.75 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.567 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.549 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -69.48 170.51 10.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -62.66 -175.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.831 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.471 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.0 t -79.15 157.87 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.046 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp -87.86 111.89 22.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.032 0.444 . . . . 0.0 110.972 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.2 149.91 9.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.061 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.488 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -64.95 149.08 97.15 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.816 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.98 -24.44 32.13 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.63 2.22 . . . . 0.0 112.204 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 77.5 p -91.0 -35.07 14.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.77 HG11 HG12 ' A' ' 158' ' ' VAL . 92.1 t -65.97 -46.13 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.203 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 67.0 mtm180 -54.64 -28.78 49.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.962 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -77.78 -44.24 28.2 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.026 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.556 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.3 t80 -63.25 -48.06 79.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.788 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.007 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.85 -45.38 86.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.98 58.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.297 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -84.71 -37.85 20.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.045 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.825 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.1 mmtt -84.06 26.28 0.75 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.979 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.88 22.17 18.58 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.131 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.841 HG22 ' CE3' ' A' ' 166' ' ' TRP . 59.9 t -106.94 137.59 36.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 122.947 0.499 . . . . 0.0 111.135 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.505 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t0 -116.07 127.71 55.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.471 HG22 ' CG1' ' A' ' 129' ' ' VAL . 31.6 mm -47.33 -26.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.687 0.28 . . . . 0.0 111.522 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -63.06 -36.42 83.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.14 0.495 . . . . 0.0 110.575 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.531 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.86 -5.28 58.67 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.959 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.5 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.81 123.54 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 CA-C-O 120.948 0.404 . . . . 0.0 111.583 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.98 109.02 17.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.374 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.422 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -87.44 139.42 16.0 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.116 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.16 26.05 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.682 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -84.14 101.0 2.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.842 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 57.52 -82.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.597 0.237 . . . . 0.0 111.54 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 153' ' ' GLY . 55.9 m-80 -96.33 29.17 2.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.707 0.289 . . . . 0.0 111.205 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.06 25.98 50.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.768 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.609 ' HA ' HG22 ' A' ' 130' ' ' ILE . 21.7 ttp-105 -80.87 140.47 35.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.783 0.325 . . . . 0.0 110.679 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.77 HG12 HG11 ' A' ' 135' ' ' VAL . 22.0 t -74.64 134.66 29.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.177 0.513 . . . . 0.0 111.344 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.8 mt -106.74 163.01 13.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.15 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -56.24 -33.39 65.37 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -36.67 84.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.2 m-20 -64.79 -47.51 77.83 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.901 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.007 HD12 ' HB2' ' A' ' 139' ' ' ALA . 44.5 mm -52.81 -52.78 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.888 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -57.98 -45.57 86.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.16 78.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.841 ' CE3' HG22 ' A' ' 144' ' ' VAL . 69.7 t90 -59.7 -57.03 14.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.13 0.491 . . . . 0.0 110.588 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.825 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.41 -32.28 56.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.996 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.33 31.03 2.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -144.12 28.06 1.98 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.493 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.372 -1.238 . . . . 0.0 112.518 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.849 0.357 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -83.39 123.39 29.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.016 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? 62.26 117.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.933 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.489 ' CG1' HG22 ' A' ' 146' ' ' ILE . 3.0 t -100.56 159.55 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.742 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -83.19 111.91 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.108 0.48 . . . . 0.0 111.07 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -170.07 152.67 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.294 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.511 ' HB2' HG23 ' A' ' 135' ' ' VAL . 35.2 mmm -60.89 159.12 28.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.686 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.72 -27.07 60.31 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.227 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.6 m -90.97 -32.52 15.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.71 HG11 HG12 ' A' ' 158' ' ' VAL . 67.7 t -64.92 -46.52 91.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 18.9 mtp180 -54.7 -27.84 43.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -77.78 -43.72 29.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.0 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.581 ' CD2' HG21 ' A' ' 163' ' ' ILE . 53.6 t80 -63.54 -48.11 78.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.772 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.016 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.18 -45.22 85.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.73 -31.84 58.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.197 178.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -84.65 -38.6 19.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.086 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.843 ' O ' HD21 ' A' ' 167' ' ' LEU . 51.4 mmtt -83.07 27.66 0.55 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.043 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.86 22.34 18.97 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.093 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.821 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.3 t -108.96 137.28 41.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 122.961 0.504 . . . . 0.0 111.252 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.492 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.5 t0 -116.1 127.74 55.1 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.489 HG22 ' CG1' ' A' ' 129' ' ' VAL . 34.7 mm -47.1 -26.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.701 ' HG3' HD23 ' A' ' 148' ' ' LEU . 19.2 ptt85 -64.07 -34.94 79.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.03 0.443 . . . . 0.0 110.639 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.701 HD23 ' HG3' ' A' ' 147' ' ' ARG . 1.0 OUTLIER -85.87 -8.36 58.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.5 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.489 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.7 t -114.63 121.59 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 CA-C-O 120.942 0.401 . . . . 0.0 111.545 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -84.58 104.96 15.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.495 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.426 ' HA3' ' N ' ' A' ' 158' ' ' VAL . . . -82.07 141.52 21.63 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.01 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.22 26.1 9.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.761 0.315 . . . . 0.0 110.829 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.05 119.0 5.53 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.242 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.58 -82.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -114.08 37.09 3.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.813 0.34 . . . . 0.0 111.201 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.96 26.0 27.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.569 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.742 ' HA ' HG22 ' A' ' 130' ' ' ILE . 3.2 ttt180 -81.16 138.94 35.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.786 0.327 . . . . 0.0 110.767 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.71 HG12 HG11 ' A' ' 135' ' ' VAL . 13.1 t -77.48 134.54 28.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 111.341 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 14.1 mt -107.17 165.23 11.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.258 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -57.85 -33.97 69.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -36.09 82.5 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 8.2 m-20 -65.71 -47.69 74.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.767 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.016 HD12 ' HB2' ' A' ' 139' ' ' ALA . 45.3 mm -52.9 -52.76 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.839 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -58.24 -44.81 88.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.42 86.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.054 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.821 ' CE3' HG22 ' A' ' 144' ' ' VAL . 77.6 t90 -57.92 -57.01 14.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.514 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.843 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.95 -33.14 62.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.975 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.39 -25.09 59.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.325 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 126.82 -28.42 4.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.561 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.463 179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m120 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.775 0.321 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -174.57 1.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.791 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.37 25.59 3.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.959 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.8 HG13 ' HB ' ' A' ' 146' ' ' ILE . 56.0 t -138.07 139.74 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.043 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.481 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.3 mp -129.99 111.97 22.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.62 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.532 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -170.02 152.54 4.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.098 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.537 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -57.41 160.02 7.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.877 179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.5 -25.81 80.1 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.557 2.171 . . . . 0.0 112.235 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.7 t -91.06 -29.2 17.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.771 HG11 HG12 ' A' ' 158' ' ' VAL . 66.0 t -68.02 -48.44 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.46 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.499 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 5.3 mtp180 -54.62 -29.13 51.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.912 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.64 -41.81 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.237 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.555 ' CD2' HG21 ' A' ' 163' ' ' ILE . 45.6 t80 -65.16 -48.13 74.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.98 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.058 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.77 -46.08 80.08 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.6 -31.81 57.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.362 178.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -84.42 -38.43 20.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.256 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.71 ' HB3' HD11 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.31 21.91 1.08 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.876 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.16 17.77 46.44 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.985 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.775 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.7 t -103.94 137.25 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 123.094 0.558 . . . . 0.0 110.851 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.456 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 10.4 t0 -116.08 127.43 54.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.8 ' HB ' HG13 ' A' ' 129' ' ' VAL . 28.0 mm -46.13 -26.84 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.812 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.579 ' HG3' HD23 ' A' ' 148' ' ' LEU . 0.1 OUTLIER -64.07 -37.33 87.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.917 0.389 . . . . 0.0 110.518 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.579 HD23 ' HG3' ' A' ' 147' ' ' ARG . 0.9 OUTLIER -82.98 -8.89 59.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.414 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.514 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.5 t -114.49 115.15 48.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.863 0.363 . . . . 0.0 111.499 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.5 109.97 6.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.668 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -71.89 130.99 17.75 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.676 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 26.19 9.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.708 0.289 . . . . 0.0 110.935 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -103.38 121.61 7.16 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.325 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 55.36 -84.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 153' ' ' GLY . 31.3 m-80 -109.19 35.72 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.045 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 84.63 26.04 40.16 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.598 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.481 ' HG3' HG22 ' A' ' 130' ' ' ILE . 31.2 ttm180 -80.97 147.0 30.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.727 0.299 . . . . 0.0 110.831 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.771 HG12 HG11 ' A' ' 135' ' ' VAL . 37.1 t -81.16 132.05 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.267 0.556 . . . . 0.0 111.331 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.0 mt -108.99 165.07 11.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.956 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.411 ' HD2' ' CG ' ' A' ' 138' ' ' TYR . 3.3 tptt -55.92 -32.08 63.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -64.65 -37.97 89.39 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -62.64 -49.74 73.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.61 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.058 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.4 mm -52.69 -52.26 28.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.582 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.47 -45.34 94.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.02 -37.13 81.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.844 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.775 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.9 t90 -58.3 -57.09 14.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.306 0.574 . . . . 0.0 110.21 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.71 HD11 ' HB3' ' A' ' 142' ' ' LYS . 9.1 mt -61.07 -31.9 71.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.865 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.44 -24.95 61.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 117.72 -28.1 7.22 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.493 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.395 -1.225 . . . . 0.0 112.448 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.829 0.347 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -103.67 147.03 27.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.36 142.1 39.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.494 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.3 t -100.88 158.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.978 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.567 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.4 mp -87.15 116.02 28.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.029 0.443 . . . . 0.0 111.145 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.697 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -167.53 148.07 5.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.043 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.504 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.1 mtm -63.02 148.72 92.05 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.751 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -51.49 -26.46 21.93 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.541 2.161 . . . . 0.0 112.402 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.2 t -90.3 -29.09 18.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 158' ' ' VAL . 99.3 t -70.73 -48.25 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.381 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.697 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 7.0 mtt85 -54.65 -29.21 51.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.965 0.412 . . . . 0.0 109.937 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.63 -44.32 28.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.191 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CD2' HG21 ' A' ' 163' ' ' ILE . 53.3 t80 -63.63 -48.01 79.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.921 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.047 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.24 -45.79 83.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.7 -31.82 58.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.299 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -84.4 -38.75 19.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.32 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.805 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.5 OUTLIER -84.3 28.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.917 -179.142 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.96 21.64 17.55 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.234 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.827 HG22 ' CE3' ' A' ' 166' ' ' TRP . 56.8 t -106.95 136.69 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 122.852 0.461 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 32.2 t0 -116.16 126.83 54.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.494 HG22 ' CG1' ' A' ' 129' ' ' VAL . 30.2 mm -46.55 -25.97 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.754 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.77 84.63 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.209 0.528 . . . . 0.0 110.585 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.535 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.26 -5.91 58.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.924 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.471 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.7 t -114.77 126.1 72.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.961 0.41 . . . . 0.0 111.397 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.87 105.7 17.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.801 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.81 139.71 23.21 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.707 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.1 26.04 9.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.9 140.44 14.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.863 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 51.49 -90.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.215 . . . . 0.0 111.4 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -114.16 25.7 10.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.757 0.313 . . . . 0.0 110.991 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.34 10.72 30.96 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.824 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.567 ' CB ' HG22 ' A' ' 130' ' ' ILE . 32.6 ttm180 -65.66 139.99 58.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.915 0.388 . . . . 0.0 110.72 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 135' ' ' VAL . 21.2 t -78.11 132.83 31.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.279 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.0 mt -104.4 165.09 11.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.208 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.03 -34.16 67.91 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.63 84.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.3 m-20 -64.75 -47.47 78.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.777 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.047 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.9 mm -52.89 -52.51 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.725 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -58.44 -41.66 85.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.04 85.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.827 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.1 t90 -59.85 -57.04 14.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.417 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.805 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -54.65 -32.44 59.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.983 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.09 -25.05 64.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.237 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 134.26 -53.47 0.79 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.483 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.368 -1.24 . . . . 0.0 112.556 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.851 0.358 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.11 -55.01 5.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.56 -175.22 1.93 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.727 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.487 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.1 t -94.19 157.08 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.926 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 157' ' ' ARG . 3.9 mp -88.95 114.67 27.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.064 0.459 . . . . 0.0 111.03 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 136' ' ' ARG . . . -169.41 146.28 3.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.035 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -57.82 160.03 8.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.851 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.11 -25.23 65.78 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.563 2.175 . . . . 0.0 112.319 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.02 -31.5 16.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.965 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.781 HG11 HG12 ' A' ' 158' ' ' VAL . 60.9 t -67.3 -46.58 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.25 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.464 ' HD2' ' HB3' ' A' ' 131' ' ' ALA . 4.6 mtp180 -54.71 -29.12 52.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.73 -43.98 29.21 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.194 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.501 ' CD2' HG21 ' A' ' 163' ' ' ILE . 47.7 t80 -63.95 -47.99 78.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.929 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.5 -46.94 77.72 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.79 58.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.235 178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.28 -38.14 20.81 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.312 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.744 ' HB3' HD11 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -83.35 19.07 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.766 -178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.36 14.89 55.84 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.161 -1.018 . . . . 0.0 112.039 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.837 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.8 t -100.11 138.29 24.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 122.98 0.512 . . . . 0.0 110.769 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.506 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 11.2 t70 -116.08 127.99 55.31 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.487 HG22 ' CG1' ' A' ' 129' ' ' VAL . 34.8 mm -47.52 -26.13 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.531 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.47 ' HG3' HG21 ' A' ' 129' ' ' VAL . 18.8 mtt85 -62.96 -36.2 82.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 110.575 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.533 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.12 -6.05 58.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.91 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.495 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.11 122.33 68.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.393 . . . . 0.0 111.365 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -85.66 115.32 23.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.69 136.7 16.94 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.2 26.01 9.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.823 0.344 . . . . 0.0 111.025 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.6 145.5 17.75 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.859 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt 48.97 -93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 122.194 0.198 . . . . 0.0 111.389 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -114.08 29.38 8.05 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.91 18.37 25.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.578 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.621 ' HA ' HG22 ' A' ' 130' ' ' ILE . 5.0 ttm180 -74.15 137.63 43.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.86 0.362 . . . . 0.0 110.753 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.781 HG12 HG11 ' A' ' 135' ' ' VAL . 21.0 t -74.23 135.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.133 0.492 . . . . 0.0 111.217 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.498 ' HA ' HG21 ' A' ' 135' ' ' VAL . 12.9 mt -108.31 166.76 10.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.317 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -58.23 -33.7 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.93 -35.25 80.05 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.7 m-20 -66.28 -47.45 73.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.784 178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.3 mm -52.8 -52.46 27.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.577 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.71 -44.82 90.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.32 -36.47 80.21 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.976 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.837 ' CE3' HG22 ' A' ' 144' ' ' VAL . 67.4 t90 -58.4 -56.99 14.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.579 . . . . 0.0 110.357 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.2 mt -59.99 -27.42 66.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.094 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -69.0 -25.04 64.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.257 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -88.42 -36.09 8.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.583 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.346 -1.252 . . . . 0.0 112.468 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.816 0.341 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.26 150.12 41.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -136.28 -172.74 3.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.851 HG13 ' HB ' ' A' ' 146' ' ' ILE . 77.0 t -102.26 135.58 38.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.551 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.5 mp -127.86 111.97 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.741 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.505 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -166.06 148.35 7.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.229 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.541 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -56.62 150.12 37.34 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.817 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.61 -26.94 13.68 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.607 2.204 . . . . 0.0 112.382 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.98 -29.4 17.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.025 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 87.0 t -68.93 -51.47 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.421 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.505 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -54.53 -29.62 51.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.884 -179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -77.66 -41.62 37.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.157 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.0 t80 -65.29 -48.17 74.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.995 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.45 -46.6 79.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -54.65 -31.67 57.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.489 178.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -84.41 -38.36 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.067 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.704 ' HB3' HD11 ' A' ' 167' ' ' LEU . 49.8 mmtt -83.95 22.62 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.05 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.48 16.46 36.29 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.293 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.818 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.3 t -101.23 137.89 27.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 122.962 0.505 . . . . 0.0 110.707 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 34.6 t0 -116.03 127.51 54.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.851 ' HB ' HG13 ' A' ' 129' ' ' VAL . 36.8 mm -47.2 -26.17 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.432 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -62.82 -37.0 85.03 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.171 0.51 . . . . 0.0 110.521 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.525 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.85 -6.63 58.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.846 179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.507 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -115.78 119.84 63.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.925 0.393 . . . . 0.0 111.527 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.63 101.82 10.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.547 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.432 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -79.39 145.45 27.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.864 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.32 25.96 9.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 0.0 110.744 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -86.93 110.1 3.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.076 -179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.27 -82.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.614 0.245 . . . . 0.0 111.491 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 153' ' ' GLY . 7.0 m-80 -104.2 29.16 6.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.766 0.317 . . . . 0.0 111.007 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.94 26.04 23.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.551 ' CB ' HG22 ' A' ' 130' ' ' ILE . 13.1 ttp-105 -75.78 139.52 41.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.832 ' CG2' HG23 ' A' ' 146' ' ' ILE . 47.4 t -74.21 131.99 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.29 0.567 . . . . 0.0 111.468 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 13.5 mt -106.29 163.47 12.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.751 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -55.7 -31.82 62.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.312 -0.555 . . . . 0.0 109.603 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -65.2 -38.0 89.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.262 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.7 m-20 -61.72 -49.9 74.6 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.729 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 33.6 mm -52.68 -54.78 14.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.789 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -56.68 -48.01 78.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.065 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.38 74.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.023 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.818 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.8 t90 -59.32 -57.01 14.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.198 0.523 . . . . 0.0 110.324 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.704 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.4 mt -60.46 -21.71 62.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.232 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.99 -24.97 64.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.142 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 152.36 -68.31 0.32 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.456 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.401 -1.221 . . . . 0.0 112.439 -179.989 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.894 0.378 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.5 108.73 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -106.18 52.31 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.482 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.8 t -132.2 158.02 43.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.5 mp -84.67 112.81 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.039 0.447 . . . . 0.0 111.088 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.468 ' HB2' HG21 ' A' ' 146' ' ' ILE . . . -165.54 154.58 12.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.089 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.5 ' HB2' HG23 ' A' ' 135' ' ' VAL . 6.7 mtp -71.37 149.85 93.98 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.757 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -51.41 -31.64 39.21 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.563 2.175 . . . . 0.0 112.53 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 60.3 p -85.18 -29.81 24.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.785 HG11 HG12 ' A' ' 158' ' ' VAL . 61.2 t -70.8 -46.86 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.531 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 4.9 mtp180 -54.77 -29.91 55.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.979 0.419 . . . . 0.0 109.946 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -77.77 -44.85 26.33 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.139 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.54 ' CD2' HG21 ' A' ' 163' ' ' ILE . 51.7 t80 -62.59 -48.21 80.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.004 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.92 -45.35 86.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.1 OUTLIER -54.62 -31.98 58.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.372 178.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.67 -38.08 20.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.173 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.799 ' O ' HD21 ' A' ' 167' ' ' LEU . 20.3 mmtp -84.18 26.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.909 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.9 21.48 16.66 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.181 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.836 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.8 t -106.17 137.49 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 122.926 0.491 . . . . 0.0 110.986 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.488 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 59.3 t0 -116.09 127.38 54.81 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.482 HG22 ' CG1' ' A' ' 129' ' ' VAL . 31.4 mm -47.01 -26.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.668 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -35.87 81.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.202 0.525 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.542 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -88.28 -5.75 58.17 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.925 179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.489 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -114.78 117.7 56.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 111.379 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.34 112.83 12.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.676 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -81.22 131.8 10.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.744 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.49 26.09 9.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.613 0.244 . . . . 0.0 110.93 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -102.61 124.69 8.26 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.461 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.46 -83.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 153' ' ' GLY . 9.0 p30 -113.13 30.62 7.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 91.64 26.03 21.34 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.56 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.598 ' HA ' HG22 ' A' ' 130' ' ' ILE . 43.5 ttm-85 -81.51 143.83 31.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.802 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.785 HG12 HG11 ' A' ' 135' ' ' VAL . 24.6 t -79.44 132.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.129 0.49 . . . . 0.0 111.322 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 16.3 mt -105.22 163.98 12.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.083 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.37 -33.22 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.25 -36.2 83.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -65.16 -47.26 77.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 139' ' ' ALA . 44.4 mm -52.81 -51.67 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.782 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -58.86 -45.4 90.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.865 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.95 -35.78 75.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.836 ' CE3' HG22 ' A' ' 144' ' ' VAL . 64.7 t90 -60.79 -57.05 14.31 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.142 0.496 . . . . 0.0 110.437 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.799 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.7 mt -55.69 -33.4 64.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.957 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.72 -24.97 59.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.198 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -80.65 -32.54 33.31 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.496 179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.75 0.309 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -123.83 127.49 48.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -174.12 0.88 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.487 ' CG1' HG22 ' A' ' 146' ' ' ILE . 2.3 t -98.32 157.65 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 157' ' ' ARG . 4.4 mp -85.34 112.42 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.085 0.469 . . . . 0.0 111.04 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -166.26 147.42 6.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.082 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.479 ' HB2' HG23 ' A' ' 135' ' ' VAL . 0.6 OUTLIER -62.89 148.49 91.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.32 -26.47 27.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 p -89.34 -34.94 16.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.945 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.69 HG11 HG12 ' A' ' 158' ' ' VAL . 99.3 t -66.02 -46.76 87.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.651 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 8.9 mtp-105 -54.71 -29.16 52.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.88 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -77.65 -42.99 32.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.301 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' ' HB ' ' A' ' 163' ' ' ILE . 48.8 t80 -64.52 -48.18 76.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.886 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.027 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -64.95 -46.39 81.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.68 -31.76 58.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.413 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -84.46 -37.68 21.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.075 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.731 ' HB3' HD11 ' A' ' 167' ' ' LEU . 47.9 mmtt -84.64 22.9 1.23 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.832 -179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.72 16.62 31.3 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.317 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.4 t -101.1 137.73 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 122.761 0.424 . . . . 0.0 110.652 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.513 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.6 t0 -116.08 127.25 54.71 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.487 HG22 ' CG1' ' A' ' 129' ' ' VAL . 32.7 mm -46.85 -26.38 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.507 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -62.87 -37.44 86.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.194 0.521 . . . . 0.0 110.527 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.537 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -86.51 -6.73 58.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.851 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.509 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.8 t -114.7 126.15 72.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.954 0.406 . . . . 0.0 111.546 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -91.92 103.96 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.509 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -76.49 143.79 29.72 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.814 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.15 26.03 9.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.307 . . . . 0.0 110.864 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.37 140.82 15.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.731 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.98 -91.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.541 0.21 . . . . 0.0 111.385 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -114.13 26.21 10.48 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.743 0.306 . . . . 0.0 111.117 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.2 6.83 33.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.818 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.609 ' HA ' HG22 ' A' ' 130' ' ' ILE . 0.9 OUTLIER -60.93 139.75 57.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.805 0.336 . . . . 0.0 110.806 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.69 HG12 HG11 ' A' ' 135' ' ' VAL . 25.2 t -79.76 131.93 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.127 0.489 . . . . 0.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.563 ' HA ' HG21 ' A' ' 135' ' ' VAL . 13.5 mt -104.43 167.16 9.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.306 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.451 ' HE2' ' CG ' ' A' ' 138' ' ' TYR . 1.3 ttmt -57.54 -35.7 70.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -62.44 -35.5 79.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.212 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.2 m-20 -66.61 -47.94 71.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.027 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.2 mm -52.92 -53.58 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.543 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.41 -39.86 80.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -65.24 -37.32 86.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.903 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 69.1 t90 -57.64 -57.03 14.52 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.294 0.569 . . . . 0.0 110.274 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.731 HD11 ' HB3' ' A' ' 142' ' ' LYS . 11.1 mt -59.23 -30.91 68.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.976 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.98 63.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.211 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -120.37 30.56 5.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.558 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.565 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.861 0.363 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.98 34.15 19.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.946 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.34 -40.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.733 HG13 ' HB ' ' A' ' 146' ' ' ILE . 46.0 t -64.93 133.98 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.021 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.507 HG22 ' HG3' ' A' ' 157' ' ' ARG . 4.7 mp -116.49 111.87 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.711 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.439 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.25 155.47 5.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.244 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.56 ' HB2' HG23 ' A' ' 135' ' ' VAL . 1.6 mtp -61.65 157.0 51.06 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.397 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.99 -25.43 77.62 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.483 2.122 . . . . 0.0 112.248 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -29.43 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.285 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.758 HG11 HG12 ' A' ' 158' ' ' VAL . 45.6 t -69.3 -46.91 76.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.773 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.502 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 8.1 mtp180 -54.56 -30.72 54.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -77.62 -40.97 40.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.281 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.51 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.5 t80 -64.66 -48.15 75.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.883 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.036 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.7 -45.5 82.53 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.65 -31.8 58.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.465 178.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.73 -38.33 19.83 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.715 ' O ' HD21 ' A' ' 167' ' ' LEU . 50.0 mmtt -83.32 27.41 0.59 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.03 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.92 21.77 17.7 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.075 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.809 HG22 ' CE3' ' A' ' 166' ' ' TRP . 58.8 t -107.94 137.14 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 122.935 0.494 . . . . 0.0 111.134 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 53.4 t0 -116.07 126.52 53.87 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.733 ' HB ' HG13 ' A' ' 129' ' ' VAL . 37.5 mm -46.95 -25.77 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.606 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -62.56 -37.56 86.64 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.0 110.439 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.52 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -85.68 -7.87 58.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.795 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.599 HG22 ' CG ' ' A' ' 166' ' ' TRP . 2.5 t -115.04 115.71 50.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.414 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 108.3 7.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.636 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -70.66 134.78 24.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.803 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.21 26.0 9.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.775 0.321 . . . . 0.0 110.801 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -89.7 101.17 2.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.863 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt 57.36 -84.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.605 0.24 . . . . 0.0 111.33 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -89.13 9.58 25.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.49 26.01 7.91 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.691 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.507 ' HG3' HG22 ' A' ' 130' ' ' ILE . 28.8 ttm180 -79.04 145.46 33.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.868 0.366 . . . . 0.0 110.796 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.758 HG12 HG11 ' A' ' 135' ' ' VAL . 17.3 t -80.14 126.48 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.222 0.534 . . . . 0.0 111.227 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 20.3 mt -105.11 164.66 11.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.185 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -56.05 -33.03 64.6 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -64.8 -37.2 86.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 4.9 m-20 -63.2 -48.91 76.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.759 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.036 HD12 ' HB2' ' A' ' 139' ' ' ALA . 39.8 mm -52.71 -53.55 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.715 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -57.61 -41.91 82.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.78 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.25 83.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.809 ' CE3' HG22 ' A' ' 144' ' ' VAL . 70.4 t90 -60.12 -56.96 15.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.334 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.715 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.3 mt -54.83 -32.77 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.046 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -99.13 26.24 6.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 55.87 81.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.594 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.322 -1.266 . . . . 0.0 112.562 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.785 0.326 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -129.79 133.54 47.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.822 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -66.97 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.51 ' CG1' HG22 ' A' ' 146' ' ' ILE . 4.1 t -135.54 158.22 39.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.914 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 157' ' ' ARG . 3.3 mp -79.99 111.94 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.092 0.472 . . . . 0.0 111.099 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' A' ' 157' ' ' ARG . . . -170.08 147.73 3.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.994 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.487 ' HB2' HG23 ' A' ' 135' ' ' VAL . 8.3 mtp -59.13 159.96 13.16 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.681 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.64 -25.52 69.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.499 2.132 . . . . 0.0 112.348 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.3 t -90.97 -33.3 15.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.14 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.651 HG11 HG12 ' A' ' 158' ' ' VAL . 46.4 t -66.32 -44.68 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.361 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 61.3 mtp85 -54.76 -29.95 55.3 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 26.7 tptt -77.66 -42.43 34.72 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.156 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.6 t80 -64.21 -47.96 77.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.976 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.023 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.0 -45.68 80.71 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.67 -31.88 58.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.26 178.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -84.62 -38.73 19.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.834 ' O ' HD21 ' A' ' 167' ' ' LEU . 0.0 OUTLIER -82.99 27.24 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.85 -178.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.44 19.94 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.25 -0.976 . . . . 0.0 111.913 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.833 HG22 ' CE3' ' A' ' 166' ' ' TRP . 57.6 t -108.39 138.01 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 0.0 110.997 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 9.9 t70 -116.16 127.02 54.46 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.51 HG22 ' CG1' ' A' ' 129' ' ' VAL . 38.0 mm -46.65 -26.14 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.667 0.27 . . . . 0.0 111.626 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 mtt85 -63.03 -37.09 85.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.26 0.553 . . . . 0.0 110.64 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.53 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.9 -5.32 59.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.958 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.8 t -115.49 118.97 60.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.872 0.367 . . . . 0.0 111.496 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -76.51 116.31 17.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.52 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 158' ' ' VAL . . . -82.05 131.65 10.55 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.048 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.29 25.96 9.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.663 0.268 . . . . 0.0 110.732 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.12 118.63 6.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.074 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.68 -87.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.631 0.253 . . . . 0.0 111.52 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -99.07 28.14 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.726 0.298 . . . . 0.0 111.04 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.17 26.13 34.86 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.737 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 130' ' ' ILE . 22.4 ttm180 -78.88 143.55 35.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 0.0 110.741 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.651 HG12 HG11 ' A' ' 135' ' ' VAL . 18.0 t -77.79 129.93 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.234 0.54 . . . . 0.0 111.334 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.468 ' HA ' HG21 ' A' ' 135' ' ' VAL . 16.5 mt -105.44 166.47 10.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.361 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -57.65 -33.69 68.57 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.18 -35.86 82.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.0 m-20 -65.67 -47.58 75.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.823 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.023 HD12 ' HB2' ' A' ' 139' ' ' ALA . 42.0 mm -52.88 -52.27 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.799 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -57.77 -46.3 84.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.83 72.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.018 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.833 ' CE3' HG22 ' A' ' 144' ' ' VAL . 62.9 t90 -61.55 -57.13 13.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.377 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.834 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.6 mt -56.44 -34.67 67.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.945 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.1 -25.1 40.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -97.96 41.27 2.31 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.499 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.466 -179.929 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.3 p30 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.843 0.354 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.86 169.63 8.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.809 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.14 114.24 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.744 HG13 ' HB ' ' A' ' 146' ' ' ILE . 28.1 t -122.94 135.86 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.056 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 157' ' ' ARG . 3.3 mt -129.56 114.01 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.449 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.479 ' HB2' HD12 ' A' ' 146' ' ' ILE . . . -165.94 149.9 7.94 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.261 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.517 ' HB2' HG23 ' A' ' 135' ' ' VAL . 2.6 mtt -59.9 148.78 75.68 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.69 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -50.96 -25.22 15.53 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.474 2.116 . . . . 0.0 112.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.2 p -90.97 -34.73 15.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.053 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.676 HG11 HG12 ' A' ' 158' ' ' VAL . 54.8 t -65.19 -44.91 95.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.322 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 22.3 mtp85 -54.67 -30.1 54.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.82 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.71 -41.32 38.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.266 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.512 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.2 t80 -65.09 -48.06 75.04 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.927 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.012 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.73 -46.12 80.09 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -54.69 -31.7 58.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.346 178.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -84.61 -38.76 19.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.279 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.814 ' O ' HD21 ' A' ' 167' ' ' LEU . 16.5 mmtp -84.16 28.17 0.63 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.988 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.02 21.22 16.68 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.223 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.818 HG22 ' CE3' ' A' ' 166' ' ' TRP . 52.9 t -106.83 137.1 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 122.975 0.51 . . . . 0.0 110.969 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.493 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 24.6 t0 -116.03 126.18 53.46 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.744 ' HB ' HG13 ' A' ' 129' ' ' VAL . 28.1 mm -46.59 -25.51 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -62.98 -37.07 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.226 0.536 . . . . 0.0 110.465 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.545 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.73 -5.8 59.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.874 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.452 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.6 t -114.8 124.5 71.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.934 0.397 . . . . 0.0 111.296 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.33 103.64 15.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.462 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -81.51 140.42 21.13 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.847 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.25 26.05 9.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.282 . . . . 0.0 110.925 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.61 120.03 6.03 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.087 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt 57.73 -86.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.549 0.214 . . . . 0.0 111.469 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -110.65 37.04 2.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.749 0.309 . . . . 0.0 111.126 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 86.96 26.09 32.55 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.635 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.584 ' CB ' HG22 ' A' ' 130' ' ' ILE . 29.0 ttm180 -80.45 142.37 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.729 HG21 HG23 ' A' ' 146' ' ' ILE . 43.5 t -76.97 132.65 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.567 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.5 mt -106.96 163.53 12.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.739 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.426 ' HE2' ' CE1' ' A' ' 138' ' ' TYR . 9.1 tttm -56.18 -32.13 64.06 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.438 -0.505 . . . . 0.0 109.744 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.83 85.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 6.5 m-20 -64.43 -49.21 72.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.882 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.012 HD12 ' HB2' ' A' ' 139' ' ' ALA . 40.1 mm -52.53 -51.78 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.88 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -58.46 -47.15 84.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.997 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.6 -34.91 71.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.088 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.818 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.4 t90 -61.71 -57.12 13.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 0.0 110.491 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.814 HD21 ' O ' ' A' ' 142' ' ' LYS . 2.5 mt -55.61 -23.91 30.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.263 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.65 31.08 1.63 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.608 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.87 -53.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.574 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.358 -1.245 . . . . 0.0 112.535 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.827 0.346 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.25 38.48 1.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.78 118.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.817 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.771 HG13 ' HB ' ' A' ' 146' ' ' ILE . 40.1 t -123.76 139.76 49.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.514 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp -130.03 111.94 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.431 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.717 ' HB3' ' HG3' ' A' ' 136' ' ' ARG . . . -162.83 154.65 18.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.413 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.506 ' HB2' HG23 ' A' ' 135' ' ' VAL . 4.4 mtp -65.82 160.02 65.05 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.88 -26.42 82.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.51 2.14 . . . . 0.0 112.186 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -91.04 -31.92 16.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.069 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.688 HG11 HG12 ' A' ' 158' ' ' VAL . 45.2 t -70.17 -46.63 71.48 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.414 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.717 ' HG3' ' HB3' ' A' ' 131' ' ' ALA . 4.8 mtt180 -54.56 -31.94 57.49 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -77.7 -39.94 43.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.462 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.523 ' CD2' HG21 ' A' ' 163' ' ' ILE . 44.8 t80 -65.89 -48.17 72.39 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.052 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.025 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -66.32 -46.29 77.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 7.1 tpp85 -54.6 -31.79 57.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.318 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.49 -38.44 20.1 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.68 ' HB3' HD11 ' A' ' 167' ' ' LEU . 17.4 mmtp -84.25 27.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 54.92 19.38 14.52 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.307 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.765 HG22 ' CE3' ' A' ' 166' ' ' TRP . 60.9 t -104.99 136.71 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 122.954 0.502 . . . . 0.0 110.59 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.428 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 14.7 t0 -116.04 126.54 53.93 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.773 HG23 ' CG2' ' A' ' 158' ' ' VAL . 34.6 mm -45.44 -26.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -64.94 -35.31 80.75 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.565 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.45 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.9 OUTLIER -84.53 -8.17 59.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.405 178.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.45 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.2 t -114.83 120.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.503 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -81.94 105.55 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.402 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -82.88 141.42 20.91 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.99 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.19 26.02 9.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.777 0.323 . . . . 0.0 110.779 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 155' ' ' ASN . . . -89.22 111.41 3.83 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.847 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt 54.84 -85.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.523 0.201 . . . . 0.0 111.483 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 153' ' ' GLY . 67.6 m-80 -100.39 36.97 1.76 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.898 0.38 . . . . 0.0 111.066 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 78.79 25.98 59.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.568 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.514 ' CB ' HG22 ' A' ' 130' ' ' ILE . 22.5 ttm180 -78.17 141.71 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.852 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.773 ' CG2' HG23 ' A' ' 146' ' ' ILE . 42.0 t -75.25 133.06 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.211 0.529 . . . . 0.0 111.332 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.0 mt -107.24 164.51 12.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.856 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' HE3' ' CD1' ' A' ' 138' ' ' TYR . 0.5 OUTLIER -55.8 -32.1 63.22 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.01 -37.65 88.33 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.456 ' CB ' HG13 ' A' ' 158' ' ' VAL . 4.6 m-20 -62.62 -49.91 73.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.761 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.025 HD12 ' HB2' ' A' ' 139' ' ' ALA . 32.5 mm -52.79 -53.2 22.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.598 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.43 -47.94 82.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.808 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.17 73.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.765 ' CE3' HG22 ' A' ' 144' ' ' VAL . 65.2 t90 -59.81 -56.68 18.72 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.242 0.544 . . . . 0.0 110.239 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.68 HD11 ' HB3' ' A' ' 142' ' ' LYS . 9.3 mt -62.32 -31.04 71.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.953 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.86 -25.08 58.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.209 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -144.69 55.94 0.55 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.536 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.545 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.816 0.341 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -91.14 -25.85 19.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 64.72 -169.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.5 ' CG1' HG22 ' A' ' 146' ' ' ILE . 1.7 t -128.09 157.82 40.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.089 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.54 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.3 mp -90.71 116.69 32.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.017 0.437 . . . . 0.0 111.155 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -169.51 144.01 2.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.088 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.2 mtp -58.95 147.65 72.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.24 -25.91 25.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.49 2.126 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.1 p -87.78 -36.75 17.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.647 HG11 HG12 ' A' ' 158' ' ' VAL . 48.0 t -67.07 -45.68 86.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.34 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.603 ' HG2' ' HB3' ' A' ' 131' ' ' ALA . 59.6 mtm180 -54.74 -29.96 55.12 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -41.16 38.62 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.201 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CD2' HG21 ' A' ' 163' ' ' ILE . 48.8 t80 -65.19 -48.16 74.42 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.836 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.46 -46.29 80.43 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 4.2 tpt85 -54.63 -31.63 57.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.29 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.47 -38.09 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.664 ' HB3' HD11 ' A' ' 167' ' ' LEU . 19.2 mmtp -84.09 22.86 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.937 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.32 16.53 35.32 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.224 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.828 HG22 ' CE3' ' A' ' 166' ' ' TRP . 61.7 t -101.31 137.99 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 123.041 0.536 . . . . 0.0 110.606 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.494 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 12.7 t0 -116.04 126.02 53.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.5 HG22 ' CG1' ' A' ' 129' ' ' VAL . 33.7 mm -45.69 -26.37 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.803 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -62.94 -37.31 86.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.277 0.56 . . . . 0.0 110.58 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.536 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -86.16 -6.01 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.884 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.438 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.5 t -114.4 123.47 70.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.332 -179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -86.13 106.34 17.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.534 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 157' ' ' ARG . . . -77.39 136.86 19.43 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.826 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.15 26.05 9.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.669 0.271 . . . . 0.0 111.065 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.34 137.96 13.86 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.967 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 53.1 -90.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.594 0.235 . . . . 0.0 111.472 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -114.05 28.56 8.66 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.776 0.322 . . . . 0.0 111.061 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.88 13.93 35.7 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.683 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.54 ' CB ' HG22 ' A' ' 130' ' ' ILE . 7.5 ttm180 -69.87 140.32 53.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.662 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.647 HG12 HG11 ' A' ' 135' ' ' VAL . 15.0 t -77.35 131.38 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.544 ' HA ' HG21 ' A' ' 135' ' ' VAL . 13.2 mt -104.54 167.77 9.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.468 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.15 -34.93 70.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -63.58 -34.62 78.22 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.267 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 5.6 m-20 -67.04 -47.29 71.82 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.756 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 139' ' ' ALA . 43.6 mm -52.87 -52.52 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.622 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.48 -44.46 89.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -60.11 -34.88 74.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.898 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.828 ' CE3' HG22 ' A' ' 144' ' ' VAL . 56.5 t90 -61.22 -56.26 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.24 0.543 . . . . 0.0 110.172 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 142' ' ' LYS . 4.6 mt -60.75 -34.38 74.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.849 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.65 -23.6 61.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.274 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -52.31 -25.25 18.71 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.7 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.085 0 CA-C-O 118.36 -1.245 . . . . 0.0 112.472 179.953 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.3 p30 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.789 0.328 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 56.88 -179.66 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.908 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -124.71 49.52 1.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.793 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.868 HG13 ' HB ' ' A' ' 146' ' ' ILE . 77.4 t -137.02 135.99 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.063 0.459 . . . . 0.0 111.355 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.513 HG22 ' CB ' ' A' ' 157' ' ' ARG . 4.6 mp -129.99 111.95 22.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.471 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.461 ' HB2' ' HB ' ' A' ' 158' ' ' VAL . . . -167.33 154.7 8.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.24 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.508 ' HB2' HG23 ' A' ' 135' ' ' VAL . 3.9 mtp -60.41 155.12 50.11 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.26 -27.39 56.8 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.656 2.237 . . . . 0.0 112.525 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.8 t -91.03 -27.29 18.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.347 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.776 HG11 HG12 ' A' ' 158' ' ' VAL . 57.6 t -69.89 -47.47 69.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.465 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 74.7 mtm180 -54.65 -30.25 54.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -42.59 33.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.263 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.574 ' CD2' HG21 ' A' ' 163' ' ' ILE . 50.2 t80 -64.42 -48.2 76.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.006 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 1.022 ' HB2' HD12 ' A' ' 163' ' ' ILE . . . -65.64 -45.98 80.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 136' ' ' ARG . 2.4 tpt180 -54.7 -31.77 58.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.335 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -84.63 -38.71 19.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.14 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.809 ' O ' HD21 ' A' ' 167' ' ' LEU . 45.4 mmtt -83.29 27.78 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.048 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.95 22.02 18.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.057 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.82 HG22 ' CE3' ' A' ' 166' ' ' TRP . 53.3 t -108.12 136.61 43.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 122.921 0.489 . . . . 0.0 110.964 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.454 ' HB3' ' HG ' ' A' ' 148' ' ' LEU . 30.5 t0 -116.18 126.49 53.73 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.868 ' HB ' HG13 ' A' ' 129' ' ' VAL . 29.7 mm -45.93 -26.18 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.803 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -62.39 -36.49 82.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.267 0.556 . . . . 0.0 110.524 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.533 HD12 ' CZ2' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -87.84 -6.8 57.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.834 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.46 HG21 ' CG1' ' A' ' 144' ' ' VAL . 2.4 t -113.67 114.73 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.867 0.365 . . . . 0.0 111.311 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.04 100.45 7.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.526 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 158' ' ' VAL . . . -76.23 141.99 27.69 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.68 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.28 26.08 9.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 110.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -91.99 118.68 5.56 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.325 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.73 -81.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -114.15 28.75 8.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.838 0.351 . . . . 0.0 110.98 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 151' ' ' GLY . . . 95.85 22.13 21.61 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.62 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.513 ' CB ' HG22 ' A' ' 130' ' ' ILE . 39.3 ttm180 -76.5 140.99 41.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 110.573 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.776 HG12 HG11 ' A' ' 135' ' ' VAL . 40.6 t -74.02 137.99 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.375 0.607 . . . . 0.0 111.539 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 11.6 mt -113.66 163.08 15.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.638 178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.75 -32.52 63.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.809 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -64.28 -36.37 83.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 159' ' ' LEU . 7.4 m-20 -64.39 -49.33 72.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.859 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.022 HD12 ' HB2' ' A' ' 139' ' ' ALA . 35.5 mm -52.68 -54.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.003 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -57.16 -47.14 81.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.983 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.72 -35.74 75.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.149 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.82 ' CE3' HG22 ' A' ' 144' ' ' VAL . 63.8 t90 -60.99 -57.0 14.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.584 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.809 HD21 ' O ' ' A' ' 142' ' ' LYS . 1.5 mt -55.18 -32.27 62.05 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.985 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.35 -25.03 61.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.194 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.29 69.94 0.74 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.414 -1.215 . . . . 0.0 112.51 179.956 . . . . . . . . 0 0 . 1 stop_ save_